 EXHIBIT 2.1 INTEREST PURCHASE
AGREEMENT    \t \t 





INTEREST PURCHASE AGREEMENT

by and among

CATALENT PHARMA SOLUTIONS, INC.,

COOK PHARMICA LLC,



COOK GROUP INCORPORATED



and

solely for purposes of Section 7.19, Catalent, Inc.



Dated: September 18, 2017









 TABLE OF CONTENTS 

--- 
| | | | 

Article I. Definitions and Rules of Construction

|

1

|


 

|

Section 1.1

|

Definitions

|

1

|


 

|

Section 1.2

|

Rules of Construction

|

18

|


 

Article II. Closing

|

19

|


 

|

Section 2.1

|

Closing

|

19

|


 

Article III. Purchase and Sale of Company Interests

|

19

|


 

|

Section 3.1

|

Purchase and Sale of Company Interests

|

19

|


 

|

Section 3.2

|

Purchase Price; Payments at the Closing

|

19

|


 

|

Section 3.3

|

Post-Closing Purchase Price Determination

|

20

|


 

|

Section 3.4

|

Post-Closing Purchase Price Adjustment

|

22

|


 

|

Section 3.5

|

Escrowed Portion of the Purchase Price; Subsequent Payment Amount

|

23

|


 

Article IV. Representations and Warranties of Seller

|

24

|


 

|

Section 4.1

|

Organization and Power

|

24

|


 

|

Section 4.2

|

Authorization and Enforceability

|

24

|


 

|

Section 4.3

|

No Violation

|

25

|


 

|

Section 4.4

|

Governmental Authorizations and Consents

|

25

|


 

|

Section 4.5

|

Litigation

|

25

|


 

|

Section 4.6

|

No Brokers

|

25

|


 

Article V. Representations and Warranties of Seller Relating to the Company

|

26

|


 

|

Section 5.1

|

Organization and Power

|

26

|


 

|

Section 5.2

|

Authorization and Enforceability

|

26

|


 

|

Section 5.3

|

Capitalization of the Company; No Subsidiaries

|

27

|


 

|

Section 5.4

|

No Violation

|

27

|


 

|

Section 5.5

|

Governmental Authorizations and Consents

|

27

|


 

|

Section 5.6

|

Financial Statements

|

28

|


 

|

Section 5.7

|

Business Records

|

28

|


 

|

Section 5.8

|

No Undisclosed Liabilities

|

29

|


 

|

Section 5.9

|

Absence of Certain Change

|

29

|


 

|

Section 5.10

|

Arrangements with Affiliates

|

29

|


 

|

Section 5.11

|

Indebtedness to and from Officers and Directors of the Company

|

29

|


 

|

Section 5.12

|

Assets

|

30

|


 

|

Section 5.13

|

Real Property

|

30

|


 

|

Section 5.14

|

Intellectual Property

|

31

|


 

|

Section 5.15

|

Contracts

|

32

|


 

|

Section 5.16

|

Compliance with Laws

|

34

|


 

|

Section 5.17

|

Regulatory Matters

|

36

|


 

|

Section 5.18

|

Environmental Matters

|

37

|


 

|

Section 5.19

|

Litigation

|

38

|


 

|

Section 5.20

|

Employee and Labor Matters

|

38

|


 

|

Section 5.21

|

Employee Benefits

|

39

|


 

|

Section 5.22

|

Tax Matters

|

41

|


 

|

Section 5.23

|

Insurance

|

43

|


 

|

Section 5.24

|

Bank Accounts; Powers of Attorney

|

43

|


 

--- 
| | | | 

|

Section 5.25

|

Customers and Suppliers

|

43

|


 

|

Section 5.26

|

No Brokers

|

44

|


 

|

Section 5.27

|

Product Warranties; Product Liabilities

|

44

|


 

|

Section 5.28

|

Accounts Receivable

|

44

|


 

|

Section 5.29

|

Limitation of Seller's Warranties

|

44

|


 

|

Section 5.30

|

No Implied Representation

|

45

|


 

Article VI. Representations and Warranties of Buyer

|

45

|


 

|

Section 6.1

|

Organization and Power

|

45

|


 

|

Section 6.2

|

Authorization

|

45

|


 

|

Section 6.3

|

Enforceability

|

45

|


 

|

Section 6.4

|

No Violation

|

45

|


 

|

Section 6.5

|

Litigation

|

46

|


 

|

Section 6.6

|

Governmental Authorizations and Consents

|

46

|


 

|

Section 6.7

|

Financial Capacity

|

46

|


 

Article VII. Covenants

|

47

|


 

|

Section 7.1

|

Conduct of the Company

|

47

|


 

|

Section 7.2

|

Certain Tax Matters

|

50

|


 

|

Section 7.3

|

Access to Information Prior to the Closing

|

53

|


 

|

Section 7.4

|

Confidentiality

|

53

|


 

|

Section 7.5

|

Public Announcements

|

55

|


 

|

Section 7.6

|

Releases

|

55

|


 

|

Section 7.7

|

Employee Matters

|

56

|


 

|

Section 7.8

|

Affiliate Arrangements

|

59

|


 

|

Section 7.9

|

Reasonable Best Efforts

|

59

|


 

|

Section 7.10

|

Non-Competition and Employee Non-Solicit

|

61

|


 

|

Section 7.11

|

No Solicitation

|

62

|


 

|

Section 7.12

|

Termination of Guarantees of Indebtedness

|

62

|


 

|

Section 7.13

|

Cooperation; Financial Information

|

63

|


 

|

Section 7.14

|

Title Matters

|

67

|


 

|

Section 7.15

|

Insurance

|

67

|


 

|

Section 7.16

|

Use of Seller Retained Names

|

67

|


 

|

Section 7.17

|

280G Shareholder Vote

|

68

|


 

|

Section 7.18

|

Discretionary Bonuses

|

68

|


 

|

Section 7.19

|

Performance

|

68

|


 

Article VIII. Closing; Conditions to Closing

|

69

|


 

|

Section 8.1

|

Deliveries by Seller and the Company

|

69

|


 

|

Section 8.2

|

Deliveries by Buyer

|

70

|


 

|

Section 8.3

|

Conditions to Seller's Obligations

|

70

|


 

|

Section 8.4

|

Conditions to Buyer's Obligations

|

71

|


 

Article IX. Survival; Indemnification

|

72

|


 

|

Section 9.1

|

Survival of Representations and Warranties

|

72

|


 

|

Section 9.2

|

Indemnification by Seller

|

73

|


 

|

Section 9.3

|

Limitations on Indemnification Obligations

|

73

|


 

|

Section 9.4

|

Procedure with Respect to Direct Claims

|

73

|


 

|

Section 9.5

|

Procedure with Respect to Third Party Claims

|

74

|


 

|

Section 9.6

|

Tax Matters

|

75

|


 

--- 
| | | | 

|

Section 9.7

|

Calculation of Losses

|

76

|


 

|

Section 9.8

|

RandW Insurance Policy

|

76

|


 

Article X. Termination

|

76

|


 

|

Section 10.1

|

Termination

|

76

|


 

|

Section 10.2

|

Procedure Upon Termination

|

77

|


 

|

Section 10.3

|

Effect of Termination

|

78

|


 

|

Section 10.4

|

Termination Fee

|

78

|


 

|

Section 10.5

|

Exclusive Remedy

|

79

|


 

Article XI. Miscellaneous

|

80

|


 

|

Section 11.1

|

Expenses

|

80

|


 

|

Section 11.2

|

Notices

|

80

|


 

|

Section 11.3

|

Governing Law

|

81

|


 

|

Section 11.4

|

Entire Agreement

|

81

|


 

|

Section 11.5

|

Severability

|

81

|


 

|

Section 11.6

|

Amendment

|

82

|


 

|

Section 11.7

|

Effect of Waiver or Consent

|

82

|


 

|

Section 11.8

|

Parties in Interest; Limitation on Rights of Others

|

82

|


 

|

Section 11.9

|

Assignability

|

82

|


 

|

Section 11.10

|

Jurisdiction; Court Proceedings; Waiver of Jury Trial

|

83

|


 

|

Section 11.11

|

Remedies

|

83

|


 

|

Section 11.12

|

Counterparts

|

84

|


 

|

Section 11.13

|

Further Assurance

|

84

|


 

|

Section 11.14

|

No Recourse to Financing Sources

|

85

|


 

|

Section 11.15

|

Legal Representation

|

85

|


 

 

Exhibits



Exhibit A Illustrative Calculation of Closing Date Working Capital

Exhibit B Form of Escrow Agreement

Exhibit C Form of Title Affidavit

Exhibit D Form of IVF Media Supply Agreement

Exhibit E Form of Transition Services Agreement

Schedules

Schedule I Company Disclosure Schedules





INTEREST PURCHASE AGREEMENT

This INTEREST PURCHASE AGREEMENT (this "Agreement"), is dated as of September
18, 2017, and is by and among Catalent Pharma Solutions, Inc., a corporation
incorporated under the Laws of Delaware ("Buyer"), Cook Group Incorporated, a
corporation incorporated under the Laws of Indiana ("Seller"), Cook Pharmica
LLC, a limited liability company organized under the Laws of Indiana (the
"Company") and, solely for purposes of Section 7.19, Catalent, Inc., a
corporation incorporated under the Laws of Delaware.

RECITALS

WHEREAS, Seller owns, and immediately prior to the Closing will own, one
hundred percent (100%) of the rights and interests in the Company in its
capacity as a member (the "Company Interests");

WHEREAS, at the Closing, Buyer desires to purchase from Seller, and Seller
desires to sell to Buyer, all right, title and interest in and to, the Company
Interests, upon the terms and subject to the conditions hereinafter set forth;
and

WHEREAS, as of the Closing, Seller will be the only holder and owner of the
Company Interests, and the Company Interests will represent one hundred
percent (100%) of the issued and outstanding Equity Securities of the Company.

NOW THEREFORE, in consideration of the premises and the representations,
warranties, covenants and agreements contained in this Agreement, and
intending to be legally bound hereby, the parties agree as follows:

ARTICLE I.

Definitions and Rules of Construction

Section 1.1 Definitions. As used in this Agreement, the following terms have
the meanings set forth below:

"Accounting Arbitrator" has the meaning set forth in Section 3.3(c).

"Adjustment Escrow Account" has the meaning set forth in Section 3.5(a).

"Adjustment Escrow Amount" has the meaning set forth in Section 3.5(a).

"Affiliate" means, as to any Person, any other Person that, directly or
indirectly, is in control of, is controlled by, or is under common control
with, such Person, and includes any Person in like relation to an Affiliate.
For purposes of this definition, "control" of a Person means the power,
directly or indirectly, either to (a) vote ten percent (10%) or more of the
securities having ordinary voting power for the election of directors of such
Person or (b) direct or cause the direction of the management and policies of
such Person, whether by contract or otherwise. For purposes of 

this Agreement, the Company shall be deemed to be an Affiliate of Seller prior
to the Closing and an Affiliate of Buyer from and after the Closing.



"Affiliate Arrangements" has the meaning set forth in Section 5.10.

"Affordable Care Act" has the meaning set forth in Section 5.21(c).

"Agreement" has the meaning set forth in the Preamble.

"Alternate Financing" has the meaning set forth in Section 7.13(a).

"Ancillary Documents" means the Escrow Agreement, the Transition Services
Agreement, the IVF Media Supply Agreement and all other agreements, documents
and instruments being executed and delivered in connection with this
Agreement.

"Anti-Corruption Laws" has the meaning set forth in Section 5.16(b).

"Base Purchase Price" has the meaning set forth in Section 3.2(a).

"Business" means the business conducted by the Company prior to the date
hereof.

"Business Day" means any day other than a Saturday, Sunday or day on which
banks are closed in either New York, New York or Bloomington, Indiana.

"Business Records" means all data and records of the Business on whatever
media and wherever located, regardless of the Person or Persons having
possession, custody or control of such data and records.

"Buyer" has the meaning set forth in the Preamble.

"Buyer 401(k) Plan" has the meaning set forth in Section 7.7(c).

"Buyer Indemnitees" has the meaning set forth in Section 9.2.

"Buyer Plan" has the meaning set forth in Section 7.7(b).

"Cafeteria Plan" has the meaning set forth in Section 7.7(b).

"Chosen Courts" has the meaning set forth in Section 11.10(a).

"Claims" means any and all manner of claims, actions, suits, damages, demands
and liabilities whatsoever in law or equity, whether known or unknown,
liquidated or unliquidated, fixed, contingent, direct or indirect.

"Closing" has the meaning set forth in Section 2.1. 

"Closing Consideration Amount" has the meaning set forth in Section 3.2(c).

"Closing Date" has the meaning set forth in Section 2.1.

"Closing Date Cash" means Company Cash as of 11:59 P.M. on the date
immediately prior to the Closing Date.

"Closing Date Company Transaction Expenses" means Company Transaction Expenses
as of 11:59 P.M. on the date immediately prior to the Closing Date.

"Closing Date Indebtedness" means Indebtedness as of 11:59 P.M. on the date
immediately prior to the Closing Date, less the amount of all Indebtedness,
including Guarantees of Indebtedness, to be repaid, satisfied or released as
of the Closing.

"Closing Date Statement" has the meaning set forth in Section 3.2(b).

"Closing Date Working Capital" means (a) the sum of the specified current
assets of the Company as of 11:59 P.M. on the date immediately prior to the
Closing Date, minus (b) the sum of the specified current liabilities of the
Company as of 11:59 P.M. on the date immediately prior to the Closing Date
including current Tax Liabilities, in each case, as calculated in accordance
with the methodologies, and including only those specified current assets and
specified current liability line items, each as set forth in Exhibit A.
Notwithstanding the foregoing, Closing Date Working Capital shall not include
Company Cash, Indebtedness, Company Transaction Expenses, deferred Tax assets
or deferred Tax Liabilities.

"Code" means the Internal Revenue Code of 1986.

"Commercial Software" means all commercially available off-the-shelf software
licensed pursuant to click wrap or shrink wrap agreements that (a) is not
material to the Company or the Business, (b) has not been modified or
customized for the Company, (c) is used internally (and not licensed or
sublicensed to third parties) by the Company, and (d) is licensed to the
Company for a one-time or annual fee of five thousand dollars ($5,000) or
less.

"Company" has the meaning set forth in the Preamble.

"Company Cash" means cash and cash equivalents of the Company, less an amount
of cash necessary to cover all outstanding checks and wire transfers,
determined in accordance with GAAP.

"Company Disclosure Schedule" means the disclosure schedule, dated the date
hereof, delivered by Seller to Buyer in connection with the execution and
delivery of this Agreement setting forth information required to be disclosed,
or relevant exceptions to, the representations and warranties set forth
herein.

"Company Intellectual Property" means the Owned Intellectual Property and
Intellectual Property that the Company is licensed or otherwise permitted by
other Persons to use. 

"Company Interests" has the meaning set forth in the Recitals.

"Company IT Assets" means all IT Assets used or held for use by, or accessible
to, the Company in connection with the Business.

"Company Material Adverse Effect" means any Event that, individually or taken
together with one or more other Events (a) is, or would reasonably be expected
to be, materially adverse to the business, condition (financial or otherwise),
assets, liabilities or results of operations of the Company; provided that any
effect resulting from any of the following shall not be considered when
determining whether a Company Material Adverse Effect shall have occurred: (i)
the announcement or pendency of the transactions contemplated by this
Agreement (provided that such announcement shall not be in breach of this
Agreement), including the loss of customers or suppliers of the Company to the
extent such loss is directly attributable to the identity of Buyer, (ii)
Events in the credit, financial or capital markets of, or the economy in the
United States or in the global economy, (iii) conditions generally affecting
the industry or states or localities in which the Company operates, (iv) acts
of terrorism, sabotage, armed hostilities or war (whether or not declared), or
any escalation of the foregoing, (v) changes in applicable Law or changes in
applicable accounting regulations or principles or interpretations thereof,
(vi) the failure of the Company or the Business to meet any internal or
external projection, estimate, budget, prediction, plan, milestone or forecast
(it being understood that the underlying Events giving rise or contributing to
such failure may be taken into account in determining whether there has been,
or would reasonably be expected to be, a Company Material Adverse Effect if
such Events are not otherwise excluded under this definition), or (vii) the
taking of any action (A) by Seller or the Company required by this Agreement,
or (B) by Seller or the Company between the date hereof and the Closing Date
with the prior written consent of Buyer that would otherwise have been
prohibited by Section 7.1, except, with respect to clauses (ii), (iii), (iv)
and (v), to the extent (and only to the extent) that the Company is not
disproportionately affected by such Events in comparison to others in the
industry or geographic markets in which it operates, or (b) prevents or
materially delays or materially impairs, or could reasonably be expected to
prevent, materially delay or materially impair, the ability of any of Seller
or the Company to perform their respective obligations under this Agreement or
consummate the transactions contemplated hereby.

"Company Released Parties" has the meaning set forth in Section 7.6(a).

"Company Releasing Parties" has the meaning set forth in Section 7.6(b).

"Company Transaction Expenses" means all fees, costs and expenses incurred,
accrued or to be paid by the Company in connection with the transactions
contemplated hereby and the Ancillary Documents, including (a) fees and
disbursements of counsel, financial advisors, Consultants and accountants
retained or acting in connection with this Agreement or the transactions
contemplated hereby; (b) all change of control, transaction, closing and/or
severance or retention or similar bonuses, benefits or payments payable or
owing to any Employee or Consultant of the Company (other than the
distribution of account balances from the Rabbi Trust), whether triggered
solely as a result of the transactions contemplated hereby or triggered as a
result of, or in connection with, the transactions contemplated hereby and the
occurrence of another event (excluding any discretionary bonuses granted in
accordance with Section 7.1(b)(xviii) to the extent to be paid or 

otherwise to be funded by Seller or its Affiliates promptly after the Closing
pursuant to the transition payroll services provided to the Company under the
Transition Services Agreement), including the employer portion of any payroll,
employment or similar Taxes payable in connection therewith; (c) filing fees
and expenses incurred by the Company related to any filing by the Company with
a Governmental Authority in connection with this Agreement or the transactions
contemplated hereby (excluding all filing fees for filings required under the
Competition Laws of the United States and Germany); (d) costs and expenses
incurred by the Company in connection with obtaining the DandO Insurance; (e)
costs of terminating any Affiliate Arrangement; and (f) fifty percent (50%) of
the fees and expenses of the Escrow Agent.

"Competing Transaction" means any transaction (a) similar to the transactions
contemplated hereby, or (b) that could be inconsistent with, or that could
otherwise preclude, the transactions contemplated hereby, including any (i)
merger, consolidation, business combination, recapitalization, restructuring,
sale or purchase of assets, securities or debt instruments, dissolution,
liquidation or other similar transaction of or involving the Company or (ii)
other acquisition or equity investment transaction involving or otherwise
relating to the Company involving any other Person other than Buyer or any of
its Affiliates, including the formation of a partnership or joint venture with
or for the Company.

"Competition Laws" means, as applicable, the HSR Act and any other United
States federal or state, or foreign, statutes, rules, regulations, Orders,
administrative or judicial decrees or other Laws that are designed to
prohibit, restrict or regulate actions having the purpose or effect of
monopolization, restraint of trade, or the lessening of competition.

"Compliant" means, as of any time of determination, with respect to the
Required Information, that (a) such Required Information, taken as a whole, at
such time does not contain any untrue statement of a material fact regarding
the Company or omit to state any material fact regarding the Company required
to be stated therein or necessary in order to make the Required Information,
in the light of the circumstances under which the statements contained therein
are made, not misleading, (b) such Required Information complies in all
material respects with all applicable requirements of Regulation S-K and
Regulation S-X under the Securities Act for a registered public offering of
securities on Form S-1 and (c) the financial statements and other financial
information included in such Required Information would not be deemed stale or
otherwise be unusable under a registered public offering of securities on Form
S-1 and are, and remain throughout the Marketing Period, sufficient to permit
the Company's independent accountants to issue comfort letters, including as
to customary negative assurances, in order to consummate any offering of debt
securities on any day during the Marketing Period, which such accountants have
confirmed they are prepared to issue.

"Confidential Information" means information that is not generally known to
the public with respect to the terms of the transactions contemplated hereby
and the non-public or proprietary information of the Company, including non-
public or proprietary Company Intellectual Property and non-public or
proprietary information related to the Business.

"Confidentiality Agreement" means the Amended and Restated Non-Disclosure
Agreement between Buyer and the Company dated May 31, 2017. 

"Consultant" means any Person who is or has been engaged as a consultant,
sales agent or independent contractor by or on behalf of the Company, other
than as an Employee, or who otherwise provides services to the Company under a
contractual arrangement other than as an Employee.

"Consultant Agreement" means any service, bonus or incentive compensation,
change in control, retention, deferred compensation or other compensatory
Contract with any Consultant and to which the Company is a party or could have
any Liability.

"Contingent Worker" has the meaning set forth in Section 5.20(f).

"Continuing Employee" has the meaning set forth in Section 7.7(a).

"Contract" means any agreement, contract, purchase order, arrangement,
understanding, obligation or commitment to which a party is bound or to which
its assets or properties are subject, whether oral or written, and any
schedules, exhibits, amendments and/or supplements to them.

"Coverage Transition Period" has the meaning set forth in Section 7.7(a).

"DandO Insurance" has the meaning set forth in Section 7.15.

"DEA" means the U.S. Drug Enforcement Administration.

"Debt Commitment Letter" has the meaning set forth in Section 6.7.

"Disputed Amounts" has the meaning set forth in Section 3.3(b).

"DOJ" has the meaning set forth in Section 7.9(b).

"Employee" means any current or former employee, officer, director or manager
of the Company.

"Employee Agreement" means any employment, severance, termination, bonus or
incentive compensation, change in control, retention, deferred compensation or
other compensatory Contract with any Employee and to which the Company is a
party or could have any Liability.

"End Date" has the meaning set forth in Section 10.1(d).

"Environmental Laws" means any applicable foreign, federal, state, provincial
or local Law governing Environmental Matters, as the same have been or may be
amended from time to time, including any common law cause of action providing
any right or remedy relating to Environmental Matters, all indemnity
agreements and other contractual obligations (including leases, asset purchase
and merger agreements) relating to Environmental Matters, and all applicable
judicial and administrative decisions, Orders, decrees, and binding guidance
documents relating to Environmental Matters. 

"Environmental Matter" means any matter arising out of, relating to, or
resulting from pollution, contamination, protection of the environment,
species protection, water rights, human health or safety, health or safety of
employees, sanitation or any matter relating to any emission, discharge,
dissemination, Release or threatened Release of any Hazardous Materials into
the air (indoor and outdoor), surface water, groundwater, soil, land surface
or subsurface, buildings, facilities, real or personal property or fixtures or
otherwise arising out of, relating to or resulting from the manufacture,
import, export, processing, distribution, use, treatment, storage, disposal,
transport, handling, Release or threatened Release of any Hazardous Materials.

"Environmental Permits" has the meaning set forth in Section 5.18(a).

"Equity Securities" of any Person means any and all shares of capital stock,
warrants, options or other rights to purchase shares of capital stock (in each
case, whether or not currently exercisable), participations or other
equivalents of or interests in (however designated) the equity (including
common stock, preferred stock and limited liability company, partnership and
joint venture interests) of such Person, and all securities exchangeable for
or convertible or exercisable into, any of the foregoing (including restricted
stock units, restricted stock, phantom stock and stock appreciation rights).

"ERISA" means The Employee Retirement Income Security Act of 1974 and the
rules and regulations promulgated thereunder.

"ERISA Affiliate" means, of any entity, each Person that at any relevant time
would be treated as a single employer with such entity for purposes of Section
4001(b)(1) of ERISA or Section 414(b), (c), (m) or (o) of the Code.

"Escrow Agent" means JP Morgan Chase Bank, N.A. or another commercial bank
mutually agreeable to Buyer and Seller.

"Escrow Agreement" has the meaning set forth in Section 3.5(a).

"Estimated Closing Cash Amount" has the meaning set forth in Section 3.2(b).

"Estimated Closing Date Company Transaction Expenses" has the meaning set
forth in Section 3.2(b).

"Estimated Closing Date Working Capital" has the meaning set forth in Section
3.2(b).

"Estimated Closing Indebtedness Amount" has the meaning set forth in Section
3.2(b).

"Estimated Working Capital Deficit" has the meaning set forth in Section
3.2(b).

"Estimated Working Capital Excess" has the meaning set forth in Section
3.2(b). 

"Event" means any event, change, development, effect, condition, circumstance,
matter, occurrence or state of facts.

"Exclusivity Agreement" means that certain Due Diligence and Exclusivity
Agreement dated as of May 31, 2017, by and between Buyer and Seller.

"Exclusivity Payment Amount" means the amount of two million dollars
($2,000,000) that was paid by Buyer to Seller pursuant to the terms of the
Exclusivity Agreement.

"Export Controls" means, to the extent applicable to the Company, any (a) U.S.
Laws restricting the export, reexport, or transfer (in-country) of any goods,
software, technology or services, including the Export Administration
Regulations and the International Traffic in Arms Regulations and (b) United
Kingdom, European Union, European Union member state, or other non-U.S. Laws
restricting the export, reexport, or transfer (in-country) of any goods,
software, technology or services.

"FDA" means the U.S. Food and Drug Administration.

"Federal Health Care Program" means any plan or program that provides health
benefits, whether directly, through insurance or otherwise, and that is funded
directly, in whole or in part, by the U.S. government or a state health care
program (except for the Federal Employees Health Benefits Program) (as defined
in 42 U.S.C. ยง 1320a-7b).

"Final Purchase Price Adjustment Statement" means the Purchase Price
Adjustment Statement as (a) agreed by Buyer and Seller, (b) made final due to
the failure of Seller to properly deliver a Purchase Price Dispute Notice
pursuant to Section 3.3(b), or (c) made final by an Accounting Arbitrator
pursuant to Section 3.3(c).

"Financial Statements" has the meaning set forth in Section 5.6(a).

"Financing" means any debt, equity or other financings in connection with the
transactions contemplated by this Agreement, including any offering or private
placement of debt securities or borrowing of loans and any related commitment
letter (including the Debt Commitment Letter) or engagement letter and
including any credit facilities or capital markets debt financing or equity or
equity-related offerings.

"Financing Sources" means the agents, arrangers, underwriters, purchasers,
lenders and other entities that have committed to provide or arrange or
otherwise entered into agreements in connection with any Financing, including
the parties to any commitment letter (including the Debt Commitment Letter) or
engagement letter in respect of any Financing or to any joinder agreements,
indentures, credit agreements or other agreements entered pursuant thereto or
relating thereto, together with their Affiliates and the current, former or
future officers, directors, employees, partners, trustees, shareholders,
equityholders, managers, members, limited partners, controlling persons,
agents and representatives of each of them and the successors and assigns of
the foregoing Persons. 

"Flexible Benefit Plan" has the meaning set forth in Section 7.7(b).

"Food, Drug and Safety Laws" means all applicable Laws relating to the use,
manufacture, fabrication, processing, testing, handling, storage, packaging,
licensing, labeling, distribution, marketing, advertising or sale of any drug,
device, biological or other medical product, including the U.S. Federal Food,
Drug, and Cosmetic Act, the Public Health Service Act, regulations of the FDA,
and all similar applicable Laws in any other jurisdiction to which the Company
is subject, including all applicable Laws regarding GMPs to which the Company
is subject and all applicable health and product safety Laws to which the
Company is subject.

"FTC" has the meaning set forth in Section 7.9(b).

"Fundamental Representations" has the meaning set forth in Section 8.4(c).

"GAAP" means U.S. generally accepted accounting principles, as in effect from
time to time.

"GMP" means current good manufacturing practices to which the Company is
subject as defined by any Governmental Authority charged with overseeing Food,
Drug and Safety Laws and such practices, including those set forth in any
applicable Law.

"Government Official" has the meaning set forth in Section 5.16(b).

"Governmental Authority" means any nation or government, any foreign or
domestic federal, state, county, municipal or other political instrumentality
or subdivision thereof and any foreign or domestic entity or body exercising
executive, legislative, judicial, regulatory, administrative or taxing
functions of or pertaining to government, including any court.

"Governmental Consents" has the meaning set forth in Section 4.4.

"Guarantee Agreement" means that certain guaranty agreement dated as of July
2, 2015, pursuant to which the Company has provided Guarantees of Indebtedness
in respect of the obligations of Cook Group Incorporated under the Note
Purchase Agreement.

"Guarantees of Indebtedness" has the meaning set forth in the definition of
"Indebtedness."

"Hazardous Materials" means any pollutant, contaminant, toxic, hazardous or
extremely hazardous substance, material, waste, constituent, compound,
chemical, natural or man-made element or force (including petroleum or any by-
product or fraction thereof, any form of natural gas, lead, asbestos and
asbestos-containing materials, building construction material and debris, any
polychlorinated biphenyl ("PCB") and PCB-containing equipment, radon and any
other radioactive element, any infectious, carcinogenic, mutagenic or
etiologic agent, pesticide, defoliant, explosive, flammable, corrosive and
urea formaldehyde foam insulation) that is regulated by, or may form the basis
of Liability under, any Environmental Laws. 

"HSR Act" means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, and
the rules and regulations promulgated thereunder.

"Indebtedness" means all obligations and indebtedness of the Company (a) for
borrowed money or in respect of loans or advances (other than trade debt and
other similar Liabilities incurred in the ordinary course of business
consistent with past practice), (b) evidenced by a note, bond, debenture or
similar instrument, (c) created or arising under any capital lease,
conditional sale, earn out or other arrangement for the deferral of purchase
price of any property, (d) under letters of credit, banker's acceptances or
similar credit transactions (without duplication of other indebtedness
supported or guaranteed thereby), (e) under interest rate swaps, forward
Contracts, futures or other hedging arrangements, including any breakage costs
associated therewith, (f) to purchase, redeem, retire, defease or otherwise
acquire for value any Equity Securities, (g) for any other Person's obligation
or indebtedness of the same type as any of the foregoing, including as secured
by Liens on any assets of the Company, whether as obligor, guarantor (direct
or indirect) or otherwise, including under the Parent Credit Agreement and the
Note Purchase Agreement (the Indebtedness referenced in this clause (g),
"Guarantees of Indebtedness"), (h) any accounts payable or loans of any kind
or nature between the Company (as obligor) on the one hand, and Seller or any
of its Affiliates (other than the Company) on the other hand, (i) with respect
to any accrued but unused vacation or other paid time off from calendar years
ended prior to the Closing Date to which any Employee is entitled as of the
Closing Date that cannot be used by Employees under Seller's policies with
respect to vacation and other paid time off during the calendar year in which
the Closing Date occurs (including the amount of the employer portion of any
payroll, employment or similar Taxes payable in connection with paying out
such vacation or other paid time off), (j) for interest, penalties or other
amounts owing on any of the foregoing and/or (k) for any premiums, prepayment
or termination fees, penalties, expenses or breakage costs due upon prepayment
of any of the foregoing.

"Indemnitor" has the meaning set forth in Section 9.4(a).

"Intellectual Property" means (a) patents; (b) Trademarks; (c) copyrights,
works of authorship, rights in data and databases; (d) Confidential
Information, including trade secrets and know-how; (e) registrations,
applications, renewals, extensions, reissues, divisions, continuations,
continuations-in-part and reexaminations (as applicable) for any of the
foregoing in (a)-(e); and (f) all other proprietary rights.

"IT Assets" means software, systems, servers, computers, hardware, firmware,
middleware, networks, data communications lines, routers, hubs, switches and
all other information technology equipment, and all associated documentation.

"IVF Media Supply Agreement" has the meaning set forth in Section 5.10.

"Knowledge of Buyer" means the actual knowledge of any of the following
personnel of Buyer, after reasonable inquiry and investigation: John
Chiminski; Matthew Walsh; Steven Fasman; Michael Grippo; and Barry
Littlejohns. 

"Knowledge of Seller" means the actual knowledge of any of the following
personnel of Seller, after reasonable inquiry and investigation: Steve
Ferguson; Pete Yonkman; John Kamstra; and Cynthia Kretz.

"Knowledge of the Company" means the actual knowledge of any of the following
personnel of Seller, their Affiliates and the Company, after reasonable
inquiry and investigation: Tedd Green; Cory Lewis; Ryan M. Hawkins; Veda
Walcott; and, solely with respect to information technology matters, Chris
Clayton.

"Law" or "Laws" means any and all laws, Orders, statutes, codes, regulations,
ordinances, decrees, rules, or other requirements with similar effect of any
Governmental Authority.

"Leases" has the meaning set forth in Section 5.13(b).

"Liability" means, with respect to any Person, any liability or obligation of
such Person of any kind, character or description, whether known or unknown,
absolute or contingent, accrued or unaccrued, liquidated or unliquidated,
secured or unsecured, joint or several, due or to become due, vested or
unvested, executory, determined, determinable or otherwise and whether or not
the same is required to be accrued on the financial statements of such Person.

"Licenses and Permits" means any license, permit, authorization, approval or
other evidence of authority issued or granted to, conferred upon, or otherwise
created for, the Company by any Governmental Authority.

"Lien" means any lien, statutory or otherwise, security interest, mortgage,
deed of trust, priority, pledge, charge, right of first refusal or other
encumbrance or similar right of others, or any agreement to give any of the
foregoing.

"Litigation" means any Claim, litigation, prosecution, proceeding or
governmental or administrative investigation, hearing, arbitration, inquiry or
action.

"Losses" means all Claims, losses, Taxes, Liabilities, damages available at
law or in equity (including diminution of value), deficiencies, fines,
interest and penalties, costs and expenses, including in connection with or
resulting from the defense, settlement and/or compromise of a Claim, and
including the reasonable costs, expenses and fees of attorneys, accountants,
expert witnesses and investigators.

"Marketing Period" means the first period of eighteen (18) consecutive
Business Days commencing on the date on which the Required Information is
delivered to Buyer throughout and at the end of which Buyer shall have the
Required Information and the Required Information is Compliant; provided that
(x) November 22, 2017 through November 24, 2017 (inclusive) shall not
constitute Business Days for purposes of such period (it being understood that
any day that occurs on such excluded days in the foregoing clause (x) after
the commencement of such period shall be disregarded for purposes of
calculating the consecutive Business Days constituting such period (but not
reset such period), and (y) if such period has not been completed by December
20, 2017, then such period shall not commence earlier than January 3, 2018.
Notwithstanding anything 

in the preceding sentence of this definition to the contrary, the Marketing
Period shall not commence or be deemed to have commenced if, after the date
hereof and prior to the completion of such eighteen (18) consecutive Business
Day period: (i) Seller or the Company has announced to Buyer, the Company's
independent auditor or any other third party (A) its intention to restate in
any material respect any of the Company's financial statements contained in
the Required Information, or (B) that any such restatement is under active
consideration, in which case the Marketing Period shall not commence unless
and until such restatement has been completed, the applicable Required
Information has been amended and, to the extent such financial statements had
previously been audited, an "unqualified" audit opinion is issued with respect
to such restated financial statements, or Seller or the Company has announced
to Buyer and the Company's independent auditor that no restatement is
required; or (ii) the Company's independent auditor shall have withdrawn any
audit opinion with respect to any of the Company's financial statements
contained in the Required Information, in which case the Marketing Period
shall not be deemed to commence unless and until a new "unqualified" audit
opinion is issued with respect to such financial statements or any restatement
thereof. Notwithstanding anything in this definition to the contrary, the
Marketing Period shall be deemed to have ended on the date the Financing has
been consummated.

"Material Contracts" has the meaning set forth in Section 5.15(a).

"Most Recent Audited Financial Statements" has the meaning set forth in
Section 5.6(a).

"Most Recent Unaudited Financial Statements" has the meaning set forth in
Section 5.6(a).

"New Commitment Letter" has the meaning set forth in Section 7.13(a).

"Non-Party Affiliates" means, with respect to the Financing Sources, their
respective Affiliates and their respective Affiliates' current, former and
future officers, directors, employees, partners, trustees, shareholders,
equityholders, managers, members, limited partners, controlling persons,
agents and representatives, and the successors and assigns of the foregoing
Persons that are not parties to this Agreement.

"Non-Qualified Plan" has the meaning set forth in Section 7.7(d).

"Note Purchase Agreement" means that certain note purchase and private shelf
agreement dated as of July 2, 2015, by and among Cook Group Incorporated,
Prudential Investment Management, the purchasers named therein and such other
persons who may become parties thereto, as amended by that certain Amendment
No. 1 dated as of October 14, 2016.

"Orders" means all judgments, orders, writs, injunctions, decisions, rulings,
decrees and awards of any Governmental Authority.

"OSHA" means the U.S. Occupational Safety and Health Administration. 

"Owned Intellectual Property" means all Intellectual Property owned or
purported to be owned by the Company.

"Parachute Payment" has the meaning set forth in Section 7.17.

"Parent Credit Agreement" means that certain credit agreement dated as of
September 28, 2012, by and among JP Morgan Chase Bank, N.A., individually and
as Administrative Agent (as defined therein), and the other Lenders (as
defined therein) and Cook Group Incorporated, an Indiana corporation as
Borrower (as defined therein), as amended by that certain Amendment No. 1
dated as of September 30, 2014, as amended by that certain Amendment No. 2
dated as of October 14, 2016.

"Pay-Off Amount" has the meaning set forth in Section 8.1(b).

"Pay-Off Letters" has the meaning set forth in Section 8.1(b).

"PCB" has the meaning set forth in the definition of "Hazardous Materials."

"Permitted Lien" means any (a) Lien in respect of current Taxes not yet due
and owing and (b) mechanics', carriers', workmen's, repairmen's or other like
Liens arising or incurred in the ordinary course of business if individually
or in the aggregate (i) they are not material or as to which appropriate
reserves have been established in the Financial Statements or (ii) the
indebtedness secured by them is not in arrears or if in arrears, is being
disputed in good faith by appropriate proceedings and as to which appropriate
reserves have been established in the Financial Statements.

"Permitted Rollover PTO" means any accrued but unused vacation or other paid
time off that an Employee is entitled to as of the Closing Date that could
have been used by the Employee in the calendar year in which the Closing Date
occurs under Seller's policies with respect to vacation and other paid time
off if the Employee had continued to be subject to such policies for the
remainder of such calendar year.

"Person" means any individual, person, entity, general partnership, limited
partnership, limited liability partnership, limited liability company,
corporation, joint venture, trust, business trust, cooperative, association,
Governmental Authority, unincorporated organization, foreign trust or foreign
business organization and the heirs, executors, administrators, legal
representatives, successors and assigns of the "Person" when the context so
permits.

"Plan" means any (a) employee benefit plan (as defined in Section 3(3) of
ERISA, whether or not subject to ERISA), (b) retirement, deferred
compensation, severance, retention, incentive, stock option or other equity
compensation, fringe benefit, insurance, vacation, paid-time off, supplemental
unemployment, supplemental or excess benefit, or other employee benefit plan,
program, or arrangement (other than an Employee Agreement or Consultant
Agreement), and (c) each "voluntary employees' beneficiary association" (VEBA)
within the meaning of Section 501(c)(9) of the Code, whether or not tax-
qualified and whether or not subject to ERISA, and in each case of (a) and
(b), (i) that is maintained or sponsored by the Company, (ii) with respect to
which 

contributions, premiums or other payments are made or required to be made by
the Company with respect to any Employee or (iii) pursuant to which the
Company could have any Liability.

"Pre-Closing Date Share" means with respect to a Straddle Period (a) in the
case of real property, personal property and similar ad valorem Taxes, the
total amount of Taxes assessed in or attributable to the entire Straddle
Period, multiplied by (i) the number of days in the Straddle Period on or
before the Closing Date divided by (ii) the total number of days in the
Straddle Period, and (b) in the case of all other Taxes, the amount of Taxes
that would be due for the portion of the taxable period beginning on the first
day of the Straddle Period and ending on the Closing Date, based on an interim
closing of the books as of the close of business on the Closing Date.

"Pre-Closing Return" has the meaning set forth in Section 7.2(a)(ii).

"Pre-Closing Tax Period" means any taxable period ending on or before the
Closing Date.

"Privacy Laws" has the meaning set forth in Section 5.14(g).

"Products and Services" has the meaning set forth in Section 5.17.

"Purchase Price" has the meaning set forth in Section 3.2(a).

"Purchase Price Adjustment Statement" has the meaning set forth in Section
3.3(a).

"Purchase Price Dispute Notice" has the meaning set forth in Section 3.3(b).

"RandW Insurance Policy" means any "Representations and Warranties" (or similar)
insurance policies obtained by Buyer and/or its Affiliates in connection with
the transactions contemplated by this Agreement (as they may be amended,
modified or otherwise supplemented from time to time).

"Rabbi Trust" means that certain rabbi trust established pursuant to the Trust
Agreement between Cook Pharmica LLC and Fidelity Management Trust Company for
the Cook Group 2005 Deferred Compensation Plan Trust.

"Real Property" means (i) all of the Company's right, title and interest in,
to and under those certain tracts or parcels of land located at 1300 S.
Patterson Drive, Bloomington, Indiana and 1400 S. Patterson Drive, consisting
of tax parcel identification nos. 53-08-05-400-032.000-009,
53-08-08-100-131.000-009, and 53-08-05-400-005.001-009, together with all
buildings, structures, improvements and fixtures located thereon, and all
easements and other rights and interests appurtenant thereto, owned by Company
and (ii) all (a) the Company's interest in any site plans, construction and
development drawings, plans and specifications, studies, reports, and surveys
for the Real Property in the Company's possession, (b) the Company's interest
in any sewer and water permits and licenses, building permits, certificates of
occupancy, demolition and excavation permits, curb cut and right-of-way
permits, drainage rights, and any and all other permits, licenses, approvals,
entitlements and similar or equivalent private and governmental documents of
every kind and character whatsoever pertaining or applicable to or in any way
connected with the development, 

construction, ownership, or operation of the Real Property, and (c) the
Company's interest in any indemnities, warranties and guaranties pertaining or
applicable to or in any way connected with the development, construction,
ownership or operation of the Real Property.

"Registered" means issued or renewed by, registered, recorded or filed with,
or the subject of a pending application before, any Governmental Authority or
internet domain name registrar.

"Release" means any release, spill, emission, leaking, dumping, injection,
pouring, deposit, disposal, discharge, dispersal, leaching or migration into
or through the indoor or outdoor environment.

"Representatives" means, with respect to any Person, the Person's Affiliates
and Subsidiaries, and its and their respective employees, officers, directors,
managing members, general partners, agents, consultants, advisors (including
financial advisors, counsel, auditors and accountants) and other
representatives, and in the case of Buyer, shall include the Financing
Sources.

"Required Information" has the meaning set forth in Section 7.13(c)(iii).

"Retained Names" has the meaning set forth in Section 7.16(a).

"Sanctioned Country" means, at any time, a country or territory which is
itself the subject of or target of any Sanctions.

"Sanctioned Person" means, to the extent applicable to the Company, any Person
(a) listed in any Sanctions-related list of designated Persons maintained by
the Office of Foreign Assets Control of the U.S. Department of the Treasury,
the U.S. Department of Commerce, the U.S. Department of State, the United
Nations Security Council, Her Majesty's Treasury of the United Kingdom, the
European Union or any European Union member state, (b) operating, organized,
or resident in a Sanctioned Country with which or whom dealings are prohibited
by any party to this Agreement, or (c) that is fifty percent (50%) or greater
owned by any Person or Persons described in clause (a).

"Sanctions" means, to the extent applicable to the Company, all economic or
financial sanctions or trade embargoes imposed, administered or enforced from
time to time by (a) the U.S. government, including those administered by the
Office of Foreign Assets Control of the U.S. Department of the Treasury, the
U.S. Department of Commerce or the U.S. Department of State, or (b) the United
Nations Security Council, Her Majesty's Treasury of the United Kingdom, the
European Union or any European Union member state.

"Securities Act" means the Securities Act of 1933.

"Seller" has the meaning set forth in the Preamble.

"Seller 401(k) Plan" means the Cook Group Profit Sharing Plan, as it may be
amended from time to time. 

"Seller Domain" has the meaning set forth in Section 7.16(c).

"Seller Released Parties" has the meaning set forth in Section 7.6(b).

"Seller Releasing Parties" has the meaning set forth in Section 7.6(a).

"Seller Taxes" means (a) all Taxes imposed on or payable by or with respect to
Seller or any of its Affiliates; (b) all Taxes imposed on or payable by or
with respect to the Company for any Pre-Closing Tax Period and the Pre-Closing
Date Share of any such Taxes for any Straddle Period; (c) any Taxes
attributable to any deferred revenue or prepaid amount received on or prior to
the Closing Date by Seller, the Company or any of their Affiliates; (d) any
and all Liabilities for Taxes for which the Company is liable under Treasury
Regulations ยง 1.1502-6 (or any corresponding or similar provision of non-U.S.,
state or local Law), as a transferee or successor, by Contract or pursuant to
any Law, or that are attributable to an event or transaction occurring before
the Closing Date or an ownership relationship existing before the Closing
Date; (e) all Transfer Taxes; (f) any Losses incurred by Buyer or any of its
Affiliates arising out of, in connection with or relating to any inaccuracy in
or breach of any representation or warranty made by Seller in Section 5.22;
and (g) any subsidies required to be repaid or Taxes arising out of, in
connection with or relating to the reduction or cancellation by a Governmental
Authority of any tax credit, tax abatement, expense reimbursement or other
public aid granted with respect to a Pre-Closing Tax Period under a Tax
Incentive Agreement to the extent such reduction or cancellation results from
Seller's or the Company's failure to perform, comply with or fulfill the
obligations and requirements thereof on or prior to the Closing.

"Straddle Period" means any taxable period beginning on or before the Closing
Date and ending after the Closing Date.

"Subsequent Payment Amount" means the amount in cash of two hundred million
dollars ($200,000,000) of the Purchase Price that shall be paid by Buyer to
Seller in accordance with Section 3.5(b).

"Subsidiary" means, with respect to any Person, any corporation or other
organization, whether incorporated or unincorporated, (a) of which such Person
or any other Subsidiary of such Person is a general partner (excluding
partnerships, the general partnership interests of which held by such Person
or any Subsidiary of such Person do not have a majority of the voting
interests in such partnership), or (b) at least a majority of the securities
or other interests of which having by their terms ordinary voting power to
elect a majority of the board of directors or others performing similar
functions with respect to such corporation or other organization is directly
or indirectly owned or controlled by such Person or by any one or more of its
Subsidiaries, or by such Person and one or more of its Subsidiaries.

"Target Working Capital" means an amount equal to eighty percent (80%) of the
aggregate amount of net sales of the Company (calculated in accordance with
the Company's past practice) for the three-month period ending on the last day
of the month immediately preceding the Closing Date. 

"Tax" or "Taxes" means all federal, state, local and non-U.S. income, profits,
franchise, gross receipts, license, environmental, customs duty, capital
stock, severance, occupation, premium, windfall profits, social security (or
similar), stamp, payroll, sales, employment, unemployment, disability, use,
property, escheat, unclaimed property, registration, withholding, excise,
production, value added, ad valorem, occupancy, alternative or add-on minimum,
estimated, transfer, and other taxes, duties or assessments of any nature
whatsoever, together with all interest, penalties or additions to tax
attributable to such taxes and any Liability for taxes of another Person by
Contract, as a transferee or successor, under Treasury Regulations ยง1.1502-6
or analogous state, local or non-U.S. Law, or otherwise, whether disputed or
not.

"Tax Contest" means any inquiry, audit, hearing, proposed adjustment,
arbitration, deficiency, assessment, suit, dispute, Claim, proceeding or other
Litigation commenced, filed or otherwise initiated or convened to investigate
or resolve the existence and extent of a Liability for Taxes.

"Tax Incentive Agreement" means any tax incentive agreement or similar
Contract (including, without limitation, any Contract relating to tax credits,
tax abatements or reimbursement of expenses) or other form of public aid
regime to which the Company is a party.

"Tax Return" means any report, return, claim for refund, statement, notice,
form or other written information (including elections, declarations,
disclosures, schedules, estimates and information returns) relating to Taxes
and any amendment thereto, including any schedule or attachment thereto.

"Taxing Authority" means any Governmental Authority or any subdivision,
agency, commission or authority thereof, or any quasi-governmental or private
body, having jurisdiction over the assessment, determination, collection or
other imposition of Taxes.

"Territory" has the meaning set forth in Section 7.10(a).

"Title Affidavit" has the meaning set forth in Section 7.14.

"Title Company" means the Chicago Title Insurance Company.

"Top Customers" has the meaning set forth in Section 5.25(a).

"Top Suppliers" has the meaning set forth in Section 5.25(b).

"Trademarks" means trademarks, service marks, certification marks, domain
names, website and social media user names, uniform resource locators, trade
dress, corporate names, business names, trade names, geographical indications
and other identifiers of source or goodwill, including the goodwill symbolized
thereby or associated therewith.

"Transfer Taxes" means all transfer, documentary, sales, use, gross receipts,
stamp, stamp duties, excise, license, filing, recordation, value added, ad
valorem, bulk sales, registration and other such Taxes and fees (including any
penalties and interest and the costs of preparing and filing any related Tax
Return) incurred in connection with the transactions contemplated hereby. 

"Transition Period" has the meaning set forth in Section 7.16(b).

"Transition Services Agreement" has the meaning set forth in Section 8.1(e).

"Treasury Regulations" means the regulations promulgated under the Code.

"WARN Act" means the Worker Adjustment and Retraining Notification Act of
1989.

"Willful Breach" has the meaning set forth in Section 10.3(b).

Section 1.2 Rules of Construction. Unless the context otherwise requires:



(a)a capitalized term has the meaning assigned to it herein;

(b)an accounting term not otherwise defined has the meaning assigned to it in
accordance with GAAP;

(c)references in the singular or to "him," "her," "it," "itself," or other
like references, and references in the plural or the feminine or masculine
reference, as the case may be, shall also, when the context so requires, be
deemed to include the plural or singular, or the masculine or feminine
reference, as the case may be;

(d)any Contract, instrument or Law defined or referred to herein means such
Contract, instrument or Law as from time to time amended, modified or
supplemented;

(e)references to Annexes, Articles, Sections, Schedules and Exhibits shall
refer to annexes, articles, sections and exhibits of this Agreement, unless
otherwise specified;

(f)the headings in this Agreement are for convenience and identification only
and are not intended to describe, interpret, define or limit the scope, extent
or intent of this Agreement or any provision thereof;

(g)this Agreement shall be construed without regard to any presumption or
other rule requiring construction against the party that drafted and caused
this Agreement to be drafted;

(h)all monetary figures shall be in U.S. dollars unless otherwise specified;

(i)if any period expires on a day which is not a Business Day or any event or
condition is required by the terms of this Agreement to occur or be fulfilled
on a day which is not a Business Day, such period shall expire or such event
or condition shall occur or be fulfilled, as the case may be, on the next
succeeding Business Day;

(j)references to "hereof", "herein", "hereunder", "hereby" and similar terms
shall refer to this entire Agreement (including the Annexes, Schedules and
Exhibits hereto);

(k)whenever this Agreement refers to a number of days, such number shall refer
to calendar days, unless such reference is specifically to "Business Days"; 

(l)references to "including" in this Agreement shall mean "including, without
limitation," whether or not so specified;

(m)the word "extent" in the phrase "to the extent" shall mean the degree to
which a subject or other thing extends and such phrase shall not mean "if";
and

(n)all documents and agreements relating to the Company that have been posted,
at least three (3) Business Days prior to the date hereof, to the electronic
data room established by or on behalf of Seller shall be deemed to have been
"delivered", "provided" or "made available" (or any phrase of similar import)
to Buyer by Seller.

ARTICLE II

Closing

Section 2.1 Closing. The closing of the purchase and sale of the Company
Interests (the "Closing") shall take place at the offices of Fried, Frank,
Harris, Shriver and Jacobson LLP, One New York Plaza, New York, NY 10004, at
9:00 A.M. local time on the third (3rd) Business Day immediately following the
day on which the last of the conditions set forth in Article VIII (other than
those conditions that by their nature are to be satisfied at Closing, but
subject to the satisfaction or waiver of those conditions) (the date of such
Closing, the "Closing Date") are satisfied or waived in accordance with this
Agreement, or on such date as Buyer and Seller may otherwise agree in writing;
provided, however, that unless waived by Buyer in its sole discretion by
written notice to Seller, in no event shall the Closing Date occur until the
third (3rd) Business Day immediately following the day that the Marketing
Period expires.



ARTICLE III

Purchase and Sale of Company Interests

Section 3.1 Purchase and Sale of Company Interests. Subject to the terms and
conditions set forth in this Agreement, at the Closing, Buyer shall purchase
from Seller, and Seller shall sell, transfer and assign to Buyer, free and
clear of all Liens, the Company Interests. The Company Interests purchased and
sold pursuant to this Section 3.1 shall constitute one hundred percent (100%)
of the outstanding Equity Securities of the Company.

Section 3.2 Purchase Price; Payments at the Closing.

(a)The purchase price to be paid by Buyer to Seller for the Company Interests
shall be nine hundred fifty million dollars ($950,000,000) (the "Base Purchase
Price"), subject to adjustment as provided in this Article III (the Base
Purchase Price, as adjusted pursuant to Section 3.3 and Section 3.4, the
"Purchase Price").

(b)Not fewer than three (3) Business Days prior to the Closing, Seller shall
deliver to Buyer a written statement (the "Closing Date Statement") setting
forth Seller's good faith estimate of the Closing Date Working Capital
("Estimated Closing Date Working Capital"), and either (i) the amount, if any,
by which such estimate exceeds Target Working Capital (any such amount, an
"Estimated Working Capital Excess") or (ii) the amount, if any, by which such
estimate 

is less than Target Working Capital (any such amount, an "Estimated Working
Capital Deficit"). The Closing Date Statement shall also include Seller's good
faith estimate of Closing Date Cash (the "Estimated Closing Cash Amount"),
Closing Date Indebtedness (the "Estimated Closing Indebtedness Amount") and
Closing Date Company Transaction Expenses (the "Estimated Closing Date Company
Transaction Expenses"). The Closing Date Statement shall describe in
reasonable detail the nature of such estimates, including the basis for the
specific items involved and the dollar amounts thereof.

(c)At the Closing, Buyer shall pay, or cause to be paid, to Seller the Closing
Consideration Amount. "Closing Consideration Amount" means the Base Purchase
Price, less (i) the Adjustment Escrow Amount, less (ii) the Subsequent Payment
Amount, less (iii) the Exclusivity Payment Amount, less (iv) the amount of any
Estimated Working Capital Deficit, plus (v) the Estimated Closing Cash Amount,
less (vi) the Estimated Closing Indebtedness Amount, less (vii) the Estimated
Closing Date Company Transaction Expenses. The Closing Consideration Amount
shall be paid by wire transfer of immediately available funds to an account
designated by Seller. Such account shall be designated no fewer than three (3)
Business Days prior to the Closing Date.

(d)At the Closing, Buyer shall pay, or cause to be paid, the Pay-Off Amount as
set forth in the Pay-Off Letters (including all amounts necessary to discharge
Indebtedness guaranteed by the Company in connection with the Parent Credit
Agreement), by wire transfer of immediately available funds to the accounts
designated in the Pay-Off Letters.

(e)At the Closing, Buyer shall pay, or cause to be paid, the Company
Transaction Expenses set forth in the Closing Date Statement to the payees
thereof, by wire transfer of immediately available funds to the accounts
designated in advance by each payee thereof, as set forth on the Closing Date
Statement.

(f)From 11:59 P.M. on the day immediately prior to the Closing Date and until
the consummation of the Closing, the Company shall not (i) use any Company
Cash to pay any Company Transaction Expenses, pay any distributions or to
repay any Indebtedness or (ii) incur any Indebtedness.

Section 3.3 Post-Closing Purchase Price Determination.

(a)After the Closing, Buyer shall prepare and, within ninety (90) days after
the Closing, Buyer shall deliver to Seller, a statement setting forth Buyer's
determination of (i) Closing Date Working Capital, (ii) Closing Date Cash,
(iii) Closing Date Indebtedness and (iv) Closing Date Company Transaction
Expenses, which statement shall describe in reasonable detail the nature of
such determination, including the basis for the specific items involved and
the dollar amounts thereof (the "Purchase Price Adjustment Statement").

(b)If Seller disagrees in good faith with the Purchase Price Adjustment
Statement, Seller shall notify Buyer in writing of such disagreement within
thirty (30) days after delivery of the Purchase Price Adjustment Statement,
which notice shall describe in reasonable detail the nature of such
disagreement, including the specific items involved and the dollar amounts
thereof (a "Purchase Price Dispute Notice"). During such thirty (30) day
period, Seller shall be 

permitted reasonable access to the Company's Books and Records and
Representatives for the purpose of reviewing the Purchase Price Adjustment
Statement during normal business hours in a manner so as to not unreasonably
interfere with the normal business operations of the Company. For purposes of
clarity, a statement to the effect that Seller objects to, or disagrees with,
the Purchase Price Adjustment Statement without specifying the items required
to be set forth in a Purchase Price Dispute Notice, shall not constitute a
valid Purchase Price Dispute Notice. Once delivered, Seller may not modify or
amend the Purchase Price Dispute Notice except to waive all or any portion of
such disagreement. If Seller does not deliver a valid Purchase Price Dispute
Notice within such thirty (30) day period, the Purchase Price Adjustment
Statement, as delivered by Buyer to Seller, shall be the Final Purchase Price
Adjustment Statement. If Seller delivers a valid Purchase Price Dispute Notice
within such thirty (30) day period, then such disputed amounts (the "Disputed
Amounts") shall be resolved pursuant to Section 3.3(c).

(c)Buyer and Seller shall negotiate in good faith to resolve any Disputed
Amounts and, if the parties are able to resolve all Disputed Amounts, the
Purchase Price Adjustment Statement, as modified to reflect such resolution,
shall be the Final Purchase Price Adjustment Statement. If Buyer and Seller
are unable to resolve all Disputed Amounts within thirty (30) days after
delivery of a Purchase Price Dispute Notice, then the Disputed Amounts may be
referred by either Buyer or Seller for final determination to
PricewaterhouseCoopers LLP (such firm, or another firm determined pursuant to
this Section 3.3(c), the "Accounting Arbitrator") within fifteen (15) days
after the end of such thirty (30) day period. If neither party refers the
Disputed Amounts to the Accounting Arbitrator within the applicable fifteen
(15) day period, then the Purchase Price Adjustment Statement, as delivered by
Buyer to Seller, shall be the final Purchase Price Adjustment Statement. If
PricewaterhouseCoopers LLP has any material relationship with Buyer, Seller or
any of their respective Affiliates, or is otherwise unwilling or unable to
serve, Buyer and Seller shall jointly appoint as the Accounting Arbitrator a
different nationally or regionally recognized firm of independent certified
public accountants, which does not have any material relationship with Buyer,
Seller or any of their respective Affiliates. If Buyer and Seller are unable
to agree upon an alternative Accounting Arbitrator within fifteen (15) days
after the conclusion of the thirty (30) day period initially specified above,
then the Accounting Arbitrator shall be an accounting firm of national
standing designated by the American Arbitration Association in New York, New
York (which does not have any material relationship with Buyer, Seller or any
of their respective Affiliates). The Accounting Arbitrator shall consider only
those Disputed Amounts which Buyer and Seller have been unable to resolve. The
Accounting Arbitrator shall make its determination based solely on
presentations and supporting materials provided by Buyer and Seller, and not
pursuant to any independent review. Buyer and Seller shall contemporaneously
provide copies to one another of all written submissions to the Accounting
Arbitrator and shall be permitted to attend (and shall receive reasonable
advance written notice of) any meeting with or presentations to the Accounting
Arbitrator. Buyer and Seller shall each use reasonable best efforts to make
their presentations as promptly as practicable following submission to the
Accounting Arbitrator of the disputed items (but in no event later than
fifteen (15) days after engagement of the Accounting Arbitrator), and Buyer
and Seller shall each be entitled, as part of its presentation, to respond to
the presentation of the other party and any questions and requests of the
Accounting Arbitrator. In deciding any matter or item in dispute, the
Accounting Arbitrator (A) shall be bound by the provisions of this Section
3.3(c) and (B) shall not assign a value to any particular item greater than
the greatest value for such 

item claimed by either Buyer or Seller, or less than the lowest value for such
item claimed by either Seller or Buyer, in each case as presented to the
Accounting Arbitrator. No party shall disclose to the Accounting Arbitrator,
and the Accounting Arbitrator shall not consider for any purpose, any
settlement discussions or settlement offer made by any party, unless otherwise
agreed in writing by Buyer and Seller. The Accounting Arbitrator shall deliver
to Buyer and Seller, as promptly as practicable, and in any event within sixty
(60) days after its appointment, a written report setting forth the resolution
of such Disputed Amounts. The findings and determinations of the Accounting
Arbitrator as set forth in its written report shall be deemed final,
conclusive and binding upon the parties. The parties shall be entitled to seek
to have a judgment entered on such written report of the Accounting Arbitrator
in any court of competent jurisdiction. Upon the decision of the Accounting
Arbitrator, the Purchase Price Adjustment Statement, as adjusted to the extent
necessary to reflect the Accounting Arbitrator's decision, shall be the Final
Purchase Price Adjustment Statement. The fees, costs and expenses of the
Accounting Arbitrator shall be allocated to and borne by Buyer, on the one
hand, and Seller, on the other hand, based on the inverse of the percentage
that the Accounting Arbitrator's determination (before such allocation) bears
to the Disputed Amount as originally submitted to the Accounting Arbitrator.
For example, should the items in dispute total an amount equal to one thousand
dollars ($1,000) and the Accounting Arbitrator awards six hundred dollars
($600) in favor of Seller's position, sixty percent (60%) of the costs of its
review would be borne by Buyer, on the one hand, and forty percent (40%) of
the costs would be borne by Seller, on the other hand.

Section 3.4 Post-Closing Purchase Price Adjustment.

(a)In the event that the Closing Date Working Capital as reflected on the
Final Purchase Price Adjustment Statement is greater than the Estimated
Closing Date Working Capital, Buyer shall pay Seller an amount equal to the
difference; provided that, if the (i) Estimated Closing Date Working Capital
was less than Target Working Capital as of the Closing Date and (ii) Closing
Date Working Capital as reflected on the Final Purchase Price Adjustment
Statement is equal to or greater than Target Working Capital, then the amount
paid by Buyer to Seller under this Section 3.4(a) shall not exceed the
difference between the Estimated Closing Date Working Capital and the Target
Working Capital. In the event that Closing Date Working Capital as reflected
on the Final Purchase Price Adjustment Statement is less than the Estimated
Closing Date Working Capital, Buyer shall be entitled to payment from Seller
of such difference or, without duplication, out of the Adjustment Escrow
Account, and if the Adjustment Escrow Account is depleted in connection with
the foregoing or the other payments made pursuant to this Section 3.4(a), the
remainder of such amount from Seller; provided that, if the (i) Estimated
Closing Date Working Capital was equal to or greater than Target Working
Capital as of the Closing Date and (ii) Closing Date Working Capital as
reflected on the Final Purchase Price Adjustment Statement is less than Target
Working Capital, then the amount paid by Seller to Buyer under this Section
3.4(a) shall equal the difference between the Target Working Capital and the
Closing Date Working Capital as reflected on the Final Purchase Price
Adjustment Statement. In the event that the Closing Date Working Capital as
reflected on the Final Purchase Price Adjustment Statement is equal to the
Estimated Closing Date Working Capital, no adjustment will be due. For the
avoidance of doubt, if both the Estimated Closing Date Working Capital and the
Closing Date Working Capital as reflected on the Final Purchase Price
Adjustment 

Statement are equal to or greater than the Target Working Capital, no
adjustment shall be required pursuant to this Section 3.4(a).

(b)In the event that the Closing Date Cash as reflected on the Final Purchase
Price Adjustment Statement is greater than the Estimated Closing Cash Amount,
Buyer shall pay Seller an amount equal to the difference. In the event that
the Closing Date Cash as reflected on the Final Purchase Price Adjustment
Statement is less than the Estimated Closing Cash Amount, Buyer shall be
entitled to a payment from Seller or, without duplication, out of the
Adjustment Escrow Account, and if the Adjustment Escrow Account is depleted in
connection with the foregoing or the other payments made pursuant to this
Section 3.4, the remainder of such amount from Seller. In the event that the
Closing Date Cash as reflected on the Final Purchase Price Adjustment
Statement is equal to the Estimated Closing Cash Amount, no adjustment will be
due.

(c)In the event that the Closing Date Indebtedness as reflected on the Final
Purchase Price Adjustment Statement is greater than the Estimated Closing
Indebtedness Amount, Buyer shall be entitled to a payment from Seller or,
without duplication, out of the Adjustment Escrow Account, and if the
Adjustment Escrow Account is depleted in connection with the foregoing or the
other payments made pursuant to this Section 3.4, the remainder of such amount
from Seller. In the event that the Closing Date Indebtedness as reflected on
the Final Purchase Price Adjustment Statement is less than the Estimated
Closing Indebtedness Amount, Buyer shall pay Seller an amount equal to the
difference. In the event that the Closing Date Indebtedness as reflected on
the Final Purchase Price Adjustment Statement is equal to the Estimated
Closing Indebtedness Amount, no adjustment will be due.

(d)In the event that the Closing Date Company Transaction Expenses as
reflected on the Final Purchase Price Adjustment Statement are greater than
the Estimated Closing Date Company Transaction Expenses, Buyer shall be
entitled to a payment from Seller or, without duplication, out of the
Adjustment Escrow Account, and if the Adjustment Escrow Account is depleted in
connection with the foregoing or the other payments made pursuant to this
Section 3.4, the remainder of such amount from Seller. In the event that the
Closing Date Company Transaction Expenses as reflected on the Final Purchase
Price Adjustment Statement are less than the Estimated Closing Date Company
Transaction Expenses, Buyer shall pay Seller an amount equal to the
difference. In the event that the Closing Date Company Transaction Expenses as
reflected on the Final Purchase Price Adjustment Statement are equal to the
Estimated Closing Date Company Transaction Expenses, no adjustment will be
due.

(e)Any amounts payable pursuant to this Section 3.4 shall be paid within two
(2) Business Days after final determination of the Final Purchase Price
Adjustment Statement by wire transfer of immediately available funds to an
account designated in advance by the party receiving the payment. If Buyer is
entitled to any payment, on the one hand, and Seller is also entitled to any
payment, on the other hand, in each case pursuant to this Section 3.4, then
such payments shall be netted against each other for purposes of determining
the aggregate net amount payable to Seller, on the one hand, or Buyer, on the
other hand, as applicable. 

(f)Seller, on the one hand, and Buyer, on the other hand, agree to treat any
payment made pursuant to this Section 3.4 as an adjustment to the Purchase
Price for all Tax purposes, except as otherwise required by applicable Law.

Section 3.5 Escrowed Portion of the Purchase Price; Subsequent Payment Amount.

(a)At the Closing, Buyer shall deliver four million five hundred thousand
dollars ($4,500,000) (the "Adjustment Escrow Amount") to the Escrow Agent by
wire transfer of immediately available funds to an account referred to herein
as the Adjustment Escrow Account (the "Adjustment Escrow Account") that will
be designated and administered by the Escrow Agent pursuant to that certain
Escrow Agreement, dated as of the Closing Date, by and among Buyer, Seller and
the Escrow Agent, substantially in the form and on terms and conditions as set
forth in Exhibit B attached hereto (the "Escrow Agreement").

(b)After the Closing, Buyer shall pay the Subsequent Payment Amount to Seller
as follows: (i) a portion of the Subsequent Payment Amount equal to fifty
million dollars ($50,000,000) on the twelve (12) month anniversary of the
Closing Date, (ii) a portion of the Subsequent Payment Amount equal to fifty
million dollars ($50,000,000) on the twenty-four (24) month anniversary of the
Closing Date, (iii) a portion of the Subsequent Payment Amount equal to fifty
million dollars ($50,000,000) on the thirty-six (36) month anniversary of the
Closing Date, and (iv) a portion of the Subsequent Payment Amount equal to
fifty million dollars ($50,000,000) on the forty-eight (48) month anniversary
of the Closing Date. The payments to be made pursuant to this Section 3.5(b)
shall be made by wire transfer of immediately available funds to an account
designated in advance by Seller.

(c)Seller and Buyer agree to treat each payment of the Adjustment Escrow
Amount and the Subsequent Payment Amount made pursuant to this Section 3.5 as
(i) additional Purchase Price for U.S. federal income tax purposes, and (ii)
composed of an interest element and a principal element, such interest element
to be determined and reported consistent with Section 483 of the Code and the
Treasury Regulations thereunder.

ARTICLE IV

Representations and Warranties of Seller

Except as set forth in the Company Disclosure Schedule (it being agreed that
any matter disclosed in the Company Disclosure Schedule with respect to any
section of this Agreement shall be deemed to have been disclosed only with
respect to that section unless another section is specifically cross-
referenced or it is reasonably apparent from the face of such disclosure that
such disclosure also relates to such other section), Seller represents and
warrants to Buyer, as of the date hereof and as of the Closing Date, as
follows:

Section 4.1 Organization and Power. Seller (i) is duly organized, and validly
existing under the Laws of Indiana and (ii) has full power (corporate or
otherwise) and authority to execute, deliver and perform this Agreement and
the Ancillary Documents, to perform its obligations hereunder and thereunder,
and to consummate the transactions contemplated hereby and thereby. 

Section 4.2 Authorization and Enforceability.

(a)The execution and delivery of this Agreement and the Ancillary Documents to
which Seller is a party and the performance by Seller of the transactions
contemplated hereby and thereby that are required to be performed by Seller
have been duly authorized by the board of directors of Seller in accordance
with applicable Law and the articles of incorporation and bylaws of Seller,
and no other corporate (or other) proceedings on the part of Seller (including
any shareholder vote or approval) are necessary to authorize the execution,
delivery and performance of this Agreement and the Ancillary Documents to
which Seller is a party or the consummation of the transactions contemplated
hereby and thereby that are required to be performed by Seller.

(b)This Agreement and each of the Ancillary Documents to be executed and
delivered at the Closing by Seller constitute, or when executed and delivered
will constitute, the valid and legally binding agreements of Seller,
enforceable against Seller in accordance with their terms, subject to
bankruptcy, insolvency, reorganization and any other Laws of general
applicability relating to or affecting creditors' rights and to general equity
principles, as applicable.

Section 4.3 No Violation. The execution and the delivery by Seller of this
Agreement and the Ancillary Documents, the performance by Seller of its
obligations hereunder or thereunder, the consummation of the transactions
contemplated hereby and thereby that are required to be performed by Seller
and compliance with the terms of this Agreement and the Ancillary Documents by
Seller do not and will not conflict with or (a) violate any provision of the
articles of incorporation, bylaws or similar organizational documents of
Seller, (b) result in any violation of or default (or an event which with or
without notice or lapse of time or both would become a default) in any
material respect, give rise to a right of termination, cause the forfeiture of
any right, or require any notice or consent, under, any provision of any
Contract to which Seller is a party or by which Seller or any of its
respective properties is bound or affected, or (c) violate in any respect any
Law applicable to Seller or by which any of its respective properties is bound
or affected, except, in the case of clauses (b) and (c), (i) for any such
conflict, violation, default, termination, forfeiture or other occurrence
which would not prevent or materially delay Seller from performing its
obligations under this Agreement or the Ancillary Documents in any material
respect, and (ii) as set forth in Section 4.3 of the Company Disclosure
Schedule.

Section 4.4 Governmental Authorizations and Consents. Other than as may be
required under the Competition Laws of the United States and Germany, no
consent, license, approval or authorization of, or registration, declaration,
ruling, permit, waiver, acknowledgement or filing with, any Governmental
Authority ("Governmental Consents"), is required from any Person pursuant to
applicable Law (a) in connection with the transactions contemplated by this
Agreement or any Ancillary Documents, or (b) which is otherwise necessary to
permit Seller to perform its obligations under this Agreement or the Ancillary
Documents, which, if not made or obtained, would prevent or delay Seller from
performing its obligations hereunder or thereunder.

Section 4.5 Litigation. There is no material Litigation pending or, to the
Knowledge of Seller, threatened against Seller that would reasonably be
expected to prevent or materially delay Seller from carrying out its
obligations under this Agreement, the Ancillary Documents or the transactions
contemplated hereby or thereby. Seller is not subject to any Order that would
reasonably 

be expected to materially affect the ability of Seller to carry out its
obligations under this Agreement, the Ancillary Documents or the transactions
contemplated hereby or thereby.

Section 4.6 No Brokers. Neither Seller nor any of Seller's Employees, agents
or Representatives, has employed or incurred any Liability to any broker,
finder or agent for any brokerage fees, finder's fees, commissions or other
amounts with respect to this Agreement, the Ancillary Documents or the
transactions contemplated hereby or thereby.

ARTICLE V.

Representations and Warranties of Seller Relating to the Company

Except as set forth in the Company Disclosure Schedule (it being agreed that
any matter disclosed in the Company Disclosure Schedule with respect to any
section of this Agreement shall be deemed to have been disclosed only with
respect to that section unless another section is specifically cross-
referenced or it is reasonably apparent from the face of such disclosure that
such disclosure also relates to such other section), Seller represents and
warrants as of the date hereof and as of the Closing Date as follows:

Section 5.1 Organization and Power. The Company is a limited liability
company, duly formed, validly existing and in good standing, as applicable,
under the Laws of Indiana. The Company has full power and authority to
execute, deliver and perform this Agreement and the Ancillary Documents and to
consummate the transactions contemplated hereby and thereby. The Company has
all power (limited liability company or otherwise) and authority, and
possesses all governmental licenses, permits, authorizations and approvals,
necessary to enable it to own or lease and to operate its properties and
assets and carry on the Business as currently conducted, except such power,
authority, licenses, permits, authorizations and approvals the absence of
which would not have, or would not reasonably be expected to have a Company
Material Adverse Effect. The Company is duly qualified to conduct its business
as a foreign entity and is in good standing under the Laws of the
jurisdictions listed on Section 5.1 of the Company Disclosure Schedule, which
are all of the jurisdictions where the nature of its business or the ownership
or leasing of its property requires such qualification, except for any
jurisdiction where the failure to be qualified would not and would not
reasonably be expected to have a Company Material Adverse Effect. Seller has
made available to Buyer a true and correct copy of Seller's articles of
incorporation and bylaws and the Company's articles of organization and
operating agreement, in each case as in effect on the date of this Agreement.
Such organizational documents have not been further amended and are in full
force and effect and neither Seller nor the Company is in material violation
of any of the provisions of its respective organizational documents. Complete
and accurate copies of all limited liability company Business Records of the
Company have been made available and such records reflect all substantive
actions taken and authorizations made or meetings of the Company's members or
boards of managers (or other equivalent governing body), or any committees
thereof, and by the equity holders thereof.

Section 5.2 Authorization and Enforceability.

(a)The execution and delivery of this Agreement and the Ancillary Documents to
which the Company is a party and the performance by the Company of the
transactions 

contemplated hereby and thereby that are required to be performed by the
Company have been duly authorized by the managing member of the Company prior
to the Closing, in accordance with applicable Law and the articles of
organization and operating agreement of the Company, and no other limited
liability company proceedings on the part of the Company (including any
equityholder vote or approval) are necessary to authorize the execution,
delivery and performance of this Agreement and the Ancillary Documents to
which the Company is a party or the consummation of the transactions
contemplated hereby and thereby that are required to be performed by the
Company.

(b)This Agreement and each of the Ancillary Documents to be executed and
delivered at the Closing by the Company constitute, or when executed and
delivered will constitute, the valid and legally binding agreements of the
Company, enforceable against the Company in accordance with their terms,
subject to bankruptcy, insolvency, reorganization and any other Laws of
general applicability relating to or affecting creditors' rights and to
general equity principles, as applicable.

Section 5.3 Capitalization of the Company; No Subsidiaries.

(a)Seller owns of record and beneficially all of the Company Interests, free
and clear of any Liens or restrictions on transfer (other than any restriction
under any securities Law or the Company's articles of organization and
operating agreement). The Company has no authorized and outstanding Equity
Securities other than the Company Interests. No Person has preemptive rights
with respect to the Company Interests or any other Equity Securities of the
Company. There are no options, warrants, purchase rights, rights of first
refusal, calls, puts or similar rights or other Contracts (other than this
Agreement) to sell, transfer or dispose of or acquire any Equity Securities of
the Company. Neither Seller nor the Company is a party to any voting trust,
proxy or other Contract relating to the voting of any Equity Securities of the
Company and there are no instruments convertible or exercisable into or
exchangeable for any Equity Securities of the Company. The Company does not
own any Equity Securities, or any interest convertible or exercisable into or
exchangeable for, at any time, any Equity Securities in, any Person.

(b)The Company does not have, and has not had, any Subsidiary.

Section 5.4 No Violation. The execution and the delivery by the Company of
this Agreement and the Ancillary Documents to which the Company is a party,
the performance by the Company of its obligations hereunder or thereunder, the
consummation of the transactions contemplated hereby and thereby, that are
required to be performed by the Company and compliance with the terms of this
Agreement and the Ancillary Documents to which the Company is a party do not
and will not (a) conflict with or violate any provision of the articles of
organization or operating agreement of the Company, (b) conflict with or
result in any violation of or default (or an event which with or without
notice or lapse of time or both would become a default), give rise to a right
of termination, cause the forfeiture of any right, or require any notice or
consent, under, any provision of any Contract to which the Company is a party
or by which the Company or any of its properties is bound or affected, or (c)
assuming that all Governmental Consents contemplated by Section 5.5 have been
obtained and all filings and expiration of any waiting period described in any
of such Governmental Consents have been made or occurred, conflict with or
violate any Law applicable to the Company or by which its or any of its
properties is bound or affected, except, in the case of 

clauses (b) and (c), for any such conflict, violation, default, termination,
forfeiture or other occurrence which would neither prevent nor materially
delay the Company or Seller from performing its obligations under this
Agreement or the Ancillary Documents.

Section 5.5 Governmental Authorizations and Consents. Other than as may be
required under the Competition Laws of the United States and Germany, no
Governmental Consent is required from any Person pursuant to applicable Law
(a) to permit the Company to carry on the Business after Closing, (b) in
connection with the transactions contemplated by this Agreement or any
Ancillary Documents, or (c) which is otherwise necessary to permit the Company
to perform its obligations under this Agreement or the Ancillary Documents,
which, if not made or obtained, would prevent or materially delay the Company
from performing its obligations hereunder or thereunder.

Section 5.6 Financial Statements.

(a)Section 5.6(a) of the Company Disclosure Schedule sets forth the following
financial statements (the "Financial Statements"): (i) the audited balance
sheet of the Company as of December 31, 2016, and the related audited
statements of income, parent company net investment in the Company and cash
flows for the fiscal year ending December 31, 2016 (the "Most Recent Audited
Financial Statements") and (ii) the unaudited balance sheet of the Company as
of June 30, 2017 and the related unaudited statements of income and cash
flows, respectively, for the six (6) month period ended on such date and the
comparable prior year period (such June 30, 2017 statements, the "Most Recent
Unaudited Financial Statements").

(b)Each of the Financial Statements has been prepared in accordance with GAAP
applied on a basis consistent with prior periods and fairly presents in all
material respects the financial condition of the Company as of its respective
date and the statements of income, parent company net investment, or cash
flows, as the case may be, of the Company for the period covered thereby,
subject, in the case of the Most Recent Unaudited Financial Statements, to
customary year-end and audit adjustments (none of which are reasonably
expected to be, in the aggregate, material) and the absence of footnote
disclosure.

(c)The Company has established and maintains a system of internal accounting
controls sufficient to provide reasonable assurance that (i) transactions are
executed in accordance with management's general or specific authorizations
and with applicable Law, (ii) transactions, including transactions between the
Company, on the one hand, and Seller or its Affiliates, on the other hand, are
recorded as necessary to permit preparation of financial statements in
conformity with GAAP and to maintain asset accountability therein, (iii)
access to assets is permitted only in accordance with management's general or
specific authorization, and (iv) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate
action is taken with respect to any difference, except, in the case of each of
(i) through (iv), for any deficiency that, individually or in the aggregate,
is insignificant. Neither the Company nor, to the Knowledge of the Company,
Seller, has received any advice or notification from its or Seller's
independent accountant or auditor that would have the effect of not reflecting
or incorrectly reflecting, in the Business Records of the Company, any
material properties, assets, liabilities, revenues, expenses, equity accounts
or other accounts. 

Section 5.7 Business Records.

(a)The Business Records have been maintained in accordance with the Company's
customary business practices and fairly and accurately reflect, in all
material respects, on a basis consistent with past periods and throughout the
periods involved, all transactions and dispositions of the Company.

(b)None of Seller, the Company or, to the Knowledge of the Company, any of
their respective Representatives, has received or, to the Knowledge of the
Company, otherwise had or obtained knowledge of any material complaint,
allegation, assertion or Claim, whether written or oral, regarding the
accounting or auditing practices, procedures, methodologies or methods of the
Company or its internal accounting controls, including any material complaint,
allegation, assertion or Claim that the Company has engaged in questionable or
improper accounting practices, practices that are contrary to GAAP or
questionable or improper behavior in connection with any audit.

Section 5.8 No Undisclosed Liabilities. Except as reflected in the Most Recent
Audited Financial Statements, the Company does not have any Liabilities
(whether or not the subject of any other representation or warranty hereunder)
except for Liabilities that may have arisen in the ordinary course of business
consistent with past practice since the date of the Most Recent Audited
Financial Statements and which are not, and would not reasonably be expected
to be, individually or in the aggregate, material to the Company.

Section 5.9 Absence of Certain Changes. Since the date of the Most Recent
Audited Financial Statements: (a) the Company has conducted the Business in
the ordinary course and in a manner consistent with past practice, and (b)
there has not been any Event that has had, or would reasonably be expected to
have a Company Material Adverse Effect. Since the date of the Most Recent
Unaudited Financial Statements, the Company has not taken any action that, if
taken after the date of this Agreement, would constitute a breach of any of
the covenants set forth in Section 7.1.

Section 5.10 Arrangements with Affiliates. Except for the activities
contemplated and intended to be continued following the Closing through either
the commercial supply agreement and corresponding quality agreement with
respect to the in vitro fertilization media manufactured by the Company on
behalf of Seller and/or its Affiliates (the "IVF Media Supply Agreement") or
the Transition Services Agreement, neither Seller, nor any direct or indirect
equity holder, officer, director or manager of Seller, nor any Affiliate of
the foregoing (other than the Company) (a) has any interest in any property
(real, personal, or mixed and whether tangible or intangible), used in or
pertaining to the Business as currently conducted or contemplated to be
conducted, (b) is a party to any Contract (except for arm's-length employment
and similar agreements, which are set forth in Section 5.10 of the Company
Disclosure Schedule) with the Company, including with respect to compensation
or remuneration to be paid to such direct or indirect equity holder, officer,
director or manager of Seller or its Affiliate in connection with this
Agreement or the transactions contemplated hereby, or (c) has any Claim
against or owes any amount (whether as obligor, guarantor or otherwise) to, or
is owed (whether as obligor, guarantor or otherwise) any amount by, the
Company (collectively, "Affiliate Arrangements"). 

Section 5.11 Indebtedness to and from Officers and Directors of the Company.
The Company does not owe any amounts for borrowed money (whether as obligor,
guarantor or otherwise), directly or indirectly, to Seller or its Affiliates
(other than the Company) or any amounts to any Person who is an officer or
director of the Company or any of its Affiliates other than for salaries or
other employment-related compensation for services rendered or reimbursable
business expenses made to Employees in the ordinary course of business and
consistent with past practice.

Section 5.12 Assets.

(a)The assets and rights of the Company include all of the assets and rights
of the Company used in the conduct of the Business as conducted as of the date
of the Most Recent Audited Financial Statements, subject only to such changes
as have occurred in the ordinary course of business consistent with past
practice since such date. All such fixed assets (other than the Real Property)
necessary for the conduct of the Business are (i) in good operating condition
and repair, ordinary wear and tear excepted, (ii) not in need of maintenance
or repair, except for ordinary routine maintenance or repairs that are not
material in nature or cost, and (iii) adequate and sufficient for the
continuing conduct of the Business as presently conducted.

(b)The Company has good and marketable title to, a valid leasehold interest
in, or a valid license to use, all of the tangible assets shown on the Most
Recent Audited Financial Statements or acquired thereafter, free and clear of
any Lien, except for (i) assets disposed of since such date in the ordinary
course of business consistent with past practice or otherwise permitted by
this Agreement, (ii) Liens reflected in the Financial Statements or the notes
thereto, (iii) assets validly leased from third parties and (iv) Permitted
Liens and Liens that will be terminated at Closing.

(c)As of the Closing, after giving effect to the transactions contemplated
hereby, the Company will own, possess, license, lease or otherwise have
control of all assets (including pursuant to Contracts) necessary for the
conduct of the Business substantially in the manner conducted immediately
prior to the Closing.

Section 5.13 Real Property.

(a)(i) The Company does not own any real property other than the Real
Property, and (ii) the Real Property is owned by the Company free and clear of
all Liens, other than Permitted Liens, zoning restrictions and other
requirements imposed by governmental and/or quasi-governmental authority,
rights of tenants in possession under the Leases, matters that would be shown
by a current and accurate survey of the Real Property, and other restrictions,
conditions, limitations, easements and reservations of record.

(b)Section 5.13 of the Company Disclosure Schedule sets forth all real
property leases, subleases or other occupancies to which the Company is party
as lessor or lessee or which the Company suffers or permits (the "Leases"). A
true, correct and complete copy of each written Lease has been made available
by Seller to Buyer. To the Knowledge of the Company, there is no material
default under any Lease, whether by a lessor, a lessee or any other party to
an occupancy. 

(c)There is no pending or, to the Knowledge of the Company, threatened,
condemnation, expropriation, eminent domain, rezoning or similar proceeding
affecting all or any part of the Real Property, and the Company has not
received any written notice thereof in the past twelve (12) months.

(d)To the Knowledge of the Company, it is not in violation in any material
respect of a condition or agreement contained in any easement, restrictive
covenant or any similar instrument or agreement affecting any of the Real
Property.

(e)To the Knowledge of the Company there is no proposed reassessment of any
Real Property by any Taxing Authority and there is no threatened or pending
special assessment or Litigation that could give rise to a material increase
in real property Taxes or assessments against any of the Real Property.

(f)The buildings and other structures on the Real Property are in good repair,
ordinary wear and tear excepted, and fit for the purposes for which they are
presently used in all material respects. For purposes of this Section 5.13(f),
"material" means any condition that requires more than two hundred fifty
thousand dollars ($250,000) of labor and/or materials to remedy.

(g)The Company has not received from any Governmental Authority written notice
in the past thirty-six (36) months requiring any work, repairs, construction,
alterations or installations on or in connection with the Real Property or
asserting or alleging any violation of any Law (including zoning or
Environmental Laws) applicable (or alleged to be applicable) to the Real
Property, or any part thereof, that has not been corrected. Neither the
Company nor, to the Knowledge of the Company, Seller or any Representative of
the Company or Seller has received in the past thirty-six (36) months written
notice of a zoning change that would affect the Real Property in any material
respect.

(h)The Company has paid, or will pay when due, for all work, labor and
materials furnished to the Company in connection with the Real Property prior
to the Closing Date, and there is no mechanic's or materialmen's Lien, filed
or otherwise claimed in writing, in connection with any such work, labor and
materials performed on or furnished in connection with the Real Property prior
to the Closing Date.

Section 5.14 Intellectual Property.

(a)Section 5.14(a) of the Company Disclosure Schedule lists all Registered
Owned Intellectual Property. The Company is the exclusive owner of, and has
good and marketable title to, the Owned Intellectual Property free and clear
of all Liens, except Liens that will be terminated at Closing. The Company
Intellectual Property is not subject to any Order or agreement that would
adversely affect the validity or enforceability of, or the Company's use of or
rights to, the Company Intellectual Property. The execution and delivery of
this Agreement and the consummation of the transactions contemplated hereby
(alone or in combination with any other event), and the compliance with the
provisions of this Agreement do not and will not conflict with, alter, or
impair any of the rights of the Company in any Company Intellectual Property
or the validity, 

enforceability, use, right to use, ownership, priority, duration, scope, or
effectiveness of any Company Intellectual Property.

(b)The operation of the Business does not infringe, misappropriate, dilute or
otherwise violate or conflict with any other Person's Intellectual Property
rights, and has not done so in the last five (5) years. To the Knowledge of
the Company, no Person is engaging, or has engaged in the last five (5) years,
in any activity that infringes, misappropriates, dilutes or otherwise violates
or conflicts with any Company Intellectual Property.

(c)There is no Claim pending, asserted in writing or threatened in writing, by
or against the Company concerning any of the matters referenced in Section
5.14(b) or otherwise concerning the ownership, validity, registerability,
enforceability or use of, or licensed right to use, any Company Intellectual
Property or Products and Services, nor has the Company received any
unsolicited written notification or other information that a license under any
other Person's Intellectual Property is or may be required to operate the
Business.

(d)The Company has taken all reasonable measures consistent with industry best
practices to maintain the confidentiality and value of all Confidential
Information used or held for use in the operation of the Business. The Company
has not experienced an unauthorized disclosure or unauthorized use of material
Confidential Information. The Company has obtained written confidentiality and
non-disclosure agreements executed by all of its suppliers, contractors and
customers obliging them to acknowledge and protect material Confidential
Information.

(e)The Company is a party to valid and enforceable written agreements with all
Persons that have conceived, developed, acquired or created Intellectual
Property for the Company, pursuant to which the entire right, title and
interest in and to that Intellectual Property is assigned to the Company and
each such Person has agreed to maintain the confidentiality of such
Intellectual Property to the extent that it constitutes Confidential
Information.

(f)The Company IT Assets are adequate for, and operate and perform in all
material respects in accordance with the requirements for, the operation of
the Business. The Company has implemented appropriate backup, security, anti-
virus, and disaster recovery measures and technology consistent with industry
best practices to adequately and properly ensure the continuing availability
of the functionality provided by the Company IT Assets and to safeguard
against the unauthorized use, copying, disclosure, modification, theft or
destruction of and access to, system programs and data comprised by the
Company IT Assets. In the five (5) years immediately preceding the Closing
Date, (i) no Person has obtained unauthorized access to any Company IT Assets
nor has any data been compromised thereby; (ii) the Company IT Assets have not
materially malfunctioned or failed; (iii) the data processing and data storage
facilities used by the Company in connection with the operation of the
Business have been adequately and properly protected consistent with industry
best practices; and (iv) the Company has been and is in material compliance
with all Company Intellectual Property Contracts pursuant to which it is
licensed or otherwise authorized to use any IT Assets.

(g)The operation of the Company IT Assets by or on behalf of the Company, and
the use, collection, storage and dissemination of personally identifiable
information, customer 

and user data, and other data and content in connection therewith or otherwise
in connection with the Business, have not violated, and do not violate, any
applicable Law or any Person's privacy, publicity or confidentiality rights
(collectively, "Privacy Laws"). There is no Claim pending or threatened by or
against the Company alleging any violation of any Privacy Laws.

Section 5.15 Contracts.

(a)Material Contracts. Section 5.15(a) of the Company Disclosure Schedule is a
true and complete list of all of the following Contracts to which the Company
is a party, by which it is bound, or which otherwise pertain to the Business
(such Contracts as are required to be listed on Section 5.15(a) of the Company
Disclosure Schedule, the "Material Contracts"):

(i)Contracts evidencing or relating to Indebtedness;

(ii)Contracts evidencing or relating to any obligations of the Company with
respect to the issuance, sale, repurchase or redemption of any Equity
Securities of the Company;

(iii)Contracts with any customers of, or suppliers to, the Company (A) that
involved payments to or from the Company in excess of one hundred fifty
thousand dollars ($150,000) in the most recent twelve (12) month period
(except that individual purchase orders with suppliers are not separately
listed) or (B) that the Company reasonably anticipates may involve payments to
or from the Company in excess of one hundred fifty thousand dollars ($150,000)
in any twelve (12) month period (except that individual purchase orders with
suppliers are not separately listed);

(iv)all Contracts (other than customary confidentiality and non-disclosure
agreements) with Top Customers and Top Suppliers;

(v)all Real Property Contracts;

(vi)the Company Intellectual Property Contracts other than licenses of
Commercial Software;

(vii)all Consultant Agreements, Employee Agreements and any proposed
amendments thereto;

(viii)all collective bargaining agreements and other Contracts with unions or
similar organizations;

(ix)Contracts evidencing partnerships or joint ventures in which the Company
has an interest;

(x)Contracts that obligate the Company with respect to contingent payments of
any type;

(xi)Contracts (other than arm's-length Employee Agreements and Consultant
Agreements) by and between the Company and (A) any Affiliate of the Company, 

(B) other Persons with whom the Company is not dealing at arm's-length, (C)
Employees or (D) entities controlled by any Employees;

(xii)leases of personal property under which the Company is the lessee and is
obligated to make payments in excess of fifty thousand dollars ($50,000) per
annum;

(xiii)Contracts that are settlement Contracts of any nature, including any
settlement with any Governmental Authority;

(xiv)Contracts with any Governmental Authority;

(xv)Contracts relating to the acquisition or disposition of any Equity
Securities, business or product line of any other Person entered into at any
time during the last five (5) years;

(xvi)Contracts limiting the freedom of the Company or any Affiliate to engage
in any line of business, acquire any entity or compete with any Person or in
any market or geographical area, or to solicit any individual or class of
individuals for employment;

(xvii)Contracts that grant, or agree to grant, any Person a right to "most
favored nation" pricing terms or which imposes on the Company any take-or-pay
or similar minimum purchase requirements;

(xviii)Contracts (other than customary confidentiality and non-disclosure
agreements) with any broker, distributor or sale representative;

(xix)Contracts pursuant to which the Company has agreed to share profits or
revenues; and

(xx)any Contracts not otherwise listed above involving payments to or from the
Company in excess of one hundred fifty thousand dollars ($150,000) per annum
or that (regardless of amount) otherwise are, individually or in the
aggregate, material to the Company.

(b)Status of Material Contracts. A true and complete copy of each Material
Contract (other than the purchase orders described in clause (a)(iii) above)
has been made available to Buyer. All Material Contracts are valid, binding
and in full force and effect and enforceable by the Company in accordance with
their respective terms, subject to bankruptcy, insolvency, reorganization and
any other Laws of general applicability relating to or affecting creditors'
rights and to general equity principles, as applicable. As to each Material
Contract, there does not exist any breach, violation or default on the part of
the Company or, to the Knowledge of the Company, any other party to such
Material Contract, and there does not exist any Event, or, to the Knowledge of
the Company, threatened Event (including the execution, delivery and
performance of this Agreement and the Ancillary Documents to which the Company
is a party or the consummation of the transactions contemplated hereby and
thereby), which (with or without notice, passage of time, or both) would
constitute a breach, violation or default thereunder on the part of the
Company, which breach, violation or default would be, or would reasonably be
expected to be, individually 

or in the aggregate, material to the Company. No waiver has been granted by
the Company or any of the other parties thereto under any of the Material
Contracts. The Company has not received (or given) notice to terminate any
Material Contract.

Section 5.16 Compliance with Laws.

(a)The Company is not, and during the last five (5) years has not been, in
violation in any material respect of any applicable Law, including the Food,
Drug and Safety Laws. To the Knowledge of the Company, no Event has occurred
or exists that (with or without notice or lapse of time) would constitute or
result in a violation in any material respect by the Company of, or failure on
the part of the Company to comply with, in any material respect, any
applicable Law. The Company has all material Licenses and Permits that are
required or used for the conduct of the Business in accordance with applicable
Law, all of which are set forth on Section 5.16(a) of the Company Disclosure
Schedule. To the Knowledge of the Company, all Licenses and Permits are in
full force and effect and are being complied with in all material respects,
and there is no Litigation pending or, to the Knowledge of the Company,
threatened that seeks a material change to or the revocation, cancellation, or
termination of, any Licenses and Permits.

(b)Neither the Company nor any Employees, nor, to the Knowledge of the
Company, its Representatives or any other Person associated with or acting on
behalf of the Company have at any time, directly or indirectly, (i) used any
funds for unlawful contributions, gifts, entertainment or other unlawful
payments relating to political activity, or failed to disclose fully any such
contributions in violation of applicable Law, (ii) given, offered, promised,
conspired or authorized to give, any money or thing of value to any foreign or
domestic government official or employee (including officials or employees of
state-owned or controlled businesses and institutions), any foreign or
domestic political party or campaign official, candidate for foreign political
office, officials or employees of public international organizations, or any
other Person connected to a government or acting on behalf of the foregoing
(collectively, a "Government Official"), for the purpose of influencing an act
or decision of the Government Official, or inducing the Government Official to
use his or her influence or position to affect any government act or decision
relating in any way to the business of the Company; or (iii) given, offered,
promised, conspired or authorized to give, any money or thing of value to any
Person (Government Official or private party) in violation of the U.S. Foreign
Corrupt Practices Act of 1977; the U.S. Travel Act, 18 U.S.C. ยง 1952; the U.K.
Bribery Act 2010; any applicable Law enacted in connection with, or arising
under, the OECD Convention on Combating Bribery of Foreign Public Officials in
International Business Transactions; or any other applicable Law or regulation
of any foreign or domestic jurisdiction relating to bribery or corruption
(collectively, "Anti-Corruption Laws"), during the last five (5) years. The
Company has not received any communication from a Governmental Authority that
alleges that the Company, or any of the Employees or Representatives of the
Company, or any other Person associated with or acting on behalf of the
Company, is or may be in violation of, or has, or may have, any unresolved
liability under, any Anti-Corruption Law. All Business Records of the Company
relating to periods prior to the Closing accurately and fairly reflect, in
reasonable detail and in accordance with applicable accounting and auditing
standards, all transactions and dispositions of funds or assets; and there
have been no intentionally false or fictitious entries made 

in such Business Records relating to any illegal payment or secret or
unrecorded fund, and the Company has not established or maintained a secret or
unrecorded fund.

(c)Each of the Company and its Employees, and, to the Knowledge of the
Company, each of the Representatives and any other Persons associated with or
acting on behalf of the Company, is, and has at all times during the last five
(5) years been, in compliance in all material respects with all applicable
Sanctions and Export Controls and no action has been taken by the Company
(including any of its Employees and, to the Knowledge of the Company, any
Representative or any other Person associated with or acting on behalf of the
Company) that would be reasonably expected to cause a material violation of
Sanctions or Export Controls. None of the Company, nor any Affiliate or
Employee of the Company, nor to the Knowledge of the Company, any
Representative or any other Person associated with or acting on behalf of the
Company, is a Sanctioned Person, nor has the Company had any direct or
indirect dealings with any Sanctioned Person or in any Sanctioned Country
during the last five (5) years. The Company has obtained all licenses,
permits, and authorizations required to comply with Sanctions and Export
Controls.

(d)To the Knowledge of the Company, (i) no director, officer or employee (as
those terms are defined in 42 C.F.R. ยง 1001.1001) of the Company and (ii) no
customer of the Company, or any other Person with which the Company does
business in the ordinary course, is excluded from participation under any
Federal Health Care Program or barred under any of the Food, Drug and Safety
Laws.

(e)To the Knowledge of the Company, during the last five (5) years, no
Employee or agent of the Company has (i) made an untrue statement of a
material fact or fraudulent statement to the FDA or any other Governmental
Authority, failed to disclose a material fact required to be disclosed to the
FDA or any other Governmental Authority, or committed an act, made a statement
or failed to make a statement that, at the time such disclosure was made,
could reasonably be expected to provide a basis for the FDA or any other
Governmental Authority to invoke with respect to the Company its policy
respecting "Fraud, Untrue Statements of Material Facts, Bribery, and Illegal
Gratuities," set forth in 56 Fed. Reg. 46191 (Sept. 10, 1991) or any similar
policy (except for any statement, omission, act or invocation as would not be
material, individually or in the aggregate, to the Company) or (ii) been
convicted of any crime or engaged in any conduct for which debarment is
mandated or authorized by 21 U.S.C. ยง 335a or any similar Law.

Section 5.17 Regulatory Matters. During the last five (5) years, the Company
has not received written notice that any U.S. or foreign Governmental
Authority (including the FDA and DEA) has (a) commenced any action to withdraw
its approval or request the recall of any products made, fabricated or
developed (or intended to be made, fabricated or developed) by the Company
(including products that the Company, or any third party on its behalf,
fabricates, manufactures, processes, tests, stores, transports, imports,
handles, packages and/or labels for sale or distribution) or the services
rendered (or intended to be rendered) by the Company or any third party on its
behalf (the "Products and Services") or (b) commenced any action to enjoin
production, distribution or advertising of the Company's Products and Services
or (c) declined to permit any product made, fabricated or developed by the
Company to enter any jurisdiction anywhere in the world, except, in the case
of each of clauses (a), (b) and (c), any such action, request or decision as
would not be 

material, individually or in the aggregate, to the Company. During the last
five (5) years, the Company has not undertaken any voluntary recall of any
product that (x) the Company makes, fabricates, develops or distributes or (y)
contains an active pharmaceutical ingredient or drug substance made,
fabricated, developed, distributed or handled by the Company where such recall
was caused by an act or omission of the Company. During the last five (5)
years, the Company has not received any FDA Form 483, warning letter, untitled
letter or other similar notification under or in connection with the Food,
Drug and Safety Laws in any jurisdiction with respect to the business,
properties or Products and Services of the Company, except for any letter or
notification as would not be material, individually or in the aggregate, to
the Company. The Company has not received any warning letter, written
communication or document from any Governmental Authority (or any customer of
the Company) relating to any of the Products and Services of the Company that
assert lack of compliance by the Company in any material respect with any
applicable Law or regulatory requirements of any Governmental Authority,
except for any letter or notification as would not be material, individually
or in the aggregate, to the Company. During the last five (5) years, the
Company has filed all reports and notifications with each relevant
Governmental Authority as required by applicable Law in relation to the
Products and Services of the Company.

Section 5.18 Environmental Matters.

(a)The Company (i) is, and at all times has been, in compliance in all
material respects with all applicable Environmental Laws, and (ii) has
obtained, and is in compliance in all material respects with, all Licenses and
Permits, registrations and other Governmental Consents required by applicable
Environmental Laws ("Environmental Permits"), and has made all appropriate
filings for issuance or renewal of such Environmental Permits.

(b)There has been no Release or, to the Knowledge of the Company, threatened
Release, of Hazardous Materials (x) at, under, about or migrating to or from
any Real Property currently or, to the Knowledge of the Company, formerly
owned, leased or operated by the Company (or any predecessor of the Company)
or (y) arising from the operations of the Company, in each case, that would
(i) require notification to any Governmental Authority, investigation and/or
remediation pursuant to any Environmental Law or (ii) be reasonably likely to
give rise to material Liabilities pursuant to any Environmental Law.

(c)To the Knowledge of the Company, there is no past or present condition,
event, circumstance, fact, activity, practice, incident, action, omission or
plan that may (i) interfere with or prevent continued material compliance by
the Company with Environmental Laws and the requirements of Environmental
Permits or (ii) give rise to any material Liability or other obligation under
any Environmental Law.

(d)Neither the Company nor, to the Knowledge of the Company, any predecessor
of the Company, has used any waste disposal site, or otherwise disposed of,
transported, or arranged for the transportation of, any Hazardous Materials to
any place or location (i) in violation of any Environmental Law in any
material respect, or (ii) in a manner that has given or is reasonably likely
to give rise to material Liabilities pursuant to any Environmental Law. 

(e)There is no Claim, notice (including any notice that the Company (or any
predecessor of the Company) or any Person whose Liability has been retained or
assumed contractually by the Company is or may be a potentially responsible
Person or otherwise liable in connection with any site or other location
containing Hazardous Materials or used for the storage, handling, treatment,
processing, disposal, generation or transportation of Hazardous Materials),
Litigation or Order or other proceeding pending or, to the Knowledge of the
Company, threatened that is based on or related to any Environmental Matter
relating to the Business.

(f)The Company has made available to Buyer true and complete copies and
results of all environmental site assessments (including Phase I or Phase II
environmental site assessments) and audits and any other material documents or
correspondence possessed or initiated by the Company or Seller pertaining to
Environmental Matters and relating to the Company or any of its predecessors
or any other Person for whose conduct they are or may be responsible, or any
facility currently or formerly owned, leased, or operated by the Company or
any of its predecessors.

Section 5.19 Litigation. There is no, and during the last five (5) years there
has not been any, Litigation pending or, to the Knowledge of the Company,
threatened, involving the Company or its properties or the Business, or that
has been settled, dismissed or resolved, in each case that, (a) involves a
Claim that, if determined adversely, would, individually or in the aggregate,
reasonably be likely to be material to the Company or the Business or (b)
would prevent or materially delay the ability of Seller to consummate the
transactions contemplated hereby. The Company is not subject to any Order.

Section 5.20 Employee and Labor Matters.

(a)Section 5.20(a) of the Company Disclosure Schedule sets forth an accurate
and complete list of all Employees (other than former Employees) as of August
31, 2017 and their positions. As of the date hereof, complete information
concerning the respective salaries, wages, bonuses and other compensation paid
or payable by the Company during 2016 and 2015 as well as dates of employment,
and date and amount of last salary increase, of such Employees listed on
Section 5.20(a) of the Company Disclosure Schedule has been made available to
Buyer.

(b)There is no Claim (other than ordinary claims under Plans), dispute,
action, grievance or disciplinary action pending or, to the Knowledge of the
Company, threatened, by or between the Company and any Employee.

(c)The Company is not and has not during the last five (5) years been, a party
to any collective bargaining agreement or similar labor agreement with a labor
union or other employee representative.

(d)No labor strike, organized work stoppage, slowdown, lockout, unfair labor
practice charge or similar labor activity or dispute affecting the Company has
occurred during the last five (5) years or, to the Knowledge of the Company,
is threatened.

(e)There is no current union organization activity or representation question
involving Employees. 

(f)The Company is in compliance in all material respects with all applicable
Laws relating to employment and labor, including Laws relating to wages,
hours, overtime, classification of Employees as exempt or non-exempt,
collective bargaining, employment discrimination, safety and health,
immigration status, workers' compensation and the collection and payment of
withholding and employment Taxes. The Company is not under audit or
investigation by the Internal Revenue Service, the U.S. Department of Labor or
any other Governmental Authority and, to the Knowledge of the Company, no such
audit or investigation is threatened, with respect to any of its employment or
labor practices. The Company does not have any Liability for the
misclassification of any Person as an independent contractor, temporary
employee, leased employee or any other service provider compensated other than
through reportable wages (as an Employee) paid by the Company (any such
Person, a "Contingent Worker"), and no Contingent Worker has been improperly
excluded from any Plan. The Company does not have any leased employees within
the meaning of Section 414(n) of the Code.

Section 5.21 Employee Benefits.

(a)Section 5.21(a) of the Company Disclosure Schedule lists all Plans,
Consultant Agreements and Employee Agreements. No Plan, Consultant Agreement,
or Employee Agreement is established or maintained by Seller or the Company
outside the jurisdiction of the U.S. or for the benefit of any Employees,
Consultants, or other individual service providers of the Company who reside
or work outside of the U.S.

(b)With respect to each Plan, the Company has made available to Buyer true and
complete copies of, to the extent applicable: (i) the Plan document (or, if
such document is not written, a written summary of the material terms) and any
amendment, (ii) the summary plan description and summary of any material
modification, (iii) the two (2) most recent annual reports (Form 5500 and 990
series or equivalent if required under applicable Law), including all exhibits
and attachments thereto, and summary annual reports, (iv) the most recent
determination letter or opinion letter, if any, issued by the Internal Revenue
Service, and any pending request for such a letter, (v) all material
correspondence and documentation, and all non-routine filings made, with any
Governmental Authority, relating to participation under any amnesty, voluntary
compliance, self-correction or similar program, (vi) all non-routine, material
correspondence with Employees regarding any Plan, (vii) the most recent
audited financial statements prepared with respect thereto, to the extent that
financial statements are customarily prepared for a plan like the Plan, and
(viii) the most recent actuarial or other valuation reports prepared with
respect thereto. The Company has made available to Buyer copies of all
Employee Agreements and Consultant Agreements and any amendments thereto.

(c)Each Plan, Consultant Agreement and Employee Agreement has been maintained
and administered in compliance with its terms and in all material respects
with the requirements of applicable Law, including the Code, ERISA and the
Patient Protection and Affordable Care Act of 2010 (Pub. L. No. 111-148) and
the Health Care and Education Reconciliation Act of 2010 (Pub. L. No. 111-152)
(collectively, the "Affordable Care Act").

(d)Each Plan that is intended to be qualified under Section 401(a) of the Code
is and at all times has been so qualified, and, along with each related trust
intended to be exempt 

from federal income taxation under Section 501(a) of the Code, has received a
currently effective favorable determination letter or, if applicable, opinion
letter, from the Internal Revenue Service as to its qualification, and nothing
has occurred that could reasonably be expected to adversely affect such
qualification.

(e)All contributions, premiums or benefits that are due from the Company under
any Plan have been paid to or in respect of each such Plan (or have been
properly accrued and accounted for on the books of the Company in accordance
with GAAP, if applicable).

(f)Neither the Company nor any of its ERISA Affiliates has incurred or is
reasonably expected to incur any Liability under Title IV of ERISA, including
any Liability arising under Sections 4062, 4063, 4069 or Subtitle E of Title
IV of ERISA (relating to multiemployer plans) nor has Company nor any of its
ERISA Affiliates now or at any time within the previous six (6) years
contributed to, sponsored, or maintained any (i) "multiemployer plan" within
the meaning of Section 3(37) of ERISA, (ii) "single-employer plan" within the
meaning of Section 4001(a)(15) of ERISA, or (iii) "multiple employer plan"
within the meaning of Section 413(c) of the Code. Neither the Company nor any
ERISA Affiliate has now or at any time within the previous six (6) years
contributed to, sponsored or maintained any "multiple employer welfare
arrangement" within the meaning of Section 3(40) of ERISA.

(g)Neither the Company nor any Employee has engaged in a "Prohibited
Transaction" within the meaning of Section 4975 of the Code or Section 406 or
407 of ERISA, that is not otherwise exempt under Section 4975 of the Code or
Section 408 of ERISA, and, to the Knowledge of the Company, no such
"Prohibited Transaction" has occurred, with respect to any Plan.

(h)No Plan or Employee Agreement provides or has, within the past six (6)
years, provided for medical, life insurance, or other welfare benefits to any
Employee or Consultant, or any spouse or dependent of any such Employee or
Consultant, beyond retirement or other termination of employment (other than
as required under Code Section 4980B, or similar state Law).

(i)No Plan is under audit or investigation by the Internal Revenue Service,
the U.S. Department of Labor or any other Governmental Authority and, to the
Knowledge of the Company, no such audit or investigation is threatened.

(j)There are no pending or, to the Knowledge of the Company, threatened Claims
with respect to any Plan or the assets or any fiduciary thereof (in that
Person's capacity as a fiduciary of such Plan), other than ordinary course
claims for benefits brought by participants or beneficiaries.

(k)Each Plan, each Consultant Agreement and each Employee Agreement that
constitutes in any part a nonqualified deferred compensation plan within the
meaning of Section 409A of the Code (and that is not otherwise excluded from
Section 409A of the Code or applicable Treasury Regulations) has been operated
and maintained in all material respects in operational and documentary
compliance with the requirements of Section 409A of the Code and applicable
Treasury Regulations and guidance thereunder during the respective time
periods in which such requirements 

were applicable. There is no Contract to which the Company is a party or by
which it is bound that require the Company or any other Person to compensate
any Employee for Taxes paid pursuant to Section 409A of the Code.

(l)Neither the execution and delivery of this Agreement nor the consummation
of the transactions contemplated hereby (either alone or upon the occurrence
of any additional or subsequent events or the passage of time) will (i) result
in any payment becoming due to any Employee, (ii) increase any benefit under
any Plan, Consultant Agreement or Employee Agreement, (iii) result in the
acceleration of the time of payment, vesting or funding of, or other rights in
respect of, any benefit under any Plan, Consultant Agreement or Employee
Agreement or (iv) result in the triggering or imposition of any restrictions
or limitations on the right of the Company to amend or terminate any Plan,
Consultant Agreement or Employee Agreement (or result in any adverse
consequences for so doing).

(m)The execution of this Agreement and the consummation of the transactions
contemplated hereby will not (either alone or upon the occurrence of any
additional or subsequent events or the passage of time), as of the Closing,
constitute an Event under any Plan, Consultant Agreement or Employee Agreement
in effect as of the date hereof, or any employee benefit plan, agreement or
arrangement that, had it been in effect as of the date hereof, would be a
Plan, Consultant Agreement or Employee Agreement (as applicable) that will or
may result in the payment of any amount that may be deemed an "excess
parachute payment" under Section 280G of the Code. There is no Contract to
which the Company is a party or by which it is bound to compensate any
Employee for excise Taxes paid pursuant to Section 4999 of the Code.

(n)Each Plan that is also a "group health plan" for purposes of the Affordable
Care Act is in material compliance with the applicable terms of the Affordable
Care Act. The Company offers minimum essential health coverage, satisfying
affordability and minimum value requirements, to its full time employees
sufficient to prevent Liability for assessable payments under Code Sections
4980H. Each Plan that is a "group health plan" under the Affordable Care Act
is operated in material compliance with: (i) market reform mandates set forth
under Public Health Services Act Sections 2701 through 2709 and Sections 2711
through 2719A; (ii) fees and reporting requirements for Patient-Centered
Outcomes Research under Code Section 4376 and applicable regulations and
transitional reinsurance under 45 C.F.R. Sections 153.10 through 153.420;
(iii) information reporting rules as set forth under Code Sections
6051(a)(14), 6055 and 6056; and (iv) standards for electronic transactions and
operating rules under Social Security Act Sections 1171 and 1173. The Company
has not attempted to maintain the grandfathered health plan status under the
Affordable Care Act of any Plan.

Section 5.22 Tax Matters.

(a)For U.S. federal (and applicable state and local) income tax purposes, (i)
the Company is, and since January 1, 2009 has been, an entity disregarded as
separate from its owner within the meaning of Treasury Regulations ยง
301.7701-2(c)(2)(i), (ii) from the time of its formation until January 1,
2009, the Company was a partnership within the meaning of Treasury Regulations
ยง 301.7701-2(c)(1), and (iii) no election has been made, pursuant to Treasury
Regulations ยง 301.7701-3 or otherwise, to treat the Company as an association
taxable as a corporation. 

(b)All Tax Returns required to be filed by the Company or with respect to any
of the Company's assets or activities have been duly and timely filed. All
such filed Tax Returns are true and correct in all material respects, and all
Taxes required to be paid by the Company (whether or not reflected on such Tax
Returns) have been paid in full.

(c)None of the properties or assets of the Company is or at the Closing Date
will be encumbered by any Liens (other than Permitted Liens) and there are no
grounds for the assertion or assessment of any Liens against any of the
properties or assets of the Company in respect of any Taxes (other than
Permitted Liens).

(d)There is no Claim, Litigation, assessment, audit or similar event pending
or threatened with respect to any Tax or Tax Return relating to the Company or
any of the Company's assets or activities.

(e)No issue has been raised by any Taxing Authority in connection with an
audit or examination of any Tax Return that, if raised with regard to any
other Tax Return not so audited or examined, would reasonably be expected to
result in a proposed deficiency with respect to the period covered by such
other Tax Return. No Taxing Authority in a jurisdiction where the Company does
not file Tax Returns has made a Claim, assertion or threat that the Company is
or may be subject to taxation in such jurisdiction.

(f)The reserves for Taxes reflected in the Most Recent Unaudited Financial
Statements are adequate for the payment of all material Taxes of the Company
due or to become due in respect of all periods through the date of the Most
Recent Unaudited Financial Statements.

(g)All material Taxes that the Company has been required to collect or
withhold have been duly withheld or collected and, to the extent required,
have been paid to the proper Taxing Authority, including any such Taxes
required to be collected or withheld with respect to any Employee, independent
contractor, creditor, stockholder or other party. The Company has not received
any reports or other written assertions by agents of any Taxing Authority of
any deficiencies or other Liabilities for Taxes with respect to taxable
periods for which the limitations period has not run. The Company has not
waived any statute of limitations in respect of Taxes or agreed to any
extension of time with respect to a Tax assessment or deficiency.

(h)The Company has not participated in any "listed transaction" or similar
transaction within the meaning of Treasury Regulations ยง 1.6011-4(b)(2).

(i)The Company has no Liability for the Taxes of any Person other than the
Company under Treasury Regulations ยง 1.1502-6 (or any similar provision of
Law), as a transferee or successor, by Contract or otherwise.

(j)The Company will not be required to include any item of income in, or
exclude any deduction from, taxable income for any taxable period (or portion
thereof) ending after the Closing Date as a result of any: (i) change in
method of accounting, or the use of an improper method of accounting, for a
taxable period ending on or prior to or including the Closing Date; (ii)
"closing agreement" as described in Section 7121 of the Code (or any
corresponding or similar 

provision of state, local or non-U.S. Tax Law) executed on or prior to the
Closing Date; (iii) intercompany transactions as described in Treasury
Regulation ยง 1.1502-13 (or any corresponding or similar provision of state,
local or non-U.S. Tax Law) or excess loss account described in Treasury
Regulation ยง 1.1502-19 (or any corresponding or similar provision of state,
local or non-U.S. Tax Law) in existence prior to the Closing Date; (iv)
installment sale or open transaction disposition made on or prior to the
Closing Date; (v) prepaid or deposit amount received on or prior to the
Closing Date; (vi) election described in Section 108(i) of the Code (or any
corresponding or similar provision of state, local or non-U.S. Tax Law) made
on or before the Closing Date; (vii) "minimum gain chargeback" provision with
respect to "minimum gain" for periods (or portions of periods) ending on or
prior to the Closing Date pursuant to Subchapter K of the Code; or (viii) debt
instrument held on or before the Closing Date that was acquired with "original
issue discount" as defined in Section 1273(a) of the Code or is subject to the
rules set forth in Section 1276 of the Code.

(k)As to each Tax Incentive Agreement (all of which are listed in Section
5.22(k) of the Company Disclosure Schedule), (i) the Company has performed,
complied with and fulfilled all obligations and requirements thereunder
(including any requirement relating to employment, wages or maintenance of
operations) required to be performed, complied with or fulfilled prior to the
Closing Date and (ii) there does not exist any breach, violation or default on
the part of the Company or, to the Knowledge of the Company, any other party
to such Tax Incentive Agreement, and, to the Knowledge of the Company, there
does not exist any Event (including the execution, delivery and performance of
this Agreement and the Ancillary Documents to which the Company is a party or
the consummation of the transactions contemplated hereby and thereby), which
(with or without notice, passage of time, or both) would constitute a breach,
violation or default thereunder on the part of the Company or otherwise result
in a reduction or cancellation by a Governmental Authority of any tax credit,
tax abatement, expense reimbursement or other public aid under a Tax Incentive
Agreement.

Section 5.23 Insurance. The Company is provided general liability, product
liability, property, casualty, motor vehicle, workers' compensation, and other
types of insurance by Seller in the amounts described in Section 5.23 of the
Company Disclosure Schedule, which insurance is in full force and effect.
Seller has not received any written notice of cancellation or non-renewal of,
any of its insurance policies. The Company has timely filed all Claims for
which it is seeking payment or other coverage under any of Seller's insurance
policies. As of the date of the Agreement, the Company has not made any Claim
against an insurance policy as to which the insurer is denying coverage or
defending the Claim under a reservation of rights. There is no Claim that,
individually or in the aggregate with other Claims, would reasonably be
expected to materially impair any current or historical limits of insurance
available to the Company. To the Knowledge of the Company, no Event has
occurred which would reasonably be expected to give rise to any Claim under
the Company's insurance policies.

Section 5.24 Bank Accounts; Powers of Attorney. Section 5.24 of the Company
Disclosure Schedule sets forth a true and complete list of (a) all bank
accounts or safe deposit boxes under the control or for the benefit of the
Company, (b) the names of all Persons authorized to draw on or have access to
such accounts and safe deposit boxes and (c) all outstanding powers of
attorney or similar authorizations granted by the Company or Seller. 

Section 5.25 Customers and Suppliers.

(a)Section 5.25(a) of the Company Disclosure Schedule sets forth a true and
complete list of the ten (10) largest customers of the Company, determined by
dollar volume of sales, for each of the twelve (12) months ended December 31,
2015 and December 31, 2016, and for the period commencing on January 1, 2017
and ending on August 31, 2017 (collectively, the "Top Customers").

(b)Section 5.25(b) of the Company Disclosure Schedule sets forth a true and
complete list of the ten (10) largest suppliers of the Company, determined by
dollar volume of purchases, for each of the twelve (12) months ended December
31, 2015 and December 31, 2016, and for the period commencing on January 1,
2017 and ending on August 31, 2017 (collectively, the "Top Suppliers").

(c)During the last twelve (12) months, there has been no termination,
cancellation or threatened in writing termination or cancellation of or
limitation of, or any material modification or change in the business
relationship between the Company and any of the Top Customers or Top
Suppliers, as applicable. There is no outstanding material dispute with any
Top Customer or Top Supplier. To the Knowledge of the Company, (i) no Top
Customer or Top Supplier, prior to or as a result of the Closing or otherwise,
has threatened to cease to contract with the Company or (ii) has threatened to
substantially reduce its business or otherwise materially change the terms of
its relationship with the Company.

Section 5.26 No Brokers. None of the Company, or any of the Company's
Employees or Representatives, has employed or incurred any Liability to any
broker, finder or agent for any brokerage fees, finder's fees, commissions or
other amounts with respect to this Agreement, the Ancillary Documents or the
transactions contemplated hereby or thereby.

Section 5.27 Product Warranties; Product Liabilities.

(a)Each Product and Service has been in compliance in all material respects
with any applicable Law, applicable government, trade association and other
mandatory requirements and specifications, contractual commitments,
guarantees, express and, to the extent not specifically disclaimed, implied,
warranties, and the Company has no material Liability or material obligations
for damages in connection therewith.

(b)There is no material Claim pending or, to the Knowledge of the Company,
threatened in connection with any product liability arising in connection with
the Products and Services, and no Governmental Authority has commenced, or, to
the Knowledge of the Company, threatened to initiate any Litigation or
requested the recall of any Products and Services, or commenced, or, to the
Knowledge of the Company, threatened to initiate any Litigation to enjoin the
manufacture, fabrication or development of any of the Products and Services.

Section 5.28 Accounts Receivable. All accounts receivable reflected on the
Most Recent Unaudited Financial Statements represent bona fide, current and
valid obligations arising from sales actually made or services actually
performed in the ordinary course of business, subject to any 

reserves adequately reflected in the Most Recent Unaudited Financial
Statements. Since the date of the Most Recent Unaudited Financial Statements,
the Company has not received written notice from any obligor of any account
receivable that such obligor is refusing to pay or contesting payment.

Section 5.29 Limitation of Seller's Warranties. Buyer acknowledges that,
except as expressly provided in this Agreement, any Ancillary Document or any
certificate delivered by or on behalf of Seller or the Company hereunder, no
representation or warranty has been made regarding the Business, the Company
or its assets, whether written or oral, or materials provided or made
available by Seller or any of its Representatives, including (i) any other
information, documents or material made available to it or its Representatives
in connection with this Agreement and the Ancillary Documents or the
consummation of the transactions contemplated hereby or thereby, or (ii) any
financial estimate, forecast, projection or other prediction delivered to it.

Section 5.30 No Implied Representation. Seller and its Representatives and
Affiliates are making no representation or warranty whatsoever, express or
implied, beyond those expressly given in this Agreement, any Ancillary
Document or any certificate delivered by or on behalf of Seller or the Company
hereunder. It is understood that any financial estimate, forecast, projection
or other prediction and all other information or materials in respect of the
Business, the Company or its assets that have been or shall hereafter be
provided by or on behalf of Seller or the Company to Buyer or any of its
Affiliates or its or their respective Representatives, whether written or
oral, are not, and shall not be relied upon as or deemed to be,
representations and warranties of Seller, the Company, or any of their
respective Affiliates or Representatives, except to the extent expressly
provided in this Agreement, any Ancillary Document or any certificate
delivered by or on behalf of Seller or the Company hereunder.

ARTICLE VI.

Representations and Warranties of Buyer

Buyer represents and warrants to Seller as of the date hereof and as of the
Closing Date as follows:

Section 6.1 Organization and Power. Buyer is a corporation duly formed,
validly existing and in good standing under the Laws of Delaware and has full
power and authority to execute and deliver this Agreement and the Ancillary
Documents to which it is a party, to perform its obligations hereunder and
thereunder and to consummate the transactions contemplated hereby and thereby.

Section 6.2 Authorization. Buyer has duly authorized the execution and
delivery of this Agreement and the Ancillary Documents to which it is a party
and the performance of its obligations hereunder and thereunder.

Section 6.3 Enforceability. This Agreement and each of the Ancillary Documents
to be executed and delivered at the Closing by Buyer constitute, or when
executed and delivered will constitute, the valid and legally binding
agreements of Buyer, enforceable against Buyer in accordance with their terms,
subject to bankruptcy, insolvency, reorganization and any other Laws of
general applicability relating to or affecting creditors' rights and to
general equity principles, as applicable. 

Section 6.4 No Violation. The execution and the delivery by Buyer of this
Agreement and the Ancillary Documents, the performance by Buyer of its
obligations hereunder or thereunder, the consummation of the transactions
contemplated hereby and thereby that are required to be performed by Buyer and
compliance with the terms of this Agreement and the Ancillary Documents do not
and will not conflict with or violate (a) any provision of the certificate of
incorporation, bylaws or similar organizational documents of Buyer or (b) any
Law applicable to Buyer or by which its respective properties is bound or
affected, in any material respect, except, in the case of clause (b), for any
such conflict, violation, default, termination, forfeiture or other occurrence
which would not prevent or materially delay Buyer from performing its
obligations under this Agreement or the Ancillary Documents.

Section 6.5 Litigation. There is no Litigation pending or, to the Knowledge of
Buyer, threatened against Buyer that would reasonably be expected to prevent
or materially delay the ability of Buyer from carrying out its obligations
under this Agreement, the Ancillary Documents or the transactions contemplated
hereby or thereby. Buyer is not subject to any Order that would reasonably be
expected to materially affect the ability of Buyer to carry out its
obligations under this Agreement, the Ancillary Documents or the transactions
contemplated hereby or thereby.

Section 6.6 Governmental Authorizations and Consents. Other than as may be
required under the Competition Laws of the United States and Germany, no
Governmental Consent is required from any Person pursuant to applicable Law
(a) in connection with the transactions contemplated by this Agreement or any
Ancillary Documents, or (b) which is otherwise necessary to permit Buyer to
perform its obligations under this Agreement or the Ancillary Documents,
which, if not made or obtained, would prevent or materially delay Buyer from
performing its obligations hereunder or thereunder.

Section 6.7 Financial Capacity. Assuming (a) that the parties to the Debt
Commitment Letter (other than Buyer) perform their obligations in accordance
with the terms thereof and (b) satisfaction of the conditions precedent to
Buyer's obligations hereunder, Buyer shall have at the Closing sufficient
cash, available lines of credit or other sources of immediately available
funds to make payment of all amounts to be paid by it hereunder on and after
the Closing Date. Buyer has provided to the Company a true and complete copy
of the fully executed commitment letter, dated as of September 18, 2017,
between the Financing Sources party thereto and Buyer (and including any
lenders who become party thereto by joinder in accordance with the terms of
such debt commitment letter, together with all exhibits, schedules, annexes
and, to the extent otherwise in accordance with the terms hereof, supplements
and amendments thereto, the "Debt Commitment Letter"), pursuant to which the
Financing Sources party thereto agreed to lend the amounts set forth therein
on the terms and subject to the conditions set forth therein (together with
any Alternate Financing) for the purpose of funding the transactions
contemplated by this Agreement. The Debt Commitment Letter has not been
amended or modified in a manner that could affect the satisfaction of the
conditions set forth in Section 8.4 hereof, and as of the date of this
Agreement the commitments contained in the Debt Commitment Letter have not
been withdrawn or rescinded in any respect. As of the date of this Agreement,
the Debt Commitment Letter is in full force and effect and constitutes the
legal, valid and binding obligation of Buyer and, to Buyer's knowledge, each
of the other parties thereto, except as may be limited by bankruptcy,
insolvency, reorganization and any 

other Laws of general applicability relating to or affecting creditors' rights
(including fraudulent conveyance laws) and by general equity principles, as
applicable. There are no conditions precedent or other contingencies related
to the funding of the full amount of the Financing, other than as expressly
set forth in the Debt Commitment Letter (including satisfaction of the
Marketing Period and changes effected pursuant to the "market flex" provisions
in the associated fee letter). Assuming the satisfaction of the conditions
precedent to Buyer's obligations hereunder, Buyer has no reason to believe
that it will not be able to satisfy any term or condition of closing of the
Financing that is required to be satisfied as a condition to the Financing, or
that the Financing will not be made available to Buyer on the Closing Date.

ARTICLE VII.

Covenants

Section 7.1 Conduct of the Company.

(a)During the period from the date of this Agreement through the earlier of
the termination of this Agreement in accordance with its terms, and the
Closing Date, except as (i) otherwise expressly contemplated by this
Agreement, (ii) otherwise consented to by Buyer, in writing or (iii) set forth
in Section 7.1 of the Company Disclosure Schedule, Seller shall cause the
Company to, and the Company shall (w) conduct its business and operations in
all material respects in the ordinary course of business consistent with past
practice, (x) use reasonable best efforts to maintain its assets and
properties and to preserve its current relationships with customers,
employees, suppliers and others having business dealings with it, and (y) use
reasonable best efforts to preserve the goodwill and ongoing operations of the
Business.

(b)Without limiting the generality of the foregoing, during the period from
the date of this Agreement through the earlier of the termination of this
Agreement in accordance with its terms, and the Closing Date, except as (i)
otherwise expressly contemplated by this Agreement or (ii) Buyer shall
otherwise expressly consent to in writing, Seller shall cause the Company not
to, and the Company shall not:

(i)declare, accrue, set aside or pay any non-cash dividend or make any other
cash or non-cash distribution in respect of any of its Equity Securities, and
shall not repurchase, redeem or otherwise reacquire any such Equity
Securities;

(ii)sell, issue, grant, authorize the issuance of, split, combine, redeem or
reclassify, or purchase or otherwise acquire any (x) Equity Securities of the
Company, (y) option or right to acquire any Equity Securities of the Company,
or (z) instrument convertible into or exchangeable for any Equity Securities
of the Company;

(iii)modify or amend any of the organizational documents of the Company;

(iv)amend, renew, terminate or waive any Material Contract or any provision
thereof, other than any amendment, renewal, termination or waiver in the
ordinary course of business consistent with past practice; 

(v)enter into any new Contract that would have been a Material Contract if it
had existed on the date hereof, except Contracts entered into in the ordinary
course of business consistent with past practice;

(vi)enter into any Contract that purports to limit, curtail or restrict the
kinds of businesses in which it or its existing or future Affiliates may
conduct their respective businesses, or the Persons with whom it or its
existing or future Affiliates can compete or to whom it or its existing or
future Affiliates can sell products or deliver services or the Person or class
of Persons it may solicit for employment (it being agreed and understood that
the Company shall not be prohibited from entering into any Contract that
purports to limit, curtail or restrict the Person or class of Persons that the
Company may solicit for employment to the extent that Buyer has expressly
provided its written consent for the Company to enter into such Contract
pursuant to any other sub-clause of this Section 7.1(b) or such Contract is
otherwise permitted pursuant to any other sub-clause of this Section 7.1(b));

(vii)acquire (x) by merging or consolidating with, or by purchasing Equity
Securities in or a substantial portion of the assets of, or in any other
manner, any Person or division thereof or (y) any assets that are material,
individually or in the aggregate, to the Company, except purchases of
inventory or equipment required for the Company to perform its obligations
pursuant to customer Contracts in the ordinary course of business consistent
with past practice;

(viii)adopt a plan or agreement of complete or partial liquidation,
dissolution, merger, consolidation, restructuring, recapitalization or other
material reorganization of the Company;

(ix)divest, sell, transfer, lease, license, pledge or otherwise dispose of, or
permit a Lien on any asset of the Company, other than the sales of products or
services or disposition of obsolete or worn-out equipment in the ordinary
course of business consistent with past practice;

(x)disclose any trade secret or Confidential Information to any Person other
than to Employees (but only current Employees) that are subject to
confidentiality or non-disclosure covenants protecting against further
disclosure, or sell, encumber, abandon or allow to lapse any Intellectual
Property;

(xi)change its fiscal year or its accounting policies or procedures except to
the extent required to conform with GAAP;

(xii)settle or compromise any pending or threatened Litigation in excess of
seventy-five thousand dollars ($75,000);

(xiii)subject to Section 7.1(b)(xiv), make any unplanned capital expenditure
with respect to the Company in excess of two hundred fifty thousand dollars
($250,000) in the aggregate; 

(xiv)fail to make any of the capital expenditures in connection with the
expansion of the Company's drug product capabilities, as reflected in Section
7.1(b)(xiv) of the Company Disclosure Schedule;

(xv)waive any right of the Company under the confidentiality provisions of any
Contract entered into with respect to the Business;

(xvi)(A) terminate or amend any Plan, Consultant Agreement or Employee
Agreement, (B) enter into or adopt any employee benefit plan, agreement or
arrangement that would have been a Plan, Consultant Agreement with expected
annual payments in excess of two hundred thousand dollars ($200,000) or
Employee Agreement if it had existed on the date hereof, (C) enter into or
adopt any employment or severance agreement that would have been an Employee
Agreement if it had existed on the date hereof, and (D) become party to,
establish, adopt, amend, enter, withdraw from, or terminate any collective
bargaining, labor, works counsel, or similar agreement or arrangement, in each
case, except to the extent required by Law or as expressly contemplated by
this Agreement;

(xvii)hire any new officer or employee (provided that the Company may (A) hire
up to twenty five (25) individuals to fill newly created positions within the
Company, each with annual total compensation of less than one hundred twenty-
five thousand dollars ($125,000) and (B) modify the position or title of any
existing officer or employee) or terminate the services of any existing
officer or employee other than for cause;

(xviii)increase the rate of annual or other compensation, commission
opportunities, bonus opportunities, or other direct or indirect remuneration
payable, or agree to pay, conditionally or otherwise, any bonus, incentive,
retention, change in control payment or other compensation, retirement,
welfare, fringe or severance benefit or vacation pay, to or in respect of any
Employee, Consultant, or other individual service provider, except (A) in
connection with across-the-board promotions or periodic reviews of employees
(but not directors or officers) with an annual base compensation less than
fifty thousand dollars ($50,000) in the ordinary course of business consistent
with past practice, (B) to the extent required by Law or the terms of any
Plan, Consultant Agreement or Employee Agreement or as otherwise disclosed in
Section 5.21(a) of the Company Disclosure Schedule, (C) to new employees hired
or engaged after the date of this Agreement as permitted pursuant to the
hiring plan referenced in clause (xvii) of this Section 7.1(b), and (D) the
discretionary bonuses set forth on Section 7.1(b)(xviii) of the Company
Disclosure Schedule, subject to the limitations set forth therein;

(xix)increase, fund, grant, accelerate the vesting of, or enhance any rights,
benefits or payments, fund benefits or make any material determinations under
any Plan (including taking any of the foregoing actions in respect of
payments);

(xx)loan or advance any money or any other property to any Employee,
Consultant, or other individual service provider;

(xxi)terminate Employees in such numbers as would trigger any Liability under
the WARN Act; 

(xxii)file or cause to be filed any Tax Return with respect to the Company,
amend any Tax Return, enter into any closing agreement, make, change or revoke
any Tax election, adopt or change any Tax method of accounting, change its Tax
year, settle or compromise any Tax audit, Litigation, other proceeding or
assessment, surrender any right to claim a refund of Taxes, agree to extend or
waive the statute of limitations in respect of any Taxes or assessment, or
take any other similar action relating to the filing of any Tax Return or the
payment of any Tax, or fail to perform, comply with or fulfill any obligation
or requirement under any Tax Incentive Agreement (including any requirement
relating to employment, wages or maintenance of operations);

(xxiii)abandon, disclaim, dedicate to the public, sell, assign or grant any
security interest in, to or under any Company Intellectual Property, Company
IT Asset or Company Intellectual Property Contract, including failing to
perform or cause to be performed all applicable filings, recordings and other
acts, or to pay or cause to be paid all required fees and Taxes, to maintain
and protect its interest in the Company Intellectual Property, Company IT
Assets and Company Intellectual Property Contracts;

(xxiv)grant to any Person any license with respect to any Company Intellectual
Property or Company IT Asset, except non-exclusive licenses granted in
connection with the sale or license of Company products in the ordinary course
of business consistent with past practice; or enter into any covenant not to
sue with respect to any Company Intellectual Property or Company IT Asset;

(xxv)jointly develop, create or invent any Intellectual Property with any
Person;

(xxvi)fail to invoice any customer or fail to pursue collection of any
accounts receivable from any customer, or accelerate the collection of,
discount or forgive any accounts receivable from any customer, delay the
payment of accounts payable or defer expenses or, except in the ordinary
course of business consistent with past practice, reduce inventories or
otherwise increase Company Cash; or

(xxvii) authorize, agree, resolve or consent to any of the foregoing.

Section 7.2 Certain Tax Matters.

(a)(i) Seller shall prepare or cause to be prepared, and timely file or caused
be timely filed, all Pre-Closing Tax Period Tax Returns of the Company
required to be filed prior to the Closing Date, and shall timely pay all Taxes
reflected as due with respect to such Tax Returns.

(ii)Seller shall prepare or cause to be prepared, at Seller\'s expense, all
Pre-Closing Tax Period Tax Returns of the Company required to be filed on or
after the Closing Date (each such Tax Return, a "Pre-Closing Return"). Seller
shall provide each Pre-Closing Return, (except for Pre-Closing Returns
relating to Indiana sales tax and payroll tax returns prepared and filed by
third parties), to Buyer for review and comment no later than twenty (20) days
before the due date of such Pre-Closing Return, and Seller shall consider in
good faith any written comments 

to such Pre-Closing Returns received from Buyer; provided, however, if Seller
shall fail to provide any such Tax Return to Buyer as set forth in this
Section 7.2(a)(ii), Buyer may prepare and file such Tax Return at Seller's
expense. If Seller and Buyer are unable to resolve any dispute regarding any
Pre-Closing Return ten (10) days after Seller submits such Tax Return to Buyer
in accordance with this Section 7.2(a)(ii), the dispute shall be resolved by
the Accounting Arbitrator in accordance with Section 3.3(c); provided,
however, that if such dispute remains unresolved by the due date of such Pre-
Closing Return, the Buyer may file such Pre-Closing Return reflecting the
Buyer\'s position and shall file an amendment to such Tax Return if the
Accounting Arbitrator subsequently determines that such amendment is required.
Buyer shall timely file all such Pre-Closing Returns as finally prepared
pursuant to this Section 7.2(a)(ii). Seller shall pay to Buyer an amount equal
to all Taxes of the Company reflected on any such Pre-Closing Return in excess
of the accrual for such Taxes included in the Closing Date Working Capital as
determined under Section 3.4 at least five (5) Business Days before the date
on which Buyer or the Company is required to pay such Taxes.

(iii)Buyer shall prepare and file, or cause to be prepared and filed, all Tax
Returns of the Company that relate to any Straddle Period and shall pay or
cause to be paid the Taxes reflected as due on such Tax Returns. Seller shall
pay to Buyer, no later than five (5) Business Days before such Taxes are due,
the Pre-Closing Date Share of any such Taxes in excess of the accrual for such
Taxes included in the Closing Date Working Capital as determined under Section
3.4. Buyer shall provide each such material Tax Return to Seller for review
and comment no later than twenty (20) before the due date of such Tax Return,
and Buyer shall consider in good faith any written comments to such Tax Return
received from Seller.

(b)Buyer and Seller shall cooperate fully, as and to the extent reasonably
requested by any party, in connection with (i) the filing of Tax Returns
pursuant to this Section 7.2, (ii) any other Tax Returns required to be filed
in connection with the transactions contemplated hereby (including required
filings under Section 6043 or Section 6043A of the Code or the Treasury
Regulations thereunder), and (iii) any Tax Contest. Such cooperation shall
include the retention and (upon the other party's request) the provision of
Business Records and information reasonably relevant to any such Tax Return or
Tax Contest and making Employees available on a mutually convenient basis to
provide additional information and explanation of any material provided
hereunder. Buyer and Seller shall (A) retain all Business Records with respect
to Tax matters pertinent to the Company and the Company's assets or
activities, as applicable, relating to any taxable period beginning before the
Closing Date until the expiration of the statute of limitations (and, to the
extent notified by Buyer or Seller, any extensions thereof) of the respective
taxable periods, and to abide by all record retention agreements entered into
with any Taxing Authority and (B) give the other party reasonable written
notice prior to transferring, destroying or discarding any such Business
Records and, if the other party so requests, Buyer or Seller, as the case may
be, shall allow the other party to take possession of such Business Records.
The Company and Seller acknowledge that no provision of this Agreement
requires Buyer to provide any party any right to access or review any Tax
Return or Tax work papers of Buyer or any Affiliate thereof (other than the
Company). 

(c)Asset Allocation.

(i)Within ninety (90) days after the Closing Date, Buyer shall prepare an
allocation (the "Asset Allocation") of the Closing Consideration Amount (and
all other amounts treated as consideration for the purchase of the assets of
the Company for U.S. federal income Tax purposes) among the assets of the
Company, in accordance with Section 1060 of the Code and the Treasury
Regulations promulgated thereunder, and any comparable provisions of state,
local or other Tax Law, and shall deliver the Asset Allocation to Seller.
Seller shall have twenty (20) days to provide comments in writing to Buyer,
which Buyer shall consider in good faith. Buyer and Seller shall negotiate in
good faith to finalize the Asset Allocation (unless Seller does not provide
any comment within such twenty-day period, in which case Buyer's determination
of the Asset Allocation shall be deemed final). If the parties agree to such
Asset Allocation, or it shall be deemed final pursuant to the prior sentence,
then Buyer, the Company, and Seller shall, unless required pursuant to a
determination within the meaning of Section 1313(a)(1) of the Code, (A) file
all Tax Returns (including IRS Form 8594) consistent with the Asset
Allocation, (B) not take any action inconsistent therewith upon any audit or
examination of any Tax Return or in any other filing or proceeding relating to
Taxes, and (C) cooperate in case of a challenge by a Taxing Authority to the
Asset Allocation; otherwise, the parties shall have no further obligation
under this Section 7.2(c), and each party shall make its own determination in
good faith of such allocation for financial and tax reporting purposes, which
determination, for the avoidance of doubt, shall not be binding on the other
party.

(ii)Buyer shall promptly revise the Asset Allocation to reflect (A)
adjustments to the Closing Consideration Amount pursuant to this Agreement
(including pursuant to Section 3.4), and (B) any payments of the Adjustment
Escrow Amount or the Subsequent Payment Amount.

(d)Seller shall be responsible for and shall pay any and all Transfer Taxes.
Seller shall timely prepare all necessary Tax Returns and other documentation
with respect to all such Transfer Taxes and shall provide a draft copy of such
Tax Returns and other documentation to Buyer at least ten (10) days prior to
the due date for such Tax Returns for Buyer's review and comment. Seller shall
timely file, or cause to be timely filed, all such Tax Returns, and Buyer
shall reasonably cooperate with Seller as may be necessary to effectuate such
filings, and, if required by applicable Law, Buyer will, and will cause its
Affiliates to, join in the execution of any such Tax Returns and other
documentation.

(e)All Tax sharing, indemnification or allocation agreements or similar
Contracts with respect to or involving the Company shall be terminated no
later than the Closing Date and, after the Closing Date, the Company shall not
be bound thereby or have any Liability thereunder. The Company and Seller
shall take all actions necessary to terminate such Contracts prior to Closing.

(f)Following the Closing, if Buyer receives a notice of any Tax Contest
involving the Taxes of the Company with respect to any Pre-Closing Tax Period,
Buyer shall notify Seller within ten (10) days, and Seller shall control, at
Seller's expense, such Tax Contest, to the extent relating to any Pre-Closing
Tax Period. Seller shall (i) keep Buyer reasonably informed with 

respect to such Tax Contest, (ii) consider in good faith Buyer's comments to
Seller regarding the conduct of or positions taken in such Tax Contest, and
(iii) with respect to any such Tax Contest that will result in an adverse
effect to Buyer or any of its Affiliates, not enter into any settlement or
compromise of such Tax Contest without the prior written consent of Buyer,
which consent shall not be unreasonably conditioned, delayed, or withheld

(g)Notwithstanding anything herein to the contrary, prior to the Closing, the
Company shall make all Tax payments, including all estimated Tax payments that
would be made in the ordinary course of business or be required by Law.

(h)Seller shall not make, or permit any of its Affiliates (including the
Company) to make, any election under Treasury Regulations ยง 301.7701-3 (or any
analogous or similar state or local Law or regulation), as a result of which
the Company would not be treated as an entity disregarded as separate from its
owner pursuant to Treasury Regulations ยง 301.7701-2(c)(2)(i) (or any analogous
or similar state or local Law or regulation).

(i)Notwithstanding anything herein to the contrary, Buyer, the Company and the
Escrow Agent may, upon prior written notice, deduct and withhold any required
Taxes from any payment to be made pursuant to this Agreement. To the extent
that any such amount is so withheld, such withheld amount shall be treated for
all purposes of this Agreement as having been delivered and paid to the Person
in respect of which such deduction and withholding was made.

(j)On the Closing Date, Seller shall deliver to Buyer an affidavit of non-
foreign status certified by Seller under penalties of perjury and dated as of
the Closing Date, in form and substance reasonably satisfactory to Buyer and
meeting the requirements of Treasury Regulations ยง 1.1445-2(b)(2).

(k)Following the Closing, Buyer shall indemnify, defend and hold Seller
harmless from any and all Losses, including, but not limited to, any refunds,
repayments or clawbacks of previously received incentive payments or other
amounts that any Seller Indemnitee may incur solely as a result of the
Company's failure to perform, comply with and fulfill all obligations and
requirements of the Company under any Tax Incentive Agreement (including
requirements relating to employment, wages or maintenance of operations)
required to be performed, complied with or fulfilled after the Closing in
order to maintain the incentives provided therein.

Section 7.3 Access to Information Prior to the Closing. During the period from
the date hereof through the earlier of the termination of this Agreement in
accordance with its terms and the Closing Date, the Company shall, and Seller
shall cause the Company to, give (a) Buyer and its authorized Representatives
and (b) the Financing Sources and their authorized Representatives, in each
case, reasonable access during regular business hours to all offices, Real
Property, and Business Records of the Company as Buyer or any of the Financing
Sources may reasonably request. With respect to any such access or visit, (i)
Buyer and its Representatives, and Financing Sources and their authorized
Representatives, shall in each case take such action as is deemed necessary in
the reasonable judgment of the Company and Seller to schedule such access or
visits through a designated officer of the Company and in such a way as to
avoid disrupting in any material respect the normal business of the Company
and (ii) the Company shall not be required to take any action 

that would constitute a waiver of the attorney-client or other privilege or to
disclose information that is deemed in the reasonable judgment of the Company
to be of a highly competitive and sensitive nature; provided, however, that
with respect to any information that the Company deems privileged or highly
competitive and sensitive in the case of clause (ii), Seller and Buyer shall
use reasonable best efforts to take, or cause to be taken, all such
alternative actions or things necessary, proper or advisable to make such
information available.

Section 7.4 Confidentiality.

(a)The Confidentiality Agreement is terminated as of the date hereof and is of
no further force or effect.

(b)During the period from the date hereof through the earlier of the
termination of this Agreement in accordance with its terms and the Closing
Date, Buyer shall, and shall cause its controlled Representatives to keep the
Confidential Information confidential and not disclose any of it to any Person
in any manner whatsoever; provided, however, that Buyer may (i) make any
disclosure of the Confidential Information to which Seller gives its prior
written consent, (ii) disclose any of such information to its respective
controlled Representatives who need to know such information and who are
advised of the confidentiality obligations that attach to the Confidential
Information (it being agreed that Buyer will be responsible for any violation
of the provisions of this Section 7.4(b) by any of its controlled
Representatives), and (iii) disclose that information which, on the advice of
counsel, is required to be disclosed by Law or pursuant to a demand of any
Governmental Authority (which requirement or demand shall not have been caused
by any act of Buyer or its controlled Representatives in violation of this
Agreement). Notwithstanding the foregoing, in the event that Buyer or any of
its controlled Representatives are required to or believe they are required by
Law to disclose any of the Confidential Information, such party shall, to the
extent legally permissible, provide Seller with prompt written notice of any
such requirement so that Seller may seek (at its cost and expense) a
protective order or other appropriate remedy and/or waive compliance with the
provisions of this Agreement; provided that, in the event that such protective
order or other appropriate remedy or waiver by Seller is not obtained or
granted, and Buyer or its controlled Representatives are nonetheless, on the
advice of counsel, required by Law to disclose Confidential Information, Buyer
or its controlled Representatives may disclose to, or as required by, the
applicable Governmental Authority, only that portion of the Confidential
Information that such counsel advises is legally required to be disclosed (and
any such disclosure shall be made only to such Persons to whom such counsel
advises such information is legally required to be disclosed); provided that
Buyer and its controlled Representatives exercise reasonable best efforts (at
their cost and expense) to preserve the confidentiality of the Confidential
Information, including by reasonably cooperating with Seller to obtain an
appropriate protective order or other reliable assurance that confidential
treatment will be accorded the Confidential Information.

(c)Following the Closing for a period of five (5) years, Seller shall, and
shall cause its Representatives to, (i) keep the Confidential Information
confidential and not disclose any of it to any Person in any manner
whatsoever, and (ii) not use the Confidential Information directly or
indirectly in any way detrimental to the Company or its Affiliates; provided,
however, that Seller may (A) make any disclosure of the Confidential
Information to which Buyer gives its prior written 

consent, (B) disclose any of such information to its Representatives who need
to know such information and who are advised of the confidentiality
obligations that attach to the Confidential Information (it being agreed that
Seller will be responsible for any violation of the provisions of this Section
7.4(c) by any of its Representatives), and (C) disclose that information
which, on the advice of its counsel, is required to be disclosed by Law or
pursuant to a demand of any Governmental Authority (which requirement or
demand shall not have been caused by any act of Seller or its Representatives
in violation of this Agreement). Notwithstanding the foregoing, in the event
that Seller or its Representatives are required to or believe they are
required by Law to disclose any of the Confidential Information, such party
shall, to the extent legally permissible, provide Buyer with prompt written
notice of any such requirement so that Buyer and the Company may seek (at
their cost and expense) a protective order or other appropriate remedy and/or
waive compliance with the provisions of this Agreement; provided that in the
event that such protective order or other appropriate remedy or waiver by
Buyer is not obtained or granted, and Seller or any of its Representatives is
nonetheless, on the advice of counsel, required by Law to disclose
Confidential Information, Seller or its applicable Representative (x) may
disclose to, or as required by, the applicable Governmental Authority only
that portion of the Confidential Information which such counsel advises is
legally required to be disclosed (and any such disclosure shall be made only
to such Persons to whom such counsel advises such information is legally
required to be disclosed); and (y) shall exercise reasonable best efforts (at
its cost and expense) to preserve the confidentiality of any such disclosed
Confidential Information, including by reasonably cooperating with Buyer and
the Company to obtain (at their cost and expense) an appropriate
confidentiality order or other reliable assurance that confidential treatment
will be accorded the Confidential Information.

Section 7.5 Public Announcements. The initial press releases regarding this
Agreement shall be made at such times and in such forms as Buyer and Seller
agree. Notwithstanding the foregoing, either of Buyer or Seller shall be
permitted to make any disclosure that may be required by Law or the rules or
regulations of any exchange to which it is subject; provided that the party
proposing to issue any press release or similar public announcement or
communication in compliance with any such disclosure obligations shall use
reasonable best efforts to consult in good faith with the other party before
doing so. Following the initial press releases, none of Buyer, the Company or
Seller or any of its or their respective Affiliates shall issue or make any
subsequent press release or public statement with respect to this Agreement or
the transactions contemplated hereby containing any substantive information in
addition to that previously permitted to be disclosed pursuant to this Section
7.5 without the prior written consent of Buyer and Seller, except as (a) may
be required by Law or the rules or regulations of any securities exchange to
which it is subject or (b) consistent with any previous internal or external
public disclosures regarding this Agreement and the transactions contemplated
hereby (including pursuant to any communications plan agreed to between Buyer
and Seller prior to such disclosure); provided that, in respect of clause (a),
the party proposing to issue any press release or similar public announcement
or communication in compliance with any such disclosure obligations shall use
reasonable best efforts to consult in good faith with the other party before
doing so. 

Section 7.6 Releases.

(a)Effective as of the Closing, Seller, on behalf of itself and its Affiliates
and each of its and their respective beneficiaries, co-trustees, successor
trustees, officers, directors, managers, employees, agents, successors and
assigns (the "Seller Releasing Parties"), hereby releases, acquits, and
forever discharges the Company and all of its successors and assigns, together
with all its present and former directors, officers, employees, agents and
Representatives (the "Company Released Parties"), from any and all Claims,
that such Seller Releasing Party ever had, has or may have against any of the
Company Released Parties for, upon, or by reason of any matter, transaction,
act, omission or thing whatsoever arising under or in connection with any of
the Company Released Parties, known or unknown, from the beginning of time
through and including the Closing Date, other than obligations or Claims
arising under or in connection with this Agreement or the Ancillary Documents.
Seller, on behalf of itself and the other Seller Releasing Parties,
understands the significance of this release of unknown Claims and waiver of
statutory protection against a release, on behalf of itself and the other
Seller Releasing Parties, of unknown Claims, and acknowledges and agrees that
this waiver is an essential and material term of this Agreement. Seller, on
behalf of itself and the other Seller Releasing Parties, acknowledges that
each Company Released Party will be relying on the waiver and release provided
in this Section 7.6 in connection with entering into this Agreement and that
this Section 7.6(a) is intended for the benefit of, and to grant third-party
beneficiary rights to each Company Released Party to enforce this Section
7.6(a).

(b)Effective as of the Closing, the Company, on behalf of itself and its
Affiliates and each of its and their respective beneficiaries, co-trustees,
successor trustees, officers, directors, managers, employees, agents,
successors and assigns (the "Company Releasing Parties"), hereby releases,
acquits, and forever discharges Seller and all of Seller's respective
successors and assigns, together with all its present and former directors,
officers, employees, agents and Representatives (the "Seller Released
Parties"), from any and all Claims, that such Company Releasing Party ever
had, has or may have against any of the Seller Released Parties for, upon, or
by reason of any matter, transaction, act, omission or thing whatsoever
arising under or in connection with any of the Seller Released Parties, known
or unknown, from the beginning of time through and including the Closing Date,
other than obligations or Claims arising under or in connection with this
Agreement or the Ancillary Documents. The Company, on behalf of itself and the
other Company Releasing Parties, understands the significance of this release
of unknown Claims and waiver of statutory protection against a release, on
behalf of itself and the other Company Releasing Parties, of unknown Claims,
and acknowledges and agrees that this waiver is an essential and material term
of this Agreement. The Company, on behalf of itself and the other Company
Releasing Parties, acknowledges that each Seller Released Party will be
relying on the waiver and release provided in this Section 7.6 in connection
with entering into this Agreement and that this Section 7.6(b) is intended for
the benefit of, and to grant third-party beneficiary rights to each Seller
Released Party to enforce this Section 7.6(b).

Section 7.7 Employee Matters.

(a)For a period of one (1) year following the Closing Date (or, if earlier,
until the date of termination of the relevant employee), Buyer shall, or shall
cause the Company to, 

provide to each individual who, immediately prior to the Closing, is an
employee of the Company and who continues in such capacity immediately
following the Closing (each, a "Continuing Employee"): (i) a total
compensation opportunity (including base salary or hourly wage rate, deferred
compensation and, to the extent applicable, cash incentive opportunity and/or
long-term incentive opportunity (including equity incentive awards)) that is
substantially comparable in the aggregate to the total compensation
opportunity (including base salary or hourly wage rate, deferred compensation
and, to the extent applicable, cash incentive opportunity and/or long-term
incentive opportunity), provided by the Company to the Continuing Employee
immediately prior to the Closing, (ii) medical and prescription drug plan
benefits that are at least substantially comparable, in the aggregate, to
those provided to the Continuing Employees by Seller or the Company
immediately prior to the Closing and (iii) all other employee benefits that
are at least substantially comparable, in the aggregate, to those provided to
similarly situated employees of Buyer (or a Subsidiary); provided that, if the
parties mutually agree in writing, in their respective sole discretions, to
extend the right of participation by such Continuing Employee in any coverage
available for such Continuing Employees under one or more Plans of Seller
immediately prior to Closing for a specified period following the Closing (the
"Coverage Transition Period"), continued participation by such Continuing
Employee in the coverage under such Plan shall satisfy this clause (iii) for
the Coverage Transition Period; and provided, further, that after Closing,
Buyer shall have no obligation to pay premiums under any universal life
policies owned by Employees. Buyer (or a Subsidiary thereof) shall provide
each Continuing Employee with credit for all periods of service with Seller,
the Company or any of their respective ERISA Affiliates under each Buyer Plan
in which such Continuing Employee is eligible to participate, except (x) for
any plan subject to Title IV of ERISA, any frozen or grandfathered Plan, or
any plan, program or policy providing retiree health or life benefits, and (y)
to the extent that such credit would result in a duplication of benefits with
respect to the same period of service.

(b)With respect to all Continuing Employees, Buyer shall, subject to Seller
providing Buyer with accurate and timely data, to the extent permitted by
ERISA: (i) waive or cause to be waived all limitations as to preexisting
conditions, exclusions and waiting periods with respect to participation and
coverage requirements applicable to such Continuing Employees under any new or
revised welfare benefit Plan maintained by Buyer, the Company or any of their
respective Affiliates (each such Plan, a "Buyer Plan") in which such
Continuing Employee is otherwise eligible to participate, except to the extent
that such conditions, exclusions or waiting periods would apply under the
Continuing Employee's then-existing coverage immediately prior to Closing, and
(ii) provide or cause to be provided each Continuing Employee with credit for
any co-payments, coinsurance and deductibles paid prior to the Closing in
satisfying any applicable deductible or out-of-pocket maximum requirements
under any Buyer Plan in which such Continuing Employee is eligible to
participate, except to the extent that the receipt of such credit would result
in a duplication of benefits with respect to the same period of service.
Effective no later than 11:59:59 p.m. on the day of Closing, Seller shall
amend each of its welfare benefit Plans as applicable to provide that the
Company shall no longer be a participating employer. Seller shall provide
COBRA Continuation Coverage under Code Section 4980B to all MandA Qualified
Beneficiaries, as defined in Treas. Reg. Section 54.5980B-9, QandA 4, under
Seller's plans. The Company or Seller shall pay all welfare benefit claims
incurred by Employees prior to 11:59:59 p.m. on the day of Closing, and Buyer
shall pay all welfare benefit claims incurred by Continuing Employees at or
after 11:59:59 p.m. on the 

day of Closing. Company or Seller shall prepare, distribute and file IRS Forms
1094 and 1095 required under the Affordable Care Act to report medical
coverage offered and provided to Company employees, spouses and dependents
during 2017, and Buyer shall prepare, distribute and file IRS Forms 1094 and
1095 required under the Affordable Care Act to report medical coverage offered
and provided to Company employees, spouses and dependents during 2018 and
later. Effective as of and contingent upon Closing, Buyer shall establish a
health flexible spending account plan and amend Buyer's existing flexible
benefit plan ("Flexible Benefit Plan"), as appropriate, to provide: (i)
general purpose and limited purpose health flexible spending accounts to
Continuing Employees, effective as of January 1, 2017; (ii) that Continuing
Employees who elected to participate in Seller's health or dependent care
flexible spending accounts during 2017 under Seller's existing cafeteria plan
("Cafeteria Plan") shall become participants in Buyer's health flexible
spending account plan and/or Flexible Benefit Plan, as appropriate, as of
January 1, 2017 at the level of coverage provided in Seller's Cafeteria Plan,
and (iii) for reimbursement of health care and/or dependent care expenses, as
appropriate, incurred by Continuing Employees at any time during 2017, up to
the amount of the Continuing Employees' 2017 salary reduction election,
reduced by amounts reimbursed prior to Closing by the Cafeteria Plan. Seller
or the Company, as applicable, shall take all actions necessary to provide
that no health care or dependent care claims will be processed by Seller's
Cafeteria Plan during the ten (10) day period immediately prior to the Closing
Date, and five (5) days prior to Closing Seller shall reconcile underspent and
overspent flexible spending accounts of Continuing Employees in its Cafeteria
Plan and transfer to Buyer the net amount, along with a breakdown by Employee
of the reconciliation. Amounts forfeited by Continuing Employees in Buyer's
flexible spending account plan and/or Flexible Benefit Plan, as appropriate,
at the end of the 2017 plan year shall be assets of Buyer.

(c)Seller and the Company shall, prior to the Closing Date, take such
corporate action as necessary to cause the Seller 401(k) Plan to be amended
such that the Company shall no longer be a participating employer in the
Seller 401(k) Plan, and the Continuing Employees will no longer be eligible to
participate in, make or receive contributions in (and make deferrals under)
the Seller 401(k) Plan as of the Closing Date (although, to the extent
permitted under the Seller 401(k) Plan, such Continuing Employees may maintain
their vested accounts under the Seller 401(k) Plan, make plan loan repayments
thereunder, direct the investment of their accounts and maintain such other
rights and privileges as are available thereunder), subject to the
consummation of the transactions contemplated by this Agreement, and provided
that, prior to the Closing Date and subject to the consummation of the
transactions contemplated by this Agreement, Buyer shall take, or cause to be
taken, all corporate action as is necessary, including amendments to the Buyer
401(k) Plan, to permit the Continuing Employees to be eligible to make salary
deferral contributions and otherwise participate in the Buyer 401(k) Plan as
soon as practicable following the Closing Date, and to roll any eligible
rollover distributions of pre-tax contributions (but excluding loans) over
into a 401(k) plan maintained by Buyer or any of its Affiliates (the "Buyer
401(k) Plan") following the Closing Date. Seller shall continue to sponsor the
Seller 401(k) Plan after Closing, and there shall be no transfer of assets or
liabilities from Seller 401(k) Plan to Buyer 401(k) Plan, except for elective
rollovers by individuals of eligible rollover distributions.

(d)Seller and the Company shall, prior to the Closing Date, take such
corporate action as necessary to cause Seller and the Company to vest all
benefits for Employees who 

participate in Seller's non-qualified deferred compensation plan (as set forth
on Section 5.21(a) of the Company Disclosure Schedule) ("Non-Qualified Plan")
and to cause the Non-Qualified Plan to be amended such that the Company shall
no longer be a participating employer, and the participating Employees will no
longer be eligible to participate in the Non-Qualified Plan as of the Closing
Date, subject to the consummation of the transactions contemplated by this
Agreement. After the Closing Date, Seller and Buyer shall cooperate to provide
that the benefits owed to each Employee who participates in the Non-Qualified
Plan be paid to such Employees from the Rabbi Trust pursuant to the terms set
forth in the Non-Qualified Plan and the Rabbi Trust shall be terminated once
all payments are made to the participating Employees.

(e)As soon as administratively practicable following the Closing, the Company
shall pay out to each Continuing Employee all accrued but unused vacation or
other paid time off accrued by the Continuing Employee from calendar years
ended prior to the Closing Date that cannot be used by the Employee under
Seller\'s policies with respect to vacation and other paid time off during the
calendar year in which the Closing Date occurs. In addition, each Continuing
Employee shall be eligible to use his or her Permitted Rollover PTO following
the Closing in accordance with Buyer's policies relating to vacation and other
paid time off; provided that each Continuing Employee who has not used all of
his or her Permitted Rollover PTO as of December 31, 2017 shall be permitted
to roll over the portion of the Permitted Rollover PTO that is unused as of
December 31, 2017 and be eligible to use such vacation or other paid time off
in calendar year 2018 in accordance with Buyer's policies relating to vacation
and other paid time off. For the avoidance of doubt, the Continuing Employee
shall not be permitted to roll over any of his or her Permitted Rollover PTO
that is unused as of December 31, 2018 and shall receive no consideration with
respect to such unused Permitted Rollover PTO.

(f)Without limiting the generality of this Section 7.7, nothing contained in
this Section 7.7, express or implied, is intended to confer upon any
individual (including Employees, retirees, or dependents or beneficiaries of
Employees or retirees) any right as a third-party beneficiary of this
Agreement and nothing herein shall be construed as an amendment to any Plan or
other compensation or benefit plan or arrangement for any purpose. Without
limiting the generality of the foregoing, nothing in this Agreement shall
obligate any of the parties or any of their respective Affiliates to (i)
maintain any particular Plan, or (ii) retain the employment or services or any
Employee, Consultant, or other service provider, or any other Person.

Section 7.8 Affiliate Arrangements. Except for the activities contemplated and
intended to be continued following the Closing through either the IVF Media
Supply Agreement or the Transition Services Agreement, on or prior to the
Closing, the Company shall terminate all Affiliate Arrangements in a manner
and on such terms that shall not subject the Company, Buyer or their
respective Affiliates to any ongoing obligations or require the Company to
make any termination or indemnity or other payments on or after the Closing
Date.

Section 7.9 Reasonable Best Efforts.

(a)Subject to the terms and conditions set forth herein and to applicable Law,
each of the parties shall cooperate and use its respective reasonable best
efforts to take, or cause to be taken, such appropriate action, and do, or
cause to be done, and assist and cooperate with the 

other parties in doing, such things necessary, proper or advisable to
consummate and make effective the transactions contemplated hereby, including
obtaining all necessary consents, registrations, notices, applications and
filings as required by any Governmental Authority or applicable Law or as
required by any Contract, lease or agreement, including those disclosed in
Section 5.4 and Section 5.5 of the Company Disclosure Schedule.

(b)As soon as reasonably practicable following the date hereof and pursuant to
the applicable requirements of the HSR Act, the parties shall cause to be
filed with the U.S. Federal Trade Commission ("FTC") and the Antitrust
Division of the U.S. Department of Justice ("DOJ") Notification and Report
Forms relating to the transactions contemplated hereby. In addition, as soon
as reasonably practicable following the date hereof and pursuant to the
Competition Laws of Germany, Buyer shall cause to be filed with the German
Federal Cartel Office such notifications relating to the transactions
contemplated hereby. Buyer and Seller each shall (a) promptly supply the other
party with any information which may be required in order to effectuate such
filings and (b) respond as promptly as practicable to any inquiry received
from FTC, DOJ, or any other Governmental Authority for additional information
or documentation. Each of Buyer and Seller shall (i) promptly notify the other
party of any material communication between that party and FTC, DOJ, or any
other Governmental Authority and, subject to applicable Law, discuss with and
permit the other party to review in advance any proposed written communication
to any of the foregoing; (ii) consult with the other party in advance of
participating in any meeting or discussion with FTC, DOJ, or any other
Governmental Authority with respect to any filing, investigation or inquiry
concerning the transactions contemplated hereby and, to the extent permitted
by such Governmental Authority, give the other party the opportunity to attend
and participate thereat; and (iii) subject to applicable Law, furnish the
other party with copies of all written correspondence and communications
between it or its Affiliates and their respective Representatives and any
Governmental Authority with respect to the transactions contemplated by this
Agreement; provided, however, that materials provided to the other party
pursuant to this Section 7.9(b) may be redacted (x) to remove references
concerning valuation or future plans for the Business, (y) as necessary to
comply with contractual obligations of confidentiality and (z) as necessary to
address reasonable privilege concerns; provided, further, that the parties
may, as they deem advisable, designate any competitively sensitive materials
provided to the other under this Section 7.9 or any other section of this
Agreement as "outside counsel only." Such materials and the information
contained therein shall be given only to outside counsel for the recipient and
will not be disclosed by such outside counsel to employees, officers, or
directors of the recipient without the prior written consent of the party
providing such materials. Subject to Section 7.9(c) and upon the terms and
conditions set forth herein, each of the parties shall use reasonable best
efforts to take, or cause to be taken, such actions and to do, or cause to be
done, and to assist and cooperate with the other parties in doing, such
things, necessary, proper or advisable to make effective the transactions
contemplated hereby, including obtaining confirmation of the expiration or
termination of any applicable waiting periods under the HSR Act, clearance
from the German Federal Cartel Office and approvals, if any, from the
Governmental Authorities set forth in Section 5.5 of the Company Disclosure
Schedule, resolving any investigation or other inquiry of any Governmental
Authority, providing supplemental information requested by a Governmental
Authority, avoiding any suit, Claim, action, investigation or proceeding of
any Governmental Authority arising from its review of the transactions
contemplated hereby and defending any suit, Claim, action or proceeding
initiated by any 

Governmental Authority under applicable Competition Laws for the purpose of
preventing the consummation of the of the transactions contemplated hereby.
Buyer shall be responsible for paying all filing fees required to complete the
merger filings under the Competition Laws of the United States and Germany (or
as otherwise required in accordance with this Section 7.9(b)) in connection
with the transactions contemplated hereby.

(c)Notwithstanding anything herein to the contrary, nothing contained in this
Agreement shall require or obligate Buyer or any of its Affiliates to, and
neither the Company nor Seller shall, without the prior written consent of
Buyer: (i) commence any Litigation with any Governmental Authority or third
party; (ii) commit, agree or otherwise become subject to any restriction,
condition, limitation or other understanding on or with respect to the
operation of the business of Buyer or any of its Affiliates or the business of
the Company; (iii) agree or otherwise be required to license, sell or
otherwise dispose of, hold separate (through the establishment of a trust or
otherwise), or divest itself of any business, assets or operations of Buyer or
any of its Affiliates or the business of the Company; or (iv) pay or commit to
pay any material amount of cash or other consideration, or incur or commit to
incur any material Liability or other obligation, in connection with obtaining
any authorization, consent, Order, registration or approval.

Section 7.10 Non-Competition and Employee Non-Solicit.

(a)For a period of five (5) years in the U.S. and the rest of the world (other
than the European Union), and a period of three (3) years in the European
Union, from and after the Closing Date anywhere in the world (the
"Territory"), neither Seller nor any of its Affiliates shall, directly or
indirectly, engage in, own, have any financial interest in, manage or operate
anywhere in the Territory, a business the same as, substantially similar to,
or which materially competes with, the Business by providing contract
manufacturing and development services with respect to the formulation,
manufacture, fill/finish and packaging of drug substances and drug products;
provided, however, that the beneficial ownership (within the meaning of
Section 13(d) of the Securities Exchange Act of 1934) of less than two percent
(2%) of the outstanding shares of common stock of a publicly held corporation
that is engaged in the Business within the Territory shall be permitted.

(b)Notwithstanding anything in Section 7.10(a) to the contrary, Buyer and
Seller agree that (i) the provisions of Section 7.10(a) shall not apply to the
formulation, manufacture, fill/finish, packaging, marketing, distribution or
sale of in vitro fertilization media and (ii) Seller and its Affiliates shall
be permitted to engage in (A) any business (other than the Business) that
Seller or its Affiliates were engaged in as of the date hereof, and (B) IVF
media, cell therapies, gene therapies, including cell
transfection/transduction, vector manufacturing, media supplements, cell-
conditioned media and veterinary products.

(c)Commencing on the date hereof and continuing for a period of three (3)
years from and after the Closing Date anywhere in the Territory, neither
Seller nor any of its Affiliates shall, directly or indirectly, solicit for
employment or employ any then-current Employee involved in the Business of the
Company or request, induce or advise any then-current Employee thereof to
leave the employ of the Company, without the prior written consent of Buyer;
provided that a general offer of employment to the public, with respect to any
non-competing business, shall not be deemed prohibited hereunder as long as
not specifically directed at any then-current Employee of the 

Company. Commencing on the date hereof and continuing for a period of three
(3) years from and after the Closing Date anywhere in the Territory, neither
Buyer nor any of its Affiliates shall, directly or indirectly, solicit for
employment or employ any current employee, officer, director or manager of
Seller or request, induce or advise any current employee, officer, director or
manager thereof to leave the employ of Seller, without the prior written
consent of Seller; provided that a general offer of employment to the public,
with respect to any non-competing business, shall not be deemed prohibited
hereunder as long as not specifically directed at any then-current employee,
officer, director or manager of Seller.

(d)The nature and scope of the foregoing protection has been carefully
considered by Buyer and Seller. Seller acknowledges and agrees that the
covenants contained in this Section 7.10 are essential elements of this
Agreement and that but for these covenants, Buyer would not have agreed to
acquire the Company Interests or otherwise become party to this Agreement.
Buyer and Seller hereby agree and acknowledge that the duration, scope and
geographic areas applicable to such provisions are fair, reasonable and
necessary and that adequate compensation has been received by Seller for such
obligations. If, however, for any reason any court determines that any such
restrictions are not reasonable or that consideration is inadequate, such
restrictions shall be interpreted, modified or rewritten to include as much of
the duration, scope and geographic area identified in this Section 7.10 as
will render such restrictions valid and enforceable, and the other provisions
hereof shall remain in full force and effect.

(e)Notwithstanding anything herein to the contrary, in the event of a breach
or threatened breach of this Section 7.10, Buyer shall be entitled, without
the posting of a bond or other security, to seek an injunction restraining
such breach or threatened breach. The foregoing shall not be construed as
prohibiting any party from pursuing any other remedy available to it for such
breach or threatened breach.

Section 7.11 No Solicitation.

(a)The Exclusivity Agreement is terminated as of the date hereof and is of no
further force and effect.

(b)Between the date hereof and the Closing Date, neither the Company, Seller,
or any of its or their respective Affiliates, shall directly or indirectly
(including by way of providing information regarding the Company or the
Business to any Person or providing access to any Person), (i) solicit any
offer, proposal or inquiry (oral, written or electronic), or encourage or
facilitate the solicitation of any offer, proposal or inquiry (oral, written
or electronic) relating to any potential Competing Transaction, (ii)
participate in, continue or engage in any discussion or negotiation relating
to, furnish any information concerning the Company, or the Business or
properties of the Company, with respect to, afford access to its properties,
Business Records in connection with, or facilitate in any other manner any
effort or attempt by any Person other than Buyer to make or seek, any
potential Competing Transaction, or (iii) enter into any agreement,
arrangement or understanding (oral, written or electronic) relating to any
potential Competing Transaction. Seller shall promptly notify Buyer if any
such offer or inquiry is received by, any such information is requested from,
or any such negotiation or discussion is sought to be initiated or continued
with, the Company, Seller or any of their respective Representatives,
including the nature and terms of 

any of the foregoing, the identity of the parties involved and any
modification to the nature or terms relating to any potential Competing
Transaction. Seller shall, and shall cause the Company and its Affiliates to
advise their applicable officers, directors, shareholders and senior Employees
of the existence of the foregoing covenants, and Seller shall, and shall cause
the Company and its Affiliates to respond to any inquiry received by their
Representatives regarding any Competing Transaction by stating that the
Company, Seller and its and their Affiliates are subject to the foregoing
covenants.

Section 7.12 Termination of Guarantees of Indebtedness. At or prior to the
Closing, the Company shall, and Seller shall cause the Company to, terminate
any and all Guarantees of Indebtedness (and any and all Liens or security
interests on assets of the Company relating thereto), including pursuant to
the Guarantee Agreement, so that on and after the Closing, the Company shall
not have any obligation with respect to any such Guarantees of Indebtedness
(to include, without limitation, any Guarantees of Indebtedness on behalf of
Seller).

Section 7.13 Cooperation; Financial Information.

(a)Except as otherwise provided herein, Buyer shall use its reasonable best
efforts to arrange the Financing, maintain the Debt Commitment Letter in full
force and effect, and obtain the financing contemplated thereby as promptly as
reasonably practicable on the terms and conditions set forth in the Debt
Commitment Letter, including using its reasonable best efforts to (i) comply
with its obligations under the Debt Commitment Letter, (ii) as promptly as
practicable (taking into account the Marketing Period), negotiate, execute,
and deliver definitive agreements with respect to the Financing contemplated
by the Debt Commitment Letter on the terms and conditions contemplated
thereby, (iii) satisfy on a timely basis (taking into account the Marketing
Period) all conditions to funding that are applicable to Buyer in the Debt
Commitment Letter and (iv) subject to the satisfaction of the conditions set
forth in the Debt Commitment Letter and Section 8.4, and the completion of the
Marketing Period, consummate the Financing at or prior to the Closing Date. In
furtherance and not in limitation of the foregoing, in the event that any
portion of the Financing becomes unavailable on the terms and conditions set
forth in the Debt Commitment Letter or it becomes reasonably likely that it
would become so unavailable, Buyer shall as promptly as practicable following
the occurrence of such event, notify Seller thereof in writing and use its
reasonable best efforts to obtain (x) alternative financing from alternative
sources in an amount sufficient to consummate the transactions contemplated by
this Agreement that does not contain any condition to funding that would be
more onerous than those contained in the Debt Commitment Letter, as
applicable, on the date hereof or any terms that would reasonably be expected
to delay or impede the consummation of the debt financing thereunder beyond
the date set forth in Section 10.1(d) (taking into account the Marketing
Period) and that is on terms no less favorable, in the aggregate, to Buyer
than the Debt Commitment Letter as of the date of this Agreement (the
"Alternate Financing"), and (y) one or more new financing commitment letters
with respect to such Alternate Financing (each, a "New Commitment Letter"), in
each case, which New Commitment Letter(s) will replace the existing Debt
Commitment Letter in whole or in part. Buyer shall promptly provide the
Company with a true, correct, and complete copy of any New Commitment Letter,
together with any related exhibits, schedules, supplements, and term sheets,
and a true, correct, and complete copy of any fee letter in connection
therewith (it being understood that such letter will be redacted in a
customary manner and none of the redacted provisions would adversely affect
the 

availability of the Alternate Financing or allow the financing sources thereof
to reduce the amount of funding to be provided under the New Commitment Letter
or the definitive documentation of the credit facilities provided thereunder
or the conditions on which such funding is available). In the event that any
New Commitment Letter is obtained, (A) any reference in this Agreement to the
"Financing" or the "Debt Commitment Letter" shall mean the Debt Commitment
Letter to the extent not superseded at the time in question, and any New
Commitment Letter (and/or any related fee letter(s)) to the extent then in
effect, and (B) any reference in this Agreement to the "Financing" will mean
the Financing contemplated by the Debt Commitment Letter as modified pursuant
to the foregoing.

(b)Buyer will not consent to any amendment, restatement, replacement,
supplement, termination, assignment, or modification to be made to, or any
waiver of any provision (including any condition) or remedy under, the Debt
Commitment Letter without the prior written consent of Seller, to the extent
such amendment, restatement, replacement, supplement, termination, assignment,
modification, or waiver would individually or in the aggregate reasonably be
expected to (i) materially delay or prevent the Closing, (ii) make the funding
of the Financing (or satisfaction of the conditions to obtaining the
Financing) in each case necessary to consummate the transactions contemplated
hereby less likely in any material respect to occur at or prior to the
Closing, or (iii) adversely impact the ability of Buyer to in any material
respect timely consummate the transactions contemplated hereby; provided,
however, that Buyer may (A) amend the Debt Commitment Letter to add lenders,
lead arrangers, bookrunners, agents, syndication agents, documentation agents,
or similar entities who had not executed the Debt Commitment Letter as of the
date of this Agreement in accordance with the provisions hereof and of the
Debt Commitment Letter, (B) amend or otherwise modify the Debt Commitment
Letter to implement any flex provisions applicable thereto, or (C) otherwise
amend, modify or replace, or agree to any waivers in respect of, the Debt
Commitment Letter so long as, with respect to replacements, the replacement
debt commitments otherwise satisfy the terms and conditions of an Alternate
Financing, or such amended, modified, replaced or waived terms would not, or
would not reasonably be expected to, materially adversely impact or materially
delay the ability of Buyer to timely consummate the transactions contemplated
hereby when required.

(c)Each of Seller and the Company shall, and Seller shall cause its
Subsidiaries and its and their respective Representatives to, provide such
cooperation and assistance to Buyer in connection with the arrangement of the
Financing as may be reasonably requested by Buyer, including the following
actions:

(i)participating in a reasonable number of meetings with (including to
participate in a reasonable number of one-on-one meetings with) the Financing
Sources and prospective investors in the Financing (and to cause the members
of senior management and Representatives of the Company to participate in such
meetings), rating agency presentations, road shows, and due diligence
sessions, and cooperating reasonably with the marketing efforts of Buyer and
the Financing Sources, in connection with all or any portion of the Financing;

(ii)assisting Buyer and the Financing Sources in the preparation of rating
agency presentations, offering documents, bank information memoranda
(including a version 

thereof that does not contain material non-public information), business
projections and pro formas, lender and investor presentations, and other
similar materials for any bank or other debt or equity financing and similar
documents required in connection with any of the Financing, including to cause
the execution and delivery of reasonable and customary representation letters
in connection with the bank information memoranda;

(iii)furnishing to Buyer and the Financing Sources as promptly as reasonably
practical and, in all cases, in a timely manner, (A) (1) the Most Recent
Audited Financial Statements and audited consolidated balance sheets and the
related audited statements of income, shareholder's equity and cash flows of
the Company for each subsequent fiscal year ended at least ninety (90)
calendar days before the Closing Date, (2) the Most Recent Unaudited Financial
Statements and unaudited consolidated balance sheets and related statements of
income, stockholders' equity and cash flows of the Company for each subsequent
fiscal quarter (other than the fourth (4th) fiscal quarter of the Company's
fiscal year) ended at least forty-five (45) calendar days prior to the Closing
Date (including the comparable prior year period) and (3) such other financial
and operating information and data relating to the Company of the type
customarily included in, or required to be included in, a registered public
offering of securities by Buyer on Form S-1 (including information necessary
for Buyer's preparation of customary pro forma financial statements to be
included therein), and of the type, form and substance necessary for an
investment bank to receive customary comfort (including "negative assurance"
comfort) (including information required by Regulation S-X and Regulation S-K
under the Securities Act), including drafts of customary "comfort letters"
(including customary "negative assurances") for a private placement
transaction from the Company's independent auditors, reasonably requested by
Buyer and the Financing Sources in connection with the arrangement, marketing,
syndication of the financing contemplated by the Financing and (B) such other
financial or pertinent information regarding the Company as may be reasonably
available to the Company, and which is (1) reasonably requested by Buyer in
connection with the preparation of a confidential information memorandum and
offering documents customary for the type of financing contemplated by the
Debt Commitment Letter as in effect on the date hereof, and (2) reasonably
necessary in order to consummate the Financing, including in connection with
the preparation of customary pro forma financial information (excluding any
historical financial statements, which are addressed solely in clause (A)
above) (all of the foregoing, the "Required Information"), all of which is
Compliant;

(iv)cooperating reasonably with the Financing Sources' customary due
diligence;

(v)using reasonable best efforts to take such actions as are reasonably
requested by Buyer or the Financing Sources to facilitate the satisfaction of
the conditions set forth in the Debt Commitment Letter (including reasonably
facilitating the taking of collateral contemplated by the Debt Commitment
Letter) and the taking of corporate actions by the Company with respect to
entering into definitive documentation with respect to the Financing; provided
that any such corporate actions shall be contingent upon and effective as of
the Closing;

(vi)to the extent required in connection with the Financing, requesting the
Company's independent auditor to provide reasonable assistance to Buyer
consistent with 

customary practices (including to provide consent to Buyer to use audit
reports relating to the Most Recent Audited Financial Statements and, to the
extent applicable, any other audited financial statements delivered pursuant
to this Section 7.13, on customary terms in connection with the Financing,
participating in due diligence sessions with the Financing Sources and
requesting the provision to the Financing Sources of customary "comfort"
letters from such auditor prior to the Closing Date, which shall provide
customary "negative assurance" comfort);

(vii)executing and delivering, at and effective as of the Closing, such
definitive financing documents and other customary closing documents, as may
be reasonably requested by Buyer and are required in connection with the
Financing;

(viii)cooperating reasonably in connection with the termination of existing
Guarantees of Indebtedness (including obtaining required payoff letters and
delivering notices of termination within the time periods required thereby)
and the release of related encumbrances, if any, and Buyer's efforts to effect
the replacement or backing of any outstanding letter of credit maintained or
provided by the Company at and effective as of the Closing; and

(ix)at least four (4) Business Days prior to the end of the Marketing Period,
providing all documentation and other information required by regulatory
authorities under applicable "know your customer" and anti-money laundering
rules and regulations, including the USA PATRIOT Act, that has been requested
in writing at least eight (8) Business Days prior to the end of the Marketing
Period.

(d)Notwithstanding the requirements of Section 7.13(c), (i) the Company shall
not be required to enter into or approve (or commit to enter into or approve)
any certificate, document, agreement, instrument, or financing agreement, in
each case, which will be effective prior to the Closing Date (other than
customary representation letters, authorization letters and confirmations
(including with respect to the absence of the presence of material non-public
information), subject to customary exclusions), (ii) the Company shall not be
required to pay or commit to pay any commitment or other fee or incur any
other Liability (including any guarantee, indemnity, or pledge) in connection
with the Financing prior to the Closing Date, except that the Company shall be
required to pay any and all fees, costs, and expenses in connection with
obtaining any required approvals under the Guarantees of Indebtedness
permitting the termination thereof on the Closing Date and the release of all
Liens on properties and assets of the Company securing such obligations, if
any, and (iii) nothing herein will require the Company or any of its
Representatives to provide any information or take any action, the disclosure
or taking of which would violate applicable Law, any fiduciary duty, any
Contract, or obligation of confidentiality owing to a third party, or
jeopardize the protection of the attorney-client privilege (it being agreed
that the Company shall give notice to Buyer of the fact that it is withholding
such information or documents on the basis of any such Law, duty, Contract,
obligation or privilege, shall withhold only that portion of such information
that is reasonably necessary to be withheld to not violate applicable Law,
duty, Contract, or obligation and to preserve attorney-client privilege, and
thereafter the Company shall use its reasonable best efforts to cause such
information to be provided in a manner that would not reasonably be expected
to violate such Law, duty, Contract, or obligation or waive attorney-client
privilege). 

(e)Buyer will, upon request by Seller, reimburse Seller for all reasonable and
documented out-of-pocket costs and expenses (including reasonable attorneys'
fees and expenses) incurred by Seller or any of its Representatives in
connection with the Financing, including in connection with the cooperation of
Seller, the Company and any of their respective Representatives contemplated
by this Section 7.13.

(f)Buyer acknowledges and agrees that obtaining the Financing is not a
condition to Closing.

(g)The Company shall give Buyer notice if it becomes aware that the Required
Information taken as a whole is or becomes incorrect in any material respect.
The Company hereby consents to the use of its logos in connection with the
Financing; provided that such logos are used solely in a manner that does not
harm or disparage the Company or any of its Affiliates or their reputation or
goodwill. All non-public information regarding the Company and its Affiliates
provided to any of Buyer, the Financing Sources or their respective
Representatives pursuant to this Section 7.13 shall be kept confidential in
accordance with Section 7.4(b), except for disclosure to potential lenders and
investors and their respective Representatives that is reasonably required in
connection with the Financing or that is otherwise required to be disclosed by
the Buyer in connection with the Financing, subject to customary
confidentiality protections to the extent applicable.

Section 7.14 Title Matters. The Company agrees to reasonably cooperate with
Buyer, at Buyer's sole cost and expense, in connection with, and shall, if
requested by Buyer, provide to the Title Company a non-imputation affidavit
substantially in the form attached hereto as Exhibit C (the "Title
Affidavit"), and other customary title affidavits and instruments, in order to
assist Buyer in obtaining new title policies from the Title Company for the
Real Property; provided that such affidavits and instruments do not materially
increase the representations and warranties set forth herein. Notwithstanding
anything herein to the contrary, the Company (i) shall not, without the
written approval of Buyer, voluntarily encumber any of the Real Property with
any Liens, easements, restrictions or covenants, in each case, that are not
Permitted Liens, and (ii) shall, at Closing, remove any mechanics' liens or
other Liens that are not Permitted Liens or Liens caused by Buyer or its
Affiliates.

Section 7.15 Insurance. Prior to the Closing, the Company shall obtain,
effective as of the Closing Date and at Seller's sole cost and expense the
non-cancellable extension of the directors' and officers' liability coverage
of Seller's existing directors' and officers' insurance policies and fiduciary
liability insurance policies (collectively, the "DandO Insurance") covering
Persons who are currently or were officers and directors of, or in a
comparable role with, the Company (but not in the capacity of any role of such
Persons with Seller), for a Claims reporting or discovery period of not less
than six (6) years from and after the Closing with respect to any Claim
related to any period prior to the Closing from any insurance carrier with the
same or better credit rating as Seller's current insurance carrier with
respect to DandO Insurance with terms, conditions, retentions and limits of
liability that are substantially comparable with, in all material respects, or
more favorable to the insureds than the coverage provided under Seller's
existing policies. 

Section 7.16 Use of Seller Retained Names.

(a)On and after the date that is seventy-five (75) days following the Closing
Date, except as expressly provided in this Section 7.16 or any Ancillary
Document, none of Buyer or any of its Affiliates shall knowingly use Seller or
"Cook" names, marks, domain names and logos (the "Retained Names") in
connection with any business that Buyer or its Affiliates may thereafter
conduct.

(b)Within one hundred thirty-five (135) days following the Closing Date, Buyer
shall, and shall cause its Affiliates to, revise print advertising, product
labeling and all other information or other materials, including any internet
or other electronic communication vehicles, change signage and stationery, and
otherwise discontinue use of the Retained Names; provided, however, that
during such one hundred thirty-five (135) day period (the "Transition
Period"), Buyer or its Affiliates may continue to distribute product
literature that uses any Retained Names and distribute products with labeling
or packaging that uses any Retained Names to the extent that such product
literature and labeling or packaging exists on the Closing Date. Buyer and its
Affiliates shall only use the Retained Names after the Closing in a manner
consistent with the use of such Retained Names by the Company prior to the
Closing. For the avoidance of doubt, with respect to the Products and Services
of the Company, Buyer, or any third party acting on Buyer's behalf, may
continue to sell such Products and Services, notwithstanding that it or its
labeling or packaging bears one or more of the Retained Names, during the
Transition Period.

(c)Effective as of the Closing Date, Seller hereby grants to Buyer during the
Transition Period a worldwide, royalty-free, non-transferable, exclusive
license to use the following Internet domain names incorporating the Retained
Names: cookpharmica.com (the "Seller Domain") as a URL in connection with the
continued operation of the Internet and Intranet websites operated under that
URL prior to the Closing Date. Seller shall maintain the registrations for the
Seller Domain in full force and effect for the duration of the Transition
Period at Seller's sole cost and expense, unless directed otherwise by Buyer.

(d)Notwithstanding anything in this Section 7.16 to the contrary, Buyer and
its Affiliates may at all times after the Closing Date (i) retain and use, for
their internal business purposes, records and other historical or archived
documents containing or referencing the Retained Names; (ii) use the Retained
Names to the extent required by or permitted as a fair use or otherwise under
applicable Law, including for filing with a Governmental Authority or uses
that would not cause confusion as to the origin or sponsorship of a good or
service; and (iii) refer on their websites and in their advertising, marketing
and promotional materials to the historical fact that the Company previously
conducted the Business under the Retained Names, as applicable.

Section 7.17 280G Shareholder Vote. To the extent any individual may receive
any payment or benefit that individually or in the aggregate would be a
"parachute payment" under Section 280G of the Code in connection with the
transactions contemplated by this Agreement ("Parachute Payment"), the
Parachute Payment shall be contingent upon a vote of the stockholders of the
Company in the manner provided under Section 280G(b)(5)(B) of the Code and its
associated Treasury Regulations. To the extent that a Parachute Payment under
Section 280G of the Code is not approved by the stockholders of the Company as
contemplated above prior to the Closing, the 

payment shall not be made or provided in any manner. Prior to the Closing, the
Company shall deliver to Buyer evidence that a vote of the stockholders of the
Company was solicited in accordance with the foregoing provisions of this
Section 7.17 and that either (a) the requisite number of votes was obtained
with respect to the Parachute Payment and payment shall be made, or (b) the
approval was not obtained in whole or in part, and, as a consequence, to the
extent the Parachute Payment was not approved, it shall not be made or
provided.

Section 7.18 Discretionary Bonuses. Promptly following the Closing, Seller
shall fund, or cause to be funded, the discretionary bonuses granted by it to
the Continuing Employees in accordance with Section 7.1(b)(xviii), including
the employer portion of any payroll, employment or similar taxes payable in
connection therewith, and shall pay or cause to be paid such discretionary
bonuses through the transitional payroll services provided to the Company
pursuant to the Transition Services Agreement.

Section 7.19 Performance. Catalent, Inc. hereby guarantees to Seller the due
and punctual payment of the Subsequent Payment Amount by Buyer and shall be
directly liable to Seller with respect thereto.

ARTICLE VIII

Closing; Conditions to Closing

Section 8.1 Deliveries by Seller and the Company. At the Closing, the Company
and Seller shall deliver or cause to be delivered to Buyer:

(a)certificates representing all of the Company Interests, to the extent such
Company Interests are certificated, duly endorsed in blank, free and clear of
all Liens and any other instruments of transfer, duly endorsed in blank, and
to the extent not certificated, appropriate instruments of transfer, duly
endorsed in blank, in each case, in form and substance reasonably satisfactory
to Buyer;

(b)a pay-off letter or pay-off letters (such documents collectively, the "Pay-
Off Letters") duly executed by the holders of all Indebtedness (or their
respective agents) that remains unpaid as of immediately prior to the Closing
(including under the Parent Credit Agreement), indicating (i) the amounts
required in order to pay in full all such Indebtedness (including, for the
avoidance of doubt, all of the outstanding obligations guaranteed by the
Company in connection with the Parent Credit Agreement) (such amounts
collectively, the "Pay-Off Amount") and (ii) that upon payment of the Pay-off
Amount, all outstanding obligations of Seller or the Company, as applicable,
arising under or related to such Indebtedness (including in connection with
the Parent Credit Agreement) shall be repaid and extinguished in full and
that, if applicable, upon receipt of such payment, such Person shall release
its Liens and other security interests in, and agree to deliver UCC-3
termination statements and such other documents or endorsements necessary to
release of record its Liens and other security interest in, and the same shall
be terminated and of no further force and effect, the assets and properties of
the Company; 

(c)a duly executed amendment to the Note Purchase Agreement, effective as of
the Closing, evidencing release from the Guarantee Agreement, releasing any
Guarantees of Indebtedness in connection therewith;

(d)a copy of the IVF Media Supply Agreement, in the form of Exhibit D, duly
executed by the Company, Cook Medical LLC and William A. Cook PTY, LTD., and
effective immediately following the Closing;

(e)a copy of an agreement with respect to services that Seller or its
Affiliates will continue to provide to the Company, on the one hand, and any
services that the Company will provide to Seller or its Affiliates on the
other hand, in the form of Exhibit E, duly executed by Seller and the Company
and effective immediately following the Closing (the "Transition Services
Agreement");

(f)written resignations, dated as of the Closing Date, of the directors and
officers of the Company;

(g)a certificate of existence with respect to the Company issued by the
Secretary of State of the State of Indiana as of a date not more than two (2)
Business Days prior to the Closing Date;

(h)a receipt for the Closing Consideration Amount;

(i)a copy of the Escrow Agreement, duly executed by Seller and the Escrow
Agent;

(j)a copy of the resolutions of (i) the Company's sole managing member,
certified by the secretary of the Company as having been duly and validly
adopted and being in full force and effect, authorizing the execution and
delivery of this Agreement and the Ancillary Documents to which the Company is
a party and the performance by the Company of its obligations hereunder and
thereunder and (ii) the board of directors (or equivalent body) of Seller,
certified by an authorized signatory of Seller as having been duly and validly
adopted and being in full force and effect, authorizing the execution and
delivery of this Agreement and the Ancillary Documents and the performance by
Seller of its obligations hereunder and thereunder;

(k)an officer's certificate signed by a duly authorized officer of Seller,
dated as of the Closing Date, certifying the fulfillment of the conditions set
forth in Section 8.4(c), Section 8.4(d) and Section 8.4(e);

(l)the Title Affidavit, together with such customary title affidavits and
other instruments as may be reasonably necessary to facilitate Buyer's
procurement of title insurance policy with respect to the Real Property,
subject to Section 7.14;

(m)a copy of the DandO Insurance obtained by the Company, in form and substance
reasonably satisfactory to Buyer as set forth in Section 7.15;

(n)the affidavit required under Section 7.2(j) of this Agreement; and 

(o)such documents of further assurance reasonably necessary and typical for
transactions similar to the transactions being consummated at the Closing.

Section 8.2 Deliveries by Buyer. At the Closing, Buyer shall deliver or cause
to be delivered to Seller:

(a)the Closing Consideration Amount;

(b)a copy of the Escrow Agreement, duly executed by Buyer and the Escrow
Agent;

(c)an officer's certificate signed by a duly authorized officer of Buyer,
dated as of the Closing Date, certifying the fulfillment of the conditions set
forth in Section 8.3(c) and Section 8.3(d); and

(d)such documents of further assurance reasonably necessary and typical for
transactions similar to the transactions being consummated at the Closing.

Section 8.3 Conditions to Seller's Obligations. The obligations of Seller to
consummate the transactions contemplated hereby are subject to the fulfillment
at or prior to the Closing of each of the following conditions (any or all of
which may be waived in whole or in part by Seller):

(a)No Injunction. No Governmental Authority shall have enacted, issued,
promulgated, enforced or entered any legal proceeding or Order (whether
temporary, preliminary or permanent), in any case which is in effect and which
prevents or prohibits consummation of the transactions contemplated hereby.

(b)Antitrust Approvals. Any applicable waiting period under the HSR Act
relating to the transactions contemplated hereby shall have expired or been
terminated, and clearance relating to the transactions contemplated hereby
shall have been obtained from the German Federal Cartel Office, or any
applicable waiting period has expired.

(c)Representations and Warranties. The representations and warranties of Buyer
set forth in Section 6.1 (Organization and Power), Section 6.2 (Authorization)
and Section 6.3 (Enforceability) shall be true and correct in all respects, as
of the date hereof and as of the Closing Date, except that representations and
warranties made as of a specified date, shall be measured only as of such
specified date. Each of the other representations and warranties made by Buyer
contained in this Agreement or in any certificate or other writing delivered
by Buyer pursuant hereto shall be true and correct, without regard to any
qualifications as to "material", or "materiality" or "material adverse effect"
(or any correlative terms) contained in such representations and warranties,
as of the date hereof and as of the Closing Date, except (i) for
representations and warranties made as of a specified date, which shall be
measured only as of such specified date, and (ii) where the failure to be true
and correct, individually or in the aggregate, has not had, and would not
reasonably be expected to have, a material adverse effect on the ability of
Buyer to consummate the transactions contemplated hereby. 

(d)Performance. Buyer shall have performed and complied in all material
respects with all the terms, provisions and conditions of this Agreement to be
complied with and performed by Buyer at or prior to Closing.

(e)Deliveries. Seller shall have received the deliveries contemplated by
Section 8.2.

Section 8.4 Conditions to Buyer's Obligations. The obligations of Buyer to
consummate the transactions contemplated hereby are subject to the fulfillment
at or prior to the Closing of each of the following conditions (any or all of
which may be waived in whole or in part by Buyer).

(a)No Injunction. No Governmental Authority shall have enacted, issued,
promulgated, enforced or entered any legal proceeding or Order (whether
temporary, preliminary or permanent), in any case which is in effect and which
prevents or prohibits consummation of the transactions contemplated hereby.

(b)Antitrust Approvals. Any applicable waiting period under the HSR Act
relating to the transactions contemplated hereby shall have expired or been
terminated, and clearance relating to the transactions contemplated hereby
shall have been obtained from the German Federal Cartel Office, or any
applicable waiting period has expired.

(c)Representations and Warranties. (i) The representations and warranties of
Seller set forth in Section 4.1 (Organization and Power), Section 4.2
(Authorization and Enforceability), Section 4.6 (No Brokers), Section 5.1
(Organization and Power), Section 5.2 (Authorization and Enforceability),
Section 5.3 (Capitalization of the Company; No Subsidiaries) and Section 5.26
(No Brokers) (collectively, the "Fundamental Representations") shall be true
and correct in all respects, as of the date hereof and as of the Closing Date,
except those Fundamental Representations made as of a specified date, which
shall be measured only as of such specified date and (ii) each of the other
representations and warranties made by Seller contained in this Agreement or
in any certificate or other writing delivered by Seller pursuant hereto shall
be true and correct, without regard to any qualifications as to "material",
"materiality", or "Company Material Adverse Effect" (or any correlative terms)
contained in such representations and warranties, as of the date hereof and as
of the Closing Date, except (x) for representations and warranties made as of
a specified date, which shall be measured only as of such specified date, and
(y) where the failure to be true and correct, has not had, and would not
reasonably be expected to have, a Company Material Adverse Effect.

(d)Performance. Each of the Company and Seller shall have performed and
complied in all material respects with all the terms, provisions and
conditions of this Agreement to be complied with and performed by such party
at or prior to Closing.

(e)No Material Adverse Effect. Since December 31, 2016, there shall not have
been a Company Material Adverse Effect. 

(f)Consents and Approvals. All of the consents or notifications set forth in
Section 8.4(f) of the Company Disclosure Schedule shall have been obtained or
made at or prior to Closing.

(g)Deliveries. Buyer shall have received the deliveries contemplated by
Section 8.1.

ARTICLE IX

Survival; Indemnification

Section 9.1 Survival of Representations and Warranties. All of the
representations and warranties of the parties set forth in this Agreement
shall terminate and expire, and shall cease to be of any force or effect on
the date following the eighteen (18) month anniversary of the Closing Date,
and all Liability with respect to breaches of such representations and
warranties shall thereupon be extinguished (except to the extent a Claim with
respect thereto has been made prior to such time in which case such
representations and warranties shall survive until such Claim is resolved).
Notwithstanding the foregoing, the representations and warranties of Seller
set forth in (a) Section 5.20 (Employee and Labor Matters) and Section 5.21
(Employee Benefits), shall survive, and all Liability with respect to breaches
of such representations and warranties, shall continue in full force and
effect until the date following the three-year (3) anniversary of the Closing
Date, (b) Section 5.22 (Tax Matters), and all Liability with respect to
breaches of such representations and warranties, shall continue in full force
and effect until the date following ninety (90) days after all applicable
statutes of limitations, including waivers and extensions, have expired with
respect to the matters addressed therein and (c) the Fundamental
Representations, and all Liability with respect to breaches of such
representations and warranties, shall survive for a period of five (5) years,
in each case, except to the extent a Claim with respect thereto has been made
prior to such time in which case such representations and warranties shall
survive solely with respect to such Claim until such Claim is resolved.
Notwithstanding anything in this Article IX to the contrary, in the event that
any breach or alleged breach of any representation or warranty by (i) the
Company or Seller results from fraud or Willful Breach of the Company or
Seller, or (ii) Buyer results from fraud or Willful Breach of Buyer, then, in
each case, such representation or warranty shall survive the Closing and the
consummation of the transactions contemplated hereby and shall continue in
full force and effect without any time limitation with respect to such breach
or alleged breach.

Section 9.2 Indemnification by Seller. From and after the Closing, Seller
shall indemnify, defend and hold harmless Buyer, its Affiliates, and their
respective officers, directors, employees, shareholders, representatives,
successors and assigns (collectively, "Buyer Indemnitees") from and against
any and all Losses incurred by any of Buyer Indemnitees arising out of, in
connection with or relating to any: (a) inaccuracy in or breach of any
representation or warranty made by Seller in Section 5.21 (Employee Benefits),
(b) Company Transaction Expenses to the extent not taken into account in
reducing the Closing Consideration Amount, (c) Indebtedness to the extent not
taken into account in reducing the Closing Consideration Amount and (d) Seller
Taxes. Notwithstanding the foregoing, Seller shall not have any obligation to
indemnify, defend or hold harmless any Buyer Indemnitee for Losses arising out
of, in connection with or relating to any inaccuracy in or breach of any other
representation or warranty not expressly set forth in clause (a) of this
Section 9.2 or in the definition of Seller Taxes, regardless of the survival
or non-survival thereof. 

Section 9.3 Limitations on Indemnification Obligations.

(a)Seller shall not be required to indemnify Buyer Indemnitees with respect to
any Claim for indemnification arising out of, in connection with or relating
to matters described in Section 9.2 unless and until the aggregate amount of
all such Claims for such matters exceeds one-half percent (0.5%) of the
Purchase Price, in which event Buyer Indemnitees will be entitled to recover
all Losses in excess of such amount arising out of, in connection with or
relating to such matters.

(b)The aggregate amount required to be paid by Seller pursuant to Section 9.2
shall not exceed in the aggregate ten percent (10%) of the Purchase Price.

(c)For the purposes of determining any inaccuracy in or breach of, or the
amount of any Losses related to the inaccuracy in or breach of, any of the
representations or warranties as set forth in this Agreement, the
representations and warranties set forth in this Agreement shall be considered
without regard to any qualifications as to "material", "materiality" or
"Company Material Adverse Effect" (or any correlative terms) set forth
therein.

Section 9.4 Procedure with Respect to Direct Claims.

(a)If a Buyer Indemnitee shall have a Claim for indemnification hereunder
other than with respect to a Claim asserted by a third party, Buyer Indemnitee
shall, as promptly as is practicable, give written notice to the party from
whom indemnification is sought (i.e., Seller) (the "Indemnitor") of the nature
and, to the extent practicable, a good faith estimate of the amount, of the
Claim. The failure to make timely delivery of such written notice by Buyer
Indemnitee to the Indemnitor shall not relieve the Indemnitor from any
Liability under this Article IX with respect to such Claim, except to the
extent the Indemnitor is actually materially prejudiced.

(b)Within thirty (30) days after receipt of a claim notice, the Indemnitor
shall, by written notice to Buyer Indemnitee, either concede or deny Liability
for the Claim set forth in the claim notice. If the Indemnitor shall deny
Liability, in whole or in part, such written notice to Buyer Indemnitee shall
be accompanied by a reasonably detailed description of the basis for denial.
If the Indemnitor fails to deliver such written notice to Buyer Indemnitee by
5:00 P.M. (Eastern Time) on the last day of the thirty (30) day period, the
Indemnitor shall be deemed to have conceded the entire amount of the Claim
and, notwithstanding anything herein to the contrary, Buyer Indemnitee shall
be entitled to the entire amount of the Claim. If the Indemnitor denies
Liability for such Claim, in whole or in part, within thirty (30) days of
receipt by the Indemnitor of a claim notice, representatives of senior
management of the Indemnitor and Buyer Indemnitee with decision-making
authority with respect to the issues set forth in the claim notice shall meet
to discuss and attempt to resolve the matter prior to taking any formal action
with respect thereto. If Buyer and Seller fail to resolve the dispute within
thirty (30) days after Buyer Indemnitee received a written notice from the
Indemnitor denying the Claim, any party may commence appropriate legal
proceedings in order to obtain a final judgment of a court of competent
jurisdiction. 

Section 9.5 Procedure with Respect to Third Party Claims.

(a)If a Buyer Indemnitee receives notice of any matter involving a Claim
asserted by a third party that would give rise to an indemnification Claim
against the Indemnitor, then Buyer Indemnitee shall, as promptly as is
practicable, deliver to the Indemnitor a written notice describing, to the
extent practicable, such matter in reasonable detail. The failure to make
timely delivery of such written notice by Buyer Indemnitee to the Indemnitor
shall not relieve the Indemnitor from any Liability under this Article IX with
respect to such matter, except to the extent the Indemnitor is actually
materially prejudiced.

(b)The Indemnitor shall have the right, at its option, to assume the defense
of any such matter with its own counsel, but only if the Indemnitor
simultaneously agrees to fully indemnify Buyer Indemnitee for such matter.
Notwithstanding anything to the contrary contained in this Article IX, the
Indemnitor shall not have the option to assume the defense of any such third
party Claim (i) which seeks any remedy other than monetary damages, (ii) which
seeks monetary damages in an amount that exceeds the portion of the Subsequent
Payment Amount then remaining to be paid to Seller (less all then pending and
unpaid indemnification Claims) (iii) which Claim, or the assumption by the
Indemnitor of the defense of which Claim, Buyer Indemnitee reasonably
determines (A) could adversely affect the continuing business operations of
Buyer Indemnitee or any of its Affiliates or their relationships with
customers, clients, suppliers or other third parties with whom Buyer
Indemnitee or any of its Affiliates has a material business relationship, (B)
would reasonably pose significant legal, financial, regulatory or reputational
risk or exposure to Buyer Indemnitee or (C) is a Claim involving a criminal
matter or Litigation in which the third party is a Governmental Authority (in
which case Buyer Indemnitee shall have the right to control the defense of
such matter and the Indemnitor shall have the right to participate in the
defense of such matter at the Indemnitor's own cost and expense) or (iv) which
claim is covered by the RandW Insurance Policy and the Losses arising from or
relating to such Claim are in excess (or are reasonably likely to be in
excess) of the retention under such RandW Insurance Policy.

(c)If the Indemnitor is able to and elects to assume the defense of any such
matter, then:

(i)Buyer Indemnitee shall have the right to participate in the defense of such
matter and to employ its own counsel, at its own cost and expense, and the
Indemnitor shall not be required to pay or otherwise indemnify Buyer
Indemnitee against any attorneys' fees or other expenses incurred on behalf of
Buyer Indemnitee in connection with such matter following the Indemnitor's
election to assume the defense of such matter, unless (A) the Indemnitor fails
to defend diligently any Claim or Litigation within ten (10) days after
receiving notice of such failure from Buyer Indemnitee, (B) Buyer Indemnitee
reasonably shall have concluded (following consultation with its counsel) that
there may be one or more legal or equitable defenses available to such Buyer
Indemnitee or other Buyer Indemnitees that are not available to the
Indemnitor, or (C) Buyer Indemnitee reasonably shall have concluded (following
consultation with its counsel) that, with respect to such Claims, Buyer
Indemnitee and the Indemnitor may have different, conflicting, or adverse
legal positions or interests. 

(ii)The Indemnitor shall not, without the prior written consent of Buyer
Indemnitee, settle or compromise any pending or threatened Litigation in
respect of which indemnification may be sought hereunder (whether or not Buyer
Indemnitee is an actual or potential party to such Litigation) or consent to
the entry of any judgment (A) which does not, to the extent that Buyer
Indemnitee may have any Liability with respect to such Litigation, include as
an unconditional term thereof the delivery by the claimant or plaintiff to
Buyer Indemnitee of a written release of Buyer Indemnitee from all Liability
in respect of such Litigation, (B) which includes any statement or admission
of fact regarding culpability of, or a failure to act by or on behalf of,
Buyer Indemnitee, or (C) in any manner that involves any injunctive or non-
monetary relief against Buyer Indemnitee.

(d)If the Indemnitor is unable to or elects not to assume the defense of such
matter, or fails to notify Buyer Indemnitee of its election to assume the
defense of such matter, within thirty (30) days after receipt of written
notice of such matter, then Buyer Indemnitee shall proceed to defend such
matter and shall be entitled to be reimbursed on an ongoing basis by the
Indemnitor for all reasonable costs, expenses and fees incurred by Buyer
Indemnitee in the defense of such matter (including attorneys' fees and
expenses).

(e)Regardless of which party assumes the defense of such matter, the parties
shall cooperate with one another in connection therewith. Such cooperation
shall include making available all non-privileged Business Records and other
documents and materials that are relevant to the defense of such matter and
making employees, officers and advisors available to provide additional
information or to act as a witness or respond to legal process.

Section 9.6 Tax Matters. The parties shall treat any indemnity payment made
pursuant to this Article IX as an adjustment to the Purchase Price for all Tax
purposes, except as otherwise required by applicable Law. Notwithstanding
anything to the contrary contained in this Article IX, all procedures relating
to Tax Contests shall be governed exclusively by the provisions of Section
7.2(f).

Section 9.7 Calculation of Losses.

(a)The amount of any Losses payable under this Article IX by the Indemnitor
shall be net of any amount actually recovered by Buyer Indemnitee under
applicable insurance policies (net of any premium increase or other out-of-
pocket expense, including co-payments, incurred by such Buyer Indemnitee in
collecting such amount). If Buyer Indemnitee receives any amount under any
applicable insurance policy subsequent to an indemnification payment by the
Indemnitor, then such Buyer Indemnitee shall reimburse the Indemnitor for any
payment made or expense incurred by such Indemnitor in connection with
providing such indemnification payment (net of any premium increase or other
out-of-pocket expense, including co-payments, incurred by such Buyer
Indemnitee in collecting such amount). Buyer Indemnitees shall use reasonable
best efforts to mitigate Losses (other than Losses incurred by any Buyer
Indemnitee arising out of, in connection with or relating to any Seller Taxes)
upon and after becoming aware of any event which could reasonably be expected
to give rise to any such Losses that are indemnifiable hereunder. 

(b)Notwithstanding anything herein to the contrary, the Indemnitor shall not
be liable under this Article IX for any Losses relating to any matter to the
extent that (A) Buyer Indemnitee shall have otherwise been fully reimbursed
for such matter pursuant to, or the Loss was fully taken into account under,
any other provision of this Agreement, so as to avoid duplication or "double
counting" of the same Loss; or (B) without limiting the generality of clause
(A), such matter was taken into account by amounts paid pursuant to Section
3.3 after the final determination of the Final Purchase Price Adjustment
Statement.

Section 9.8 RandW Insurance Policy. Each party and its Representatives shall
reasonably cooperate with the insurer under the RandW Insurance Policy in
connection with the defense of any matter which might reasonably constitute a
Loss (as defined under the RandW Insurance Policy). The insurer under the RandW
Insurance Policy shall have the right to participate in the investigation,
defense and settlement of any Third Party Claim (as defined in the RandW
Insurance Policy) or other matter reasonably likely to be covered under the
RandW Insurance Policy.

ARTCILE X.

Termination

Section 10.1 Termination. This Agreement may be terminated and the
transactions contemplated hereby may be abandoned:

(a)at any time, by mutual written agreement of Buyer and Seller;

(b)by Buyer, at any time prior to the Closing, if (i) the Company or Seller is
in breach, in any material respect, of the representations, warranties or
covenants made by it in this Agreement, (ii) such breach is not cured within
ten (10) Business Days of written notice of such breach from Buyer (to the
extent such breach is curable) and (iii) such breach, if not cured, would
render the conditions set forth in Section 8.4 incapable of being satisfied;
provided, however, that Buyer shall not be entitled to terminate this
Agreement pursuant to this Section 10.1(b) if there has been a violation or
breach of this Agreement by Buyer that has prevented or would prevent
satisfaction of any conditions set forth in Section 8.3;

(c)by Seller, at any time prior to the Closing, if (i) Buyer is in breach, in
any material respect, of the representations, warranties or covenants made by
it in this Agreement, (ii) such breach is not cured within ten (10) Business
Days of written notice of such breach from Seller (to the extent such breach
is curable) and (iii) such breach, if not cured, would render the conditions
set forth in Section 8.3 incapable of being satisfied; provided, however, that
Seller shall not be entitled to terminate this Agreement pursuant to this
Section 10.1(c) if there has been a violation or breach of this Agreement by
the Company or Seller that has prevented or would prevent satisfaction of any
conditions set forth in Section 8.4;

(d)by Buyer or Seller, at any time after March 18, 2018 (the "End Date") if
the Closing shall not have occurred on or prior to such date; provided that
the right to terminate this Agreement under this Section 10.1(d) shall not be
available to such party if the action or inaction of such party or any of its
Affiliates has been a principal cause of or resulted in the failure of the 

Closing to occur on or before such date and such action or failure to act
constitutes a breach of this Agreement;

(e)by Buyer or Seller if any Governmental Authority shall have enacted,
issued, promulgated, enforced or entered any Law or Order, or refused to grant
any required consent or approval, that has the effect of making the
consummation of the transactions contemplated by this Agreement illegal or
that otherwise prohibits the consummation of transactions contemplated by this
Agreement and such Law, Order or other action shall have become final and non-
appealable; or

(f)by Seller if (i) the Marketing Period has ended and all the conditions set
forth in Section 8.3 and Section 8.4 have been, and continue to be, satisfied
or waived (other than those conditions that by their terms are to be satisfied
at the Closing, each of which shall be capable of being satisfied if the
Closing Date were the date that notice of termination is delivered by Seller
to Buyer), (ii) Buyer does not consummate the transactions contemplated by
this Agreement on or prior to the day the Closing is required to occur
pursuant to Section 2.1, (iii) Seller shall have irrevocably confirmed in
writing to Buyer that it is ready, willing and able to consummate the
transactions contemplated by this Agreement on the date of such confirmation
and throughout the five (5) Business Day period following delivery of such
confirmation and (iv) Buyer fails to effect the Closing by the earlier to
occur of (x) five (5) Business Days following the date on which the Closing
shall have occurred pursuant to Section 2.1 or (y) the End Date.

Section 10.2 Procedure Upon Termination. In the event of the termination of
this Agreement and the abandonment of the transactions contemplated hereby,
written notice thereof shall be given by a terminating party to the other
parties, and this Agreement shall terminate and the transactions contemplated
hereby shall be abandoned without further action by any of the parties.

Section 10.3 Effect of Termination. If this Agreement is validly terminated
pursuant to Section 10.1, then:

(a)Buyer on the one hand, and Seller on the other hand, shall promptly cause
to be returned to Seller or Buyer, as applicable, or cause the destruction of,
all documents and information, including Confidential Information, in whatever
format, obtained in connection with this Agreement and the transactions
contemplated hereby and all documents and information, in whatever format,
obtained by either party in connection with Buyer's investigation of the
Company, including any copies made by or supplied to Buyer, Seller or any of
their respective Representatives of any such documents or information.
Notwithstanding the foregoing, one copy of such documents or information may
be retained by each of Buyer and Seller's external legal counsel for
evidentiary purposes in the case of any legal proceedings or threatened legal
proceedings relating to this Agreement or any of the transactions contemplated
hereby; and each of Buyer and Seller need not delete from its electronic
archival systems any information archived in an integrated fashion with other,
unrelated information of Buyer or Seller, as applicable, as long as Buyer and
Seller make no effort to retrieve such archived information.

(b)No party shall have any duties or obligations to the other parties hereto
after the date of such termination and none of the parties will have any
further liability hereunder; 

provided, however, (i) except as provided in Section 10.5, no such termination
shall relieve any party from Liability for any fraud or Willful Breach by that
party, and (ii) Section 7.5, this Section 10.3, Section 10.4, Section 10.5 and
Article XI shall remain in full force and effect and survive any termination
of this Agreement (together with any corresponding defined terms) in
accordance with their respective terms. For purposes of this Agreement,
"Willful Breach" means a breach of any representation, warranty or covenant or
other agreement set forth in this Agreement that is a consequence of an act or
failure to act by the breaching party with the actual knowledge that the
taking of such act or failure to take such act would, or would reasonably be
expected to, be inconsistent with or contrary to the terms of this Agreement.

Section 10.4 Termination Fee.

(a)In the event (i) Seller terminates this Agreement as provided in Section
10.1(c) or Section 10.1(f), or (ii) Buyer or Seller terminates this Agreement
as provided in Section 10.1(d) or Section 10.1(e) (other than due to the
failure to receive clearance of the transactions contemplated by this
Agreement and the Ancillary Documents under the Competition Laws of the United
States or Germany or because a Governmental Authority has enacted, issued,
promulgated, enforced or entered a legal proceeding or Order pursuant to its
Competition Laws that is in effect and which prevents or prohibits the
consummation of the transactions contemplated hereby), Buyer shall, no later
than five (5) Business Days after the date of such termination, pay or cause
to be paid to Seller an amount equal to thirty-five million dollars
($35,000,000) (the "Termination Fee"), by wire transfer of immediately
available funds to an account or accounts designated in advance by Seller.

(b)Notwithstanding anything herein to the contrary, the parties agree that in
no event shall Buyer be required to pay the Termination Fee on more than one
occasion.

Section 10.5 Exclusive Remedy.

(a)From and after the date of this Agreement until the Closing, the sole and
exclusive remedy of each party in the event of a breach (including any Willful
Breach) of any representation, warranty, covenant or agreement set forth in
this Agreement by another party will be (i) termination of this Agreement in
accordance with Section 10.1 and pursuit of the post-termination remedies
permitted under Section 10.3 or Section 10.4 as applicable, or (ii) specific
performance in accordance with Section 11.11. Notwithstanding the foregoing,
in the event that this Agreement is terminated by Seller pursuant to Section
10.1(c) or Section 10.1(f) (or pursuant to any other provision of Section 10.1
under circumstances in which it was entitled to terminate this Agreement
pursuant to Section 10.1(c) or Section 10.1(f)), the right of Seller to
receive the Termination Fee pursuant to Section 10.4 shall be the sole and
exclusive remedy against Buyer, its Affiliates and their respective
Representatives for any Losses suffered by Seller, the Company and any of
their respective Affiliates or in connection with this Agreement and the
transactions contemplated by this Agreement, and no other amount shall be due
and payable by Buyer, its Affiliates and their respective Representatives as a
result thereof. For the avoidance of doubt, while Seller may seek specific
performance in accordance with Section 11.11 and payment of the Termination
Fee pursuant to Section 10.4, in no circumstance shall Seller be permitted or
entitled to receive (A) payment of monetary damages prior to the termination
of this Agreement or in amounts 

in excess of the Termination Fee, (B) payment of both monetary damages and the
Termination Fee or (C) both a grant of specific performance to cause the
consummation of the transactions contemplated by this Agreement and payment of
the Termination Fee or any monetary damages. In no event shall Seller be
entitled to seek the remedy of specific performance of this Agreement against
any Financing Sources in its or their capacity as a lender, purchaser,
underwriter or arranger in connection with the Financing.

(b)Notwithstanding anything in this Agreement to the contrary, in connection
with any Loss suffered as a result of any breach (including any Willful
Breach) of any representation, warranty, covenant or agreement in this
Agreement, the transactions contemplated hereby, the Financing, or in respect
of any oral representation made or alleged to have been made in connection
herewith, in each case, other than in a circumstance in which Seller is
permitted to terminate this Agreement and receive the Termination Fee pursuant
to Section 10.4, Seller agrees that the maximum aggregate Liability of Buyer
shall be limited to an amount equal to the amount of the Termination Fee, and
in no event shall Seller, the Company or their Affiliates seek to recover any
monetary damages in excess of such amount in the aggregate. In no event shall
Seller or the Company seek to recover monetary damages from any Person
(including the Financing Sources) other than Buyer in connection with the
transactions contemplated by this Agreement. The parties acknowledge that the
agreements contained in Section 10.3 and Section 10.4 and this Section 10.5
are an integral part of the transactions contemplated by this Agreement, and
that, without these agreements, the parties would not enter into this
Agreement.

(c)From and after the Closing, the right to indemnification under Article IX,
subject to all of the terms, conditions and limitations thereof, shall
constitute the sole and exclusive right and remedy available to Buyer against
Seller or any of its Affiliates for any breach of this Agreement, and Buyer
shall not initiate or maintain any lawsuit or other legal proceeding at law or
in equity against Seller which is directly or indirectly related to any breach
of this Agreement, except that Buyer may pursue legal or equitable relief
against Seller for any claim for fraud. Nothing in this Section 10.5(c) shall
preclude Buyer from seeking specific performance, injunctive or similar
equitable relief as provided in Section 11.11. For the avoidance of doubt, any
inaccuracy in or breach of any representation or warranty of Seller set forth
in this Agreement shall not, of itself, constitute fraud by Seller.

ARTICLE XI.

Miscellaneous

Section 11.1 Expenses. Except as otherwise provided herein, all fees and
expenses incurred in connection with this Agreement, the Ancillary Documents
and the transactions contemplated hereby and thereby shall be paid by the
party incurring such expenses, whether or not the transactions contemplated
hereby or thereby are consummated.

Section 11.2 Notices. All notices and other communications given or made
pursuant hereto shall be in writing and shall be deemed to have been duly
given or made (a) as of the date delivered, if delivered personally, (b) on
the date the delivering party receives confirmation of good transmission, if
delivered by facsimile or E-mail (in which case, it will be effective upon
receipt of confirmation of good transmission, excluding automatic
acknowledgements of receipt), or (c) as 

of the date delivered, if sent by overnight courier (providing proof of
delivery), to the parties at the following addresses (or at such other address
for a party as shall be specified in a notice given in accordance with this
Section 11.2):

If to Seller: Cook Group Incorporated

750 Daniels Way

Bloomington, Indiana 47404

Attn: General Counsel

Fax: (812) 339-5369

E-mail: cynthia.kretz@cookmedical.com



With a copy (which shall not constitute notice) to:

Ice Miller LLP

One American Square, Suite 2900

Indianapolis, Indiana 46282

Attn: Stephen J. Hackman

Fax: (317) 592-4666

E-mail: stephen.hackman@icemiller.com



If to Buyer: c/o Catalent, Inc.

14 Schoolhouse Road

Somerset, New Jersey 08873

Attn: General Counsel - Steven L. Fasman

Fax: 732.537.6490

E-mail: GenCouns@catalent.com



With a copy (which shall not constitute notice) to:

Fried, Frank, Harris, Shriver and Jacobson LLP

One New York Plaza

New York, New York 10004

Attn: Steven Epstein

Matthew V. Soran

Fax: 212.859.4000

E-mail: steven.epstein@friedfrank.com,

matthew.soran@friedfrank.com



Section 11.3 Governing Law. This Agreement and all controversies arising out
of, in connection with or relating to it shall be governed by, and construed
in accordance with, the Laws of the State of Delaware applicable to agreements
made and entirely to be performed within Delaware by its citizens, without
giving effect to any choice of law or conflict of law provision or rule
(whether of the State of Delaware or any other jurisdiction) that would cause
the application of the Law of 

any jurisdiction other than the State of Delaware, including all matters of
construction, validity and performance; provided that all claims or causes of
action (whether at law, in equity, in contract, in tort or otherwise) against
any of the Financing Sources in any way relating to the Financing or the
performance thereof shall be exclusively governed by, and construed in
accordance with, the Laws of the State of New York, without giving effect to
any choice of law or conflict of law provision or rule (whether of the State
of New York or any other jurisdiction) that would cause the application of the
laws of any jurisdiction other than the State of New York.

Section 11.4 Entire Agreement. This Agreement, together with the Exhibits
hereto, the Company Disclosure Schedule and the Ancillary Documents,
constitute the entire agreement between the parties concerning the subject
matter hereof and supersede all previous agreements, written or oral, relating
to the subject matter hereof.

Section 11.5 Severability. Should any provision of this Agreement or the
application thereof to any Person or circumstance be held invalid or
unenforceable to any extent: (a) such provision shall be ineffective to the
extent, and only to the extent, of such unenforceability or prohibition and
shall be enforced to the greatest extent permitted by Law, (b) such
unenforceability or prohibition in any jurisdiction shall not invalidate or
render unenforceable such provision as applied to other Persons or
circumstances or in any other jurisdiction, (c) such unenforceability or
prohibition shall not affect or invalidate any other provision of this
Agreement and (d) the parties shall negotiate in good faith to modify this
Agreement so as to effect the original intent of the parties as closely as
possible in a reasonable manner so that the transactions contemplated hereby
may be consummated as originally contemplated to the fullest extent possible.
Moreover, if any term or other provision of this Agreement shall be invalid,
illegal or incapable of being enforced by any rule of law or public policy
because it is excessively broad as to duration, scope, activity or subject,
the parties intend that such provision shall be deemed modified to the minimum
degree necessary to make such provision valid and enforceable under applicable
Law and that such modified provision shall thereafter be enforced to the
fullest extent permitted under applicable Law.

Section 11.6 Amendment. Neither this Agreement nor any of the terms hereof may
be terminated, amended, supplemented or modified orally, but only by an
instrument in writing signed by Buyer and Seller; provided that (i) the
observance of any provision of this Agreement may be waived in writing by the
party that will lose the benefit of such provision as a result of such waiver
and (ii) Section 7.6, Section 10.5, Section 11.3, this Section 11.6, Section
11.8, Section 11.10, and Section 11.14 (and any related definitions insofar as
they affect such Sections) may not be amended, supplemented, waived, or
otherwise modified in a manner adverse to the Financing Sources, in each case,
without the prior written consent of the Financing Sources (other than Non-
Party Affiliates).

Section 11.7 Effect of Waiver or Consent. At any time prior to the Closing,
any party may, (a) waive any inaccuracies in the representations and
warranties of any other party hereto, (b) extend the time for the performance
of any of the obligations or acts of any other party hereto or (c) unless
prohibited by applicable Law, waive compliance by any other party with any of
the agreements contained herein or, except as otherwise provided herein, waive
any of such party's conditions. Notwithstanding the foregoing, no failure or
delay by Seller or Buyer in exercising any right hereunder shall operate as a
waiver thereof nor shall any single or partial exercise thereof preclude 

any other or further exercise thereof or the exercise of any other right
hereunder. Any agreement on the part of a party hereto to any such extension
or waiver shall be valid only if set forth in an instrument in writing signed
on behalf of such party.

Section 11.8 Parties in Interest; Limitation on Rights of Others. The terms of
this Agreement shall be binding upon, and inure to the benefit of, the parties
hereto and their respective successors and assigns. Nothing in this Agreement,
whether express or implied, shall be construed to give any Person (other than
the parties hereto and their respective successors and assigns and as
expressly provided herein) any legal or equitable right, remedy or claim under
or in respect of this Agreement or any covenants, conditions or provisions
contained herein, as a third-party beneficiary or otherwise; provided that (i)
Buyer Indemnitees who are not otherwise a party to this Agreement shall be
express third-party beneficiaries of this Agreement, (ii) Company Released
Parties and Seller Released Parties who are not otherwise a party to this
Agreement shall be express third-party beneficiaries of Section 7.6 and (iii)
the Financing Sources shall be express third-party beneficiaries of Section
10.5, Section 11.3, Section 11.6, this Section 11.8, Section 11.10, and
Section 11.14, each of such Sections shall expressly inure to the benefit of
the Financing Sources and the Financing Sources shall be entitled to rely on
and enforce the provisions of such Sections.

Section 11.9 Assignability. This Agreement shall not be assigned by Seller
without the prior written consent of Buyer or by Buyer without the prior
written consent of Seller; provided that Buyer may assign all or any portion
of its rights and obligations under this Agreement without such consent to (a)
an Affiliate of Buyer, (b) any wholly owned U.S. Subsidiary of Buyer and/or
(c) any lender (or any agent or other representative thereof) under the Debt
Commitment Letter or any of Buyer's other financing arrangements as collateral
security for Buyer's obligations thereunder (including any refinancings,
extensions, refundings, or renewals thereof), in each case which assignment
shall not relieve Buyer of its obligations hereunder.

Section 11.10 Jurisdiction; Court Proceedings; Waiver of Jury Trial.

(a)Any Litigation against any party to this Agreement arising out of, in
connection with or relating to this Agreement shall be brought solely in the
U.S. District Court for the Southern District of Indiana (or, if the U.S.
District Court for the Southern District of Indiana declines to accept
jurisdiction over a particular matter, any state court sitting in
Indianapolis, Indiana) (the "Chosen Courts") and each of the parties submits
to the exclusive jurisdiction of the Chosen Courts for the purpose of any such
Litigation; provided that a final judgment in any such Litigation may be
enforced in other jurisdictions by suit on the judgment or in any other manner
provided by Law. Each party irrevocably and unconditionally agrees not to
assert any (i) objection that it may ever have to the laying of venue of any
such Litigation in either Chosen Court, (ii) Claim that any such Litigation
brought in either Chosen Court has been brought in an inconvenient forum and
(iii) Claim that either Chosen Court does not have personal jurisdiction over
such party with respect to such Litigation; provided that each of the parties
hereto agrees that they will not bring or support any action, cause of action,
claim, cross-claim or third party Claim of any kind or description, whether in
law or in equity, whether in contract or in tort or otherwise, against the
Financing Sources in any way relating to this Agreement or any of the
transactions contemplated by this Agreement, including any dispute arising out
of or relating in any way to the Financing (or any alternative or 

replacement financing) or the performance thereof, in any forum other than the
New York Supreme Court located in New York County or the United States
District Court for the Southern District of New York and the appellate courts
having jurisdiction of appeals in such courts.

(b)Each party agrees that service of process in any Litigation may be made by
mailing a copy thereof by registered or certified mail or by overnight courier
service, postage prepaid, to it at its address specified herein. Nothing in
this Agreement will affect the right of any party to serve process in any
other manner permitted by Law.

(c)EACH OF THE PARTIES TO THIS AGREEMENT HEREBY WAIVES, TO THE FULLEST EXTENT
PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY ACTION (I) ARISING UNDER
THIS AGREEMENT OR (II) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO
THE DEALINGS OF THE PARTIES OR ANY FINANCING SOURCE IN RESPECT OF THIS
AGREEMENT, ANY FINANCING, OR ANY OF THE TRANSACTIONS RELATED HERETO, IN EACH
CASE, WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER AT LAW OR IN
EQUITY, BASED IN CONTRACT OR IN TORT OR OTHERWISE. EACH PARTY HEREBY FURTHER
AGREES AND CONSENTS THAT ANY SUCH ACTION SHALL BE DECIDED BY COURT TRIAL
WITHOUT A JURY AND THAT THE PARTIES MAY FILE A COPY OF THIS AGREEMENT WITH ANY
COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES TO THE WAIVER OF THEIR
RIGHT TO TRIAL BY JURY.

Section 11.11 Remedies.

(a)Subject to Section 10.4, the parties agree that irreparable harm for which
monetary damages, even if available, would not be an adequate remedy in the
event that the parties hereto do not perform the provisions of this Agreement
(including failing to take such actions as are required of such party
hereunder to consummate the transactions contemplated by this Agreement) in
accordance with its specified terms or otherwise breach such provisions.
Accordingly, except as provided in Section 11.11(c), the parties hereto
acknowledge and agree that in the event of any breach or threatened breach by
Seller on the one hand, or Buyer, on the other hand, of any of their
respective covenants or obligations set forth in this Agreement, Buyer, on the
one hand, and Seller, on the other hand, shall be entitled to seek an
injunction, specific performance and other equitable relief to prevent
breaches of this Agreement and to enforce specifically the terms and
provisions hereof, in addition to any other remedy to which they are entitled
at law or in equity, subject to Section 10.4. Each of the parties hereto
agrees that it will not oppose the granting of an injunction, specific
performance or other equitable relief on the basis that any other party has an
adequate remedy at law or that any award of specific performance is not an
appropriate remedy for any reason at law or in equity, subject to Section 10.4
and Section 11.11(c). Subject to Section 11.11(c), each of the parties further
agrees that the only permitted objection that it may raise in response to any
action of equitable relief is that it contests the existence of a breach or
threatened breach of this Agreement. Any party seeking an injunction or
injunctions to prevent breaches of this Agreement and to enforce specifically
the terms and provisions of this Agreement shall not be required to provide
any bond or other security in connection with any such Order or injunction.
Except as 

provided in Section 10.4 or Section 11.11(c), the pursuit of an injunction,
specific performance or other equitable relief by any party hereto will not be
deemed a waiver of the right to pursue any other right or remedy (whether at
law or in equity) to which such party may be entitled at any time.

(b)Except as otherwise provided herein, any and all remedies herein expressly
conferred upon a party will be deemed cumulative with and not exclusive of any
other remedy conferred hereby, or by law or equity upon such party, and the
exercise by one party of any one remedy will not preclude the exercise at any
time of any other remedy.

(c)Notwithstanding anything herein to the contrary, it is explicitly agreed
that the right of Seller to obtain an injunction, or other appropriate form of
equitable relief to cause Buyer to complete the Closing shall be subject to
the following: (i) all conditions set forth in Section 8.4 have been satisfied
or waived (other than those conditions that by their terms are to be satisfied
at the Closing; provided that each of which shall be capable of being
satisfied if the Closing Date were on such date), (ii) the Financing has been
funded in full or would be funded in full at the Closing if the Closing were
to occur, (iii) Buyer has failed to complete the Closing in accordance with
Section 2.1 when required to do so hereunder and (iv) Seller has irrevocably
confirmed in writing that, if specific performance is granted and the
Financing is funded, then the Closing will occur pursuant to Section 2.1.

Section 11.12 Counterparts. This Agreement may be executed by facsimile
signatures and in any number of counterparts with the same effect as if all
signatory parties had signed the same document. All counterparts shall be
construed together and shall constitute one and the same instrument.

Section 11.13 Further Assurance. If at any time after the Closing any further
action is necessary or desirable to carry out the intent of this Agreement and
to fully effect the transactions contemplated by this Agreement or any other
of the Ancillary Documents, each of the parties shall take such further action
(including the execution and delivery of such further instruments and
documents) as any other party reasonably may request. Each party shall
cooperate affirmatively with the other parties, to the extent reasonably
requested by such other parties, to enforce the rights and obligations herein
provided.

Section 11.14 No Recourse to Financing Sources. Notwithstanding anything
herein to the contrary, each of Seller and the Company (each on behalf of
itself, its controlled Affiliates, its Subsidiaries and its and their
Employees and Representatives) acknowledges and agrees that it (and such other
Persons) shall have no recourse against the Financing Sources, and the
Financing Sources shall be subject to no Liability or Claims by Seller or the
Company (or such other Persons) in connection with any Financing or in any way
relating to this Agreement or any of the transactions contemplated hereby or
thereby, whether at law, in equity, in contract, in tort, or otherwise.

Section 11.15 Legal Representation. In the event any dispute arises following
Closing between Buyer or the Company, on the one hand, and Seller, on the
other hand, Ice Miller LLP may represent Seller even though the interests of
Seller may be directly adverse to Buyer or the Company, and notwithstanding
the prior representation of the Company by Ice Miller LLP. Buyer acknowledges
and agrees that as to all pre-Closing communications between or among Seller
and/ 

or the Company and their respective employees and agents, on the one hand, and
Ice Miller LLP, on the other hand, relating to the Transaction Documents or
the transactions contemplated thereby, the attorney-client privilege and the
expectation of client confidence belongs to and may be controlled by Seller,
and will not pass to or be claimed by Buyer or the Company. Notwithstanding
the foregoing, in the event that a dispute arises between Buyer or the
Company, on the one hand, and a third party (other than a party to this
Agreement), on the other hand, after the Closing, Buyer and the Company may
assert the attorney-client privilege to prevent disclosure of confidential
communications by Ice Miller LLP to such third party; provided, however, that
neither Buyer nor the Company may waive such privilege without the prior
written consent of the Seller.



(signature pages follow) 

IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be
duly executed and delivered in its name and on its behalf, as of the day and
year first above written.

BUYER:

CATALENT PHARMA SOLUTIONS, INC.

By: /s/ Matthew Walsh

Name: Matthew Walsh

Title: Executive Vice President, Chief Financial Officer





[Signature Page - Interest Purchase Agreement] 

CATALENT, INC., solely for purposes of Section 7.19

By: /s/ Matthew Walsh

Name: Matthew Walsh

Title: Executive Vice President, Chief Financial Officer





[Signature Page - Interest Purchase Agreement] 

SELLER:

COOK GROUP INCORPORATED

By: /s/ Pete Yonkman

Name: Pete Yonkman

Title: President





[Signature Page - Interest Purchase Agreement] 

The Company:

COOK PHARMICA LLC

By: /s/ Tedd M. Green

Name: Tedd M. Green

Title: President





[Signature Page - Interest Purchase Agreement]



\t    '

